Yearling	O
Brangus	O
×	O
Hereford	O
×	O
Angus	O
steers	O
fed	O
a	O
high	O
grain	O
diet	O
(	O
79	O
%	O
corn	O
)	O
had	O
more	O
growth	O
performance	O
,	O
greater	O
MS	O
,	O
and	O
higher	O
grade	O
meat	O
than	O
did	O
steers	O
fed	O
a	O
forage	O
diet	O
(	O
winter	O
wheat	O
pasture	O
with	O
sorghum	O
-	O
Sudan	O
and	O
Bermuda	O
grass	O
pasture	O
)	O
[	O
117	O
].	O

Concentrate	O
diets	O
are	O
generally	O
a	O
major	O
glucose	O
source	O
through	O
either	O
production	O
of	O
rumen	O
propionate	O
or	O
glucose	O
absorption	O
from	O
the	O
small	O
intestine	O
from	O
a	O
rumen	O
-	O
bypassed	O
concentrate	O
,	O
as	O
described	O
above	O
,	O
whereas	O
roughage	O
is	O
a	O
major	O
acetate	O
source	O
that	O
results	O
from	O
the	O
rumen	O
fermentation	O
process	O
.	O

This	O
experiment	O
was	O
performed	O
over	O
5	O
replicates	O
.	O

AA	O
exists	O
in	O
limited	O
levels	O
in	O
liver	O
,	O
meat	O
and	O
eggs	O
,	O
but	O
can	O
be	O
metabolized	O
in	O
humans	O
from	O
other	O
fatty	O
acids	O
in	O
the	O
omega	O
-	O
6	O
fatty	O
acid	O
family	O
.	O

Of	O
279	O
papers	O
sourced	O
,	O
eight	O
were	O
included	O
in	O
the	O
final	O
review	O
.	O

Tissue	O
sampling	O
included	O
offspring	O
of	O
these	O
sows	O
at	O
one	O
prenatal	O
(	O
94	O
dpc	O
)	O
and	O
three	O
postnatal	O
(	O
1	O
,	O
28	O
,	O
188	O
dpn	O
)	O
time	O
points	O
(	O
Figure3	O
).	O

Moreover	O
,	O
alcohol	O
consumption	O
has	O
been	O
shown	O
to	O
induce	O
higher	O
IgE	O
levels	O
against	O
aeroallergens	O
in	O
atopic	O
patients	O
[	O
76	O
].	O

We	O
made	O
initial	O
comparisons	O
of	O
time	O
-	O
to	O
-	O
an	O
-	O
episode	O
between	O
the	O
two	O
groups	O
with	O
log	O
-	O
rank	O
tests	O
and	O
Kaplan	O
–	O
Meier	O
plots	O
.	O

PubMed	O
Central	O
:	O

MTCs	O
,	O
like	O
other	O
neuroendocrine	O
tumours	O
,	O
can	O
express	O
somatostatin	O
receptors	O
.	O

However	O
,	O
contact	O
with	O
and	O
exposure	O
to	O
antigens	O
may	O
be	O
necessary	O
in	O
early	O
life	O
to	O
develop	O
tolerance	O
in	O
the	O
immune	O
system	O
[	O
118	O
].	O

A	O
53	O
%	O
decreased	O
risk	O
for	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
was	O
observed	O
with	O
high	O
(>	O
81	O
nmol	O
/	O
L	O
)	O
“	O
standardised	O
”	O
vitamin	O
D	O
status	O
when	O
compared	O
to	O
moderate	O
-	O
high	O
(	O
63	O
–	O
81	O
nmol	O
/	O
L	O
,	O
aRR	O
,	O
0	O
.	O
47	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
).	O

Van	O
Eijk	O
et	O
al	O
.	O

After	O
all	O
,	O
we	O
know	O
that	O
insulin	O
therapy	O
is	O
safe	O
and	O
usually	O
effective	O
.	O

A	O
transgenerational	O
change	O
thus	O
represents	O
epigenetic	O
inheritance	O
.	O

Ten	O
thousand	O
permutations	O
were	O
used	O
,	O
and	O
a	O
hypothesized	O
association	O
was	O
considered	O
significant	O
at	O
the	O
p	O
≤	O
0	O
.	O
05	O
level	O
.	O

Treatment	O
with	O
calcium	O
usually	O
reverses	O
the	O
symptoms	O
rapidly	O
.	O

From	O
birth	O
to	O
PND	O
22	O
(	O
lactation	O
),	O
three	O
-	O
way	O
repeated	O
measures	O
ANOVA	O
showed	O
a	O
main	O
and	O
significant	O
effect	O
of	O
time	O
on	O
body	O
weight	O
[	O
F	O
(	O
22	O
,	O
145	O
)=	O
675	O
.	O
53	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
Figure2B	O
].	O

In	O
recent	O
times	O
,	O
when	O
food	O
has	O
become	O
cheaper	O
and	O
more	O
widely	O
available	O
,	O
excessive	O
WAT	O
storage	O
contributed	O
to	O
the	O
worldwide	O
alarming	O
development	O
of	O
obesity	O
mentioned	O
above	O
(	O
World	O
Health	O
Organization	O
,	O
2009	O
).	O

Many	O
farm	O
chemicals	O
are	O
classified	O
as	O
probable	O
or	O
likely	O
human	O
carcinogens	O
by	O
the	O
US	O
Environmental	O
Protection	O
Agency	O
(	O
EPA	O
),	O
most	O
notably	O
acephate	O
,	O
dichlorvos	O
,	O
dimethoate	O
,	O
lindane	O
,	O
parathion	O
,	O
phosmet	O
,	O
and	O
tetrachlorvinphos	O
[	O
28	O
].	O

The	O
upper	O
and	O
lower	O
edges	O
of	O
the	O
box	O
represent	O
the	O
75thpercentile	O
and	O
the	O
25thpercentile	O
of	O
cathelicidin	O
concentration	O
,	O
respectively	O
,	O
measured	O
by	O
ELISA	O
and	O
reported	O
in	O
ng	O
/	O
mL	O
.	O

CC	O
and	O
RC	O
females	O
showed	O
a	O
lower	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
than	O
those	O
of	O
the	O
respective	O
CC	O
and	O
RC	O
males	O
.	O

Data	O
collection	O
is	O
projected	O
to	O
be	O
complete	O
by	O
mid	O
-	O
2008	O
.	O

2011	O
.	O

CHL	O
is	O
measured	O
by	O
placing	O
the	O
newborn	O
in	O
supine	O
position	O
on	O
the	O
tape	O
measure	O
on	O
a	O
flat	O
surface	O
with	O
all	O
limbs	O
extended	O
and	O
measurement	O
taken	O
from	O
vertex	O
to	O
heel	O
of	O
foot	O
,	O
with	O
foot	O
held	O
in	O
a	O
perpendicular	O
position	O
to	O
the	O
leg	O
.	O

The	O
association	O
between	O
the	O
positive	O
and	O
the	O
depressive	O
dimension	O
in	O
CAPE	O
,	O
which	O
we	O
unfortunately	O
could	O
not	O
include	O
for	O
practical	O
reasons	O
,	O
is	O
fairly	O
low	O
when	O
distress	O
associated	O
with	O
positive	O
symptoms	O
is	O
held	O
constant	O
(	O
r	O
=	O
0	O
.	O
25	O
;	O
Stefanis	O
et	O
al	O
.,	O
2002	O
[	O
1	O
]).	O

Patients	O
with	O
active	O
DTC	O
can	O
be	O
reassured	O
that	O
,	O
as	O
mentioned	O
above	O
,	O
pregnancy	O
itself	O
does	O
not	O
appear	O
to	O
increase	O
disease	O
progression	O
,	O
and	O
therefore	O
a	O
gap	O
in	O
treatment	O
during	O
pregnancy	O
is	O
not	O
contraindicated	O
.	O

Participants	O
completed	O
the	O
questionnaire	O
in	O
reference	O
to	O
intake	O
over	O
the	O
past	O
month	O
.	O

There	O
is	O
emerging	O
evidence	O
,	O
both	O
from	O
animal	O
and	O
human	O
studies	O
,	O
of	O
an	O
association	O
between	O
maternal	O
obesity	O
and	O
significantly	O
higher	O
risks	O
of	O
impaired	O
offspring	O
cognitive	O
,	O
motor	O
and	O
behavioural	O
aspects	O
of	O
neurodevelopment	O
[	O
44	O
–	O
46	O
].	O

Another	O
possible	O
explanation	O
may	O
be	O
that	O
the	O
frequent	O
intake	O
of	O
fish	O
and	O
PUFA	O
may	O
be	O
advantageous	O
in	O
lower	O
doses	O
but	O
disadvantageous	O
in	O
higher	O
doses	O
.	O

Poor	O
nutrition	O
(	O
reduced	O
folate	O
),	O
detoxification	O
of	O
arsenic	O
and	O
consumption	O
of	O
glutathione	O
during	O
the	O
detoxification	O
of	O
reactive	O
oxygen	O
species	O
can	O
all	O
lead	O
to	O
reduced	O
levels	O
of	O
the	O
DNMT	O
co	O
-	O
substrate	O
S	O
-	O
adenosylmethionine	O
(	O
Hou	O
et	O
al	O
.	O
2012	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

[	O
32	O
],	O
the	O
proportion	O
of	O
women	O
taking	O
folic	O
acid	O
varies	O
between	O
0	O
.	O
9	O
%	O
and	O
49	O
%	O
before	O
conception	O
and	O
between	O
0	O
.	O
5	O
%	O
and	O
52	O
%	O
in	O
the	O
peri	O
-	O
conception	O
period	O
.	O

On	O
the	O
other	O
hand	O
,	O
it	O
might	O
be	O
associated	O
to	O
the	O
transcriptional	O
excursions	O
within	O
the	O
lipid	O
metabolism	O
in	O
LP	O
offspring	O
.	O

Intranasal	O
cromolyn	O
,	O
intranasal	O
steroids	O
,	O
and	O
montelukast	O
are	O
the	O
preferred	O
drugs	O
for	O
the	O
treatment	O
of	O
rhinitis	O
because	O
of	O
the	O
low	O
risk	O
of	O
systemic	O
effects	O
.	O

Infant	O
morbidity	O
Infant	O
morbidity	O
assessment	O
is	O
performed	O
at	O
each	O
postnatal	O
visit	O
by	O
a	O
medical	O
doctor	O
with	O
a	O
structured	O
questionnaire	O
.	O

The	O
focus	O
of	O
this	O
review	O
is	O
set	O
on	O
asthma	O
and	O
type	O
I	O
allergy	O
associated	O
with	O
pregnancy	O
.	O

It	O
is	O
also	O
possible	O
that	O
children	O
who	O
become	O
autistic	O
may	O
also	O
be	O
slow	O
to	O
deliver	O
that	O
the	O
prolonged	O
delivery	O
is	O
a	O
symptom	O
of	O
,	O
rather	O
than	O
a	O
cause	O
of	O
,	O
autism	O
.	O

Serum	O
vitamin	O
D3	O
level	O
was	O
found	O
to	O
be	O
low	O
(	O
4	O
.	O
7	O
ng	O
/	O
ml	O
).	O

We	O
therefore	O
propose	O
that	O
one	O
explanation	O
for	O
our	O
main	O
findings	O
is	O
that	O
high	O
fetal	O
exposure	O
to	O
fructose	O
may	O
cause	O
persistence	O
of	O
Th2	O
immune	O
responses	O
post	O
-	O
natally	O
and	O
allergic	O
inflammation	O
in	O
the	O
developing	O
lung	O
.	O

Furthermore	O
,	O
multivitamin	O
supplements	O
available	O
during	O
the	O
study	O
period	O
contained	O
very	O
little	O
(	O
maximum	O
50	O
IU	O
),	O
if	O
any	O
,	O
vitamin	O
D	O
and	O
thus	O
are	O
an	O
unlikely	O
source	O
of	O
variation	O
within	O
the	O
population	O
.	O

25	O
-	O
OH	O
Vitamin	O
D2	O
is	O
also	O
detected	O
in	O
the	O
serum	O
of	O
these	O
four	O
participants	O
.	O

The	O
Block	O
Children	O
’	O
s	O
Food	O
Frequency	O
questionnaire	O
was	O
administered	O
at	O
each	O
yearly	O
visit	O
[	O
24	O
].	O

These	O
animals	O
were	O
from	O
four	O
separate	O
litters	O
per	O
experimental	O
group	O
.	O

Nine	O
integrated	O
public	O
health	O
centres	O
which	O
accounted	O
for	O
about	O
two	O
thirds	O
of	O
the	O
total	O
study	O
population	O
were	O
selected	O
as	O
study	O
sites	O
.	O

Effects	O
of	O
nutritional	O
restriction	O
from	O
early	O
gestation	O
to	O
parturition	O
and	O
/	O
or	O
throughout	O
lactation	O
on	O
offspring	O
growth	O
and	O
production	O
characteristics	O
to	O
30	O
mo	O
of	O
age	O
and	O
health	O
and	O
reproductive	O
performance	O
of	O
cows	O
were	O
studied	O
in	O
large	O
maternal	O
grazing	O
systems	O
with	O
offspring	O
of	O
Hereford	O
cows	O
mated	O
to	O
Piedmontese	O
or	O
Wagyu	O
sires	O
[	O
33	O
].	O

The	O
coordination	O
of	O
several	O
factors	O
affects	O
IMF	O
deposition	O
.	O

Blood	O
Measures	O
Total	O
circulating	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
measured	O
in	O
duplicate	O
within	O
the	O
month	O
the	O
blood	O
sample	O
was	O
obtained	O
using	O
radioimmunoassay	O
(	O
RIA	O
;	O
DiaSorin	O
,	O
Stillwater	O
,	O
MN	O
).	O

Figure2gives	O
a	O
comprehensive	O
overview	O
of	O
the	O
pathways	O
found	O
regulated	O
between	O
stages	O
and	O
diets	O
.	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
as	O
the	O
main	O
precursor	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
has	O
a	O
circulating	O
half	O
-	O
life	O
of	O
2	O
–	O
3	O
weeks	O
.	O

More	O
than	O
20	O
%	O
of	O
the	O
women	O
in	O
the	O
sample	O
were	O
from	O
non	O
-	O
Caucasian	O
origin	O
.	O

To	O
verify	O
physical	O
presence	O
of	O
the	O
data	O
collectors	O
at	O
the	O
households	O
we	O
will	O
record	O
a	O
Geographic	O
Information	O
System	O
(	O
GIS	O
)	O
data	O
point	O
.	O

A	O
step	O
in	O
this	O
direction	O
will	O
go	O
a	O
long	O
way	O
to	O
consolidate	O
the	O
improvement	O
in	O
health	O
care	O
delivery	O
sought	O
by	O
Cameroon	O
in	O
the	O
framework	O
of	O
the	O
MDGs	O
.	O

Early	O
recognition	O
by	O
the	O
emergency	O
physician	O
in	O
addition	O
to	O
successful	O
coordination	O
of	O
care	O
between	O
the	O
emergency	O
physician	O
,	O
obstetrician	O
,	O
and	O
cardiothoracic	O
/	O
vascular	O
surgeon	O
is	O
necessary	O
for	O
a	O
successful	O
outcome	O
.	O

Enhanced	B
knowledge	I
of	O
possible	O
metabolic	O
consequences	O
of	O
sleep	O
disturbances	O
in	O
pregnancy	O
will	O
likely	O
have	O
important	O
clinical	O
implications	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
impaired	O
glucose	O
tolerance	O
and	O
GDM	O
among	O
pregnant	O
women	O
.	O

Data	O
was	O
collected	O
using	O
a	O
pretested	O
interviewer	O
-	O
administered	O
semi	O
-	O
structured	O
questionnaire	O
modeled	O
according	O
to	O
that	O
devised	O
by	O
the	O
WHO	O
in	O
assessing	O
women	O
'	O
s	O
perceptions	O
about	O
quality	O
of	O
care	O
[	O
11	O
]	O
and	O
after	O
due	O
consultation	O
on	O
questionnaire	O
design	O
[	O
12	O
].	O

All	O
estimates	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Infant	O
gut	O
microbiome	O
cluster	O
is	O
influenced	O
by	O
maternal	O
dietOR	O
(	O
95	O
%	O
confidence	O
interval	O
)	O
1	O
,	O
2Dietary	O
factorCluster	O
2Cluster	O
3aMED	O
score1	O
.	O
31	O
(	O
0	O
.	O
90	O
,	O
1	O
.	O
89	O
)	O
0	O
.	O
96	O
(	O
0	O
.	O
73	O
,	O
1	O
.	O
27	O
)	O
Dairy0	O
.	O
87	O
(	O
0	O
.	O
56	O
,	O
1	O
.	O
37	O
)	O
0	O
.	O
84	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
18	O
)	O
Fruit2	O
.	O
73	O
(	O
1	O
.	O
36	O
,	O
5	O
.	O
46	O
)	O
31	O
.	O
61	O
(	O
0	O
.	O
97	O
,	O
2	O
.	O
68	O
)	O
3Vegetables0	O
.	O
88	O
(	O
0	O
.	O
60	O
,	O
1	O
.	O
28	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
60	O
,	O
1	O
.	O
11	O
)	O
Whole	O
grains0	O
.	O
94	O
(	O
0	O
.	O
36	O
,	O
2	O
.	O
41	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
57	O
,	O
2	O
.	O
13	O
)	O
Fish	O
and	O
seafood0	O
.	O
67	O
(	O
0	O
.	O
01	O
,	O
32	O
.	O
26	O
)	O
0	O
.	O
50	O
(	O
0	O
.	O
02	O
,	O
12	O
.	O
57	O
)	O
Nuts	O
,	O
legumes	O
,	O
and	O
soy0	O
.	O
49	O
(	O
0	O
.	O
20	O
,	O
1	O
.	O
20	O
)	O
0	O
.	O
48	O
(	O
0	O
.	O
24	O
,	O
0	O
.	O
96	O
)	O
Red	O
and	O
processed	O
meat4	O
.	O
39	O
(	O
0	O
.	O
82	O
,	O
23	O
.	O
47	O
)	O
2	O
.	O
35	O
(	O
0	O
.	O
62	O
,	O
8	O
.	O
95	O
)	O
Polyunsaturated	O
fat0	O
.	O
84	O
(	O
0	O
.	O
65	O
,	O
1	O
.	O
09	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
72	O
,	O
1	O
.	O
06	O
)	O
EPA0	O
.	O
24	O
(	O
0	O
.	O
00	O
,	O
72	O
.	O
57	O
)	O
4	O
.	O
13	O
(	O
0	O
.	O
08	O
,	O
217	O
.	O
72	O
)	O
DHA0	O
.	O
15	O
(	O
0	O
.	O
00	O
,	O
62	O
.	O
82	O
)	O
2	O
.	O
66	O
(	O
0	O
.	O
04	O
,	O
158	O
.	O
91	O
)	O
MUFA	O
:	O
SFA	O
ratio1	O
.	O
64	O
(	O
0	O
.	O
15	O
,	O
17	O
.	O
73	O
)	O
1	O
.	O
78	O
(	O
0	O
.	O
26	O
,	O
12	O
.	O
28	O
)	O
1Models	O
include	O
vaginally	O
delivered	O
infants	O
(	O
n	O
=	O
97	O
)	O
2Cluster	O
1	O
is	O
the	O
reference	O
group	O
3Corresponds	O
to	O
Fig	O
.	O

It	O
is	O
relevant	O
to	O
note	O
that	O
in	O
Sweden	O
low	O
-	O
fat	O
dairy	O
products	O
and	O
margarines	O
are	O
fortified	O
with	O
vitamin	O
D	O
.	O
Otherwise	O
the	O
dietary	O
intake	O
of	O
vitamin	O
D	O
would	O
be	O
lower	O
.	O

Introduction	O
Anthropometric	O
measurements	O
,	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
of	O
newborn	O
infants	O
,	O
are	O
widely	O
assessed	O
as	O
determinants	O
of	O
impaired	O
fetal	O
growth	O
,	O
intrauterine	O
environment	O
,	O
and	O
maternal	O
nutrition	O
[	O
1	O
].	O

Altogether	O
,	O
the	O
existing	O
literature	O
suggests	O
that	O
BAT	O
activation	O
is	O
not	O
only	O
involved	O
in	O
non	O
-	O
shivering	O
thermogenesis	O
,	O
but	O
also	O
in	O
the	O
regulation	O
of	O
insulin	O
-	O
mediated	O
glucose	O
disposal	O
.	O

These	O
findings	O
suggest	O
that	O
proteins	O
involved	O
in	O
SNAP	O
and	O
SNARE	O
mediated	O
vesicle	O
release	O
may	O
be	O
disrupted	O
in	O
the	O
DVD	O
model	O
.	O

In	O
addition	O
,	O
residual	O
confounding	O
due	O
to	O
genetic	O
backgrounds	O
could	O
not	O
be	O
excluded	O
,	O
although	O
we	O
controlled	O
some	O
important	O
potential	O
confounding	O
factors	O
.	O

The	O
absorption	O
of	O
dietary	O
vitamin	O
D	O
is	O
generally	O
high	O
at	O
all	O
stages	O
of	O
life	O
[	O
34	O
],	O
but	O
serum	O
levels	O
also	O
depend	O
on	O
the	O
endogenous	O
production	O
of	O
vitamin	O
D	O
due	O
to	O
sun	O
exposure	O
which	O
is	O
subject	O
to	O
seasonal	O
variations	O
.	O

Promising	O
evidence	O
came	O
from	O
a	O
trial	O
in	O
China	O
investigating	O
the	O
effects	O
of	O
IFA	O
supplements	O
in	O
pregnancy	O
on	O
neonatal	O
deaths	O
[	O
19	O
].	O

Further	O
adjustments	O
were	O
made	O
for	O
physical	O
activity	O
and	O
social	O
-	O
economic	O
levels	O
in	O
model	O
2	O
,	O
and	O
additionally	O
adjustment	O
for	O
delivery	O
status	O
,	O
IUGR	O
,	O
preterm	O
delivery	O
,	O
history	O
of	O
abortion	O
,	O
and	O
stillbirth	O
were	O
made	O
in	O
model	O
3	O
.	O

2	O
).	O

Reduction	O
of	O
energy	O
intake	O
induced	O
SIRT1	O
in	O
brain	O
(	O
21	O
).	O

The	O
patients	O
were	O
divided	O
into	O
two	O
groups	O
,	O
Vitamin	O
D	O
supplement	O
intake	O
and	O
control	O
group	O
.	O

In	O
clinical	O
studies	O
,	O
researchers	O
from	O
Kaiser	O
Permanente	O
Northern	O
California	O
Hospitals	O
examined	O
291	O
children	O
born	O
from	O
1995	O
to	O
1999	O
,	O
compared	O
to	O
284	O
controls	O
.	O

It	O
was	O
remarkably	O
observed	O
that	O
preparation	O
for	O
hibernation	O
was	O
characterized	O
by	O
striking	O
increases	O
in	O
body	O
weight	O
and	O
in	O
fat	O
mass	O
.	O

Oral	O
antidiabetic	O
agents	O
in	O
gestational	O
diabetes	O
There	O
is	O
controversy	O
regarding	O
the	O
use	O
of	O
oral	O
hypoglycemic	O
agents	O
during	O
pregnancy	O
.	O

Thus	O
,	O
although	O
the	O
current	O
literature	O
remains	O
incomplete	O
regarding	O
specific	O
mechanisms	O
of	O
epigenetically	O
mediated	O
environmentally	O
induced	O
toxicity	O
in	O
humans	O
at	O
doses	O
relevant	O
to	O
human	O
exposures	O
,	O
there	O
is	O
sufficient	O
information	O
to	B
perform	I
retrospective	O
epigenetic	O
analysis	O
of	O
existing	O
regulatory	O
studies	O
and	O
identify	O
future	B
research	I
needs	B
.	O

Anaemia	O
during	O
pregnancy	O
is	O
a	O
public	O
health	O
problem	O
that	O
affects	O
both	O
developed	O
and	O
developing	O
countries	O
and	O
has	O
an	O
impact	O
not	O
only	O
on	O
health	O
providers	O
,	O
but	O
also	O
on	O
the	O
socio	O
-	O
economic	O
environment	O
[	O
12	O
].	O

It	O
is	O
important	O
,	O
however	O
,	O
to	O
assess	O
the	O
intrinsic	O
iatrogenic	O
risk	O
of	O
birth	O
defects	O
or	O
perinatal	O
complications	O
and	O
the	O
general	O
safety	O
for	O
the	O
expectant	O
mother	O
before	O
discontinuing	O
anticonvulsants	O
[	O
31	O
].	O

Additionally	O
,	O
it	O
was	O
assessed	O
the	O
spontaneous	O
and	O
compulsive	O
feeding	O
behavior	O
,	O
growing	O
parameters	O
,	O
leptin	O
,	O
plasma	O
metabolites	O
,	O
and	O
adiposity	O
after	O
weaning	O
(	O
adolescence	O
and	O
adulthood	O
).	O

Interestingly	O
fetal	O
death	O
and	O
malformations	O
were	O
not	O
a	O
component	O
of	O
the	O
primary	O
outcome	O
;	O
however	O
,	O
19	O
events	O
in	O
the	O
metformin	O
group	O
were	O
classified	O
as	O
serious	O
fetal	O
or	O
neonatal	O
adverse	O
events	O
(	O
including	O
11	O
congenital	O
anomalies	O
)	O
compared	O
to	O
23	O
events	O
in	O
the	O
insulin	O
arm	O
(	O
including	O
18	O
congenital	O
anomalies	O
and	O
one	O
fetal	O
death	O
).	O

Furthermore	O
,	O
we	O
did	O
not	O
record	O
when	O
during	O
the	O
pregnancy	O
the	O
supplements	O
were	O
taken	O
,	O
which	O
is	O
of	O
particular	O
importance	O
for	O
folic	O
acid	O
.	O

This	O
effect	O
,	O
exerted	O
within	O
the	O
ventromedial	O
hypothalamus	O
(	O
VMH	O
),	O
was	O
described	O
as	O
being	O
AMPK	O
-	O
dependent	O
,	O
resulting	O
in	O
the	O
activation	O
of	O
the	O
sympathetic	O
outlflow	O
to	O
BAT	O
,	O
without	O
any	O
change	O
in	O
the	O
feeding	O
behavior	O
(	O
Whittle	O
et	O
al	O
.,	O
2012	O
;	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

Investigators	O
will	O
extract	O
and	O
code	O
the	O
symptoms	O
from	O
both	O
the	O
closed	O
-	O
ended	O
questions	O
and	O
open	O
narratives	O
.	O

Overall	O
,	O
this	O
book	O
will	O
be	O
of	O
benefit	O
to	O
postgraduates	O
in	O
the	O
field	O
of	O
nutrition	O
,	O
nutritionists	O
in	O
hospitals	O
and	O
physicians	O
.	O

ATP	O
citrate	O
and	O
NADP	O
malate	O
dehydrogenase	O
are	O
two	O
key	O
enzymes	O
utilizing	O
glucose	O
in	O
the	O
FA	O
de	O
novo	O
synthesis	O
pathway	O
.	O

Geographical	O
accessibility	O
was	O
the	O
main	O
reason	O
for	O
choosing	O
an	O
ANC	O
site	O
,	O
followed	O
by	O
perceived	O
quality	O
of	O
care	O
provided	O
.	O

The	O
significant	O
associations	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
with	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
remained	O
,	O
unattenuated	O
,	O
on	O
mutual	O
adjustment	O
for	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
post	O
-	O
natal	O
exposure	O
(	O
table	O
4and	O
supplementary	O
table	O
E4	O
,	O
respectively	O
).	O

It	O
was	O
also	O
shown	O
that	O
iron	O
fortification	O
of	O
sugar	O
(	O
with	O
mean	O
intake	O
of	O
4	O
mg	O
/	O
day	O
)	O
in	O
nonpregnant	O
Guatemalan	O
women	O
over	O
three	O
years	O
resulted	O
in	O
a	O
substantial	O
increase	O
in	O
iron	O
stores	O
,	O
with	O
reserves	O
still	O
increasing	O
by	O
about	O
40	O
mg	O
/	O
year	O
after	O
the	O
third	O
year	O
[	O
41	O
].	O

The	O
association	O
between	O
GWG	O
and	O
offspring	O
overweight	O
may	O
decrease	O
as	O
children	O
grow	O
older	O
[	O
49	O
,	O
50	O
].	O

For	O
example	O
,	O
serum	O
ferritin	O
level	O
,	O
being	O
an	O
acute	O
-	O
phase	O
protein	O
,	O
is	O
raised	O
in	O
associated	O
underlying	O
infections	O
and	O
long	O
-	O
term	O
diseases	O
;	O
it	O
can	O
therefore	O
give	O
a	O
false	O
normal	O
or	O
high	O
level	O
in	O
a	O
state	O
of	O
iron	O
deficiency	O
.	O

This	O
committee	O
will	O
assist	O
in	O
translating	O
the	O
Shonjibon	O
study	O
findings	O
into	O
policy	O
.	O

Liver	O
samples	O
and	O
the	O
brains	O
were	O
also	O
collected	O
,	O
frozen	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Therefore	O
,	O
the	O
observed	O
mRNA	O
expression	O
patterns	O
might	O
contribute	O
to	O
an	O
impaired	O
developmental	O
growth	O
in	O
LP	O
offspring	O
.	O

Protected	O
dietary	O
fats	O
are	O
bypassed	O
in	O
the	O
rumen	O
without	O
digestion	O
,	O
and	O
they	O
are	O
digested	O
and	O
absorbed	O
in	O
the	O
small	O
intestine	O
.	O

When	O
women	O
were	O
categorised	O
based	O
on	O
clinical	O
definitions	O
of	O
vitamin	O
D	O
deficiency	O
and	O
serum	O
25	O
(	O
OH	O
)	O
D	O
between	O
50	O
and	O
75	O
nmol	O
/	O
L	O
used	O
as	O
the	O
reference	O
,	O
no	O
significant	O
relationship	O
between	O
vitamin	O
D	O
status	O
and	O
adverse	O
pregnancy	O
outcome	O
was	O
found	O
(	O
Table2	O
).	O

Serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
is	O
recognized	O
as	O
the	O
best	O
indicator	O
of	O
Vitamin	O
D	O
status	O
.	O

In	O
rodents	O
,	O
many	O
studies	O
reported	O
an	O
impact	O
of	O
maternal	O
low	O
protein	O
diets	O
on	O
expression	O
and	O
affinity	O
of	O
the	O
glucocorticoid	O
receptor	O
and	O
its	O
signaling	O
molecules	O
[	O
8	O
,	O
48	O
,	O
59	O
-	O
61	O
].	O

Management	O
and	O
training	O
Overall	O
around	O
3920	O
SS	O
and	O
100	O
FI	O
will	O
deliver	O
the	O
intervention	O
,	O
under	O
the	O
supervision	O
of	O
central	O
field	O
supervisory	O
team	O
.	O

In	O
Australia	O
and	O
New	O
Zealand	O
,	O
the	O
deficiency	O
cut	O
-	O
offs	O
are	O
based	O
on	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
bone	O
health	O
where	O
serum	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
at	O
the	O
end	O
of	O
winter	O
is	O
required	O
for	O
optimal	O
musculoskeletal	O
health	O
[	O
1	O
].	O

Perceptions	O
about	O
the	O
knowledge	O
of	O
ANC	O
and	O
the	O
service	O
ratings	O
for	O
quality	O
were	O
compared	O
among	O
these	O
different	O
groups	O
using	O
the	O
Chi	O
-	O
squared	O
test	O
to	O
determine	O
associations	O
and	O
where	O
it	O
was	O
not	O
valid	O
,	O
the	O
Fisher	O
'	O
s	O
exact	O
test	O
was	O
used	O
.	O

In	O
addition	O
,	O
a	O
significant	O
effect	O
of	O
sex	O
on	O
the	O
plasma	O
levels	O
of	O
total	O
cholesterol	O
,	O
HDL	O
,	O
ALKP	O
,	O
and	O
AST	O
/	O
ALT	O
ratio	O
was	O
also	O
observed	O
.	O

The	O
data	O
show	O
adverse	O
effects	O
of	O
maternal	O
mental	O
illness	O
on	O
pregnancy	O
outcomes	O
and	O
infant	O
neurodevelopment	O
but	O
are	O
not	O
robust	O
enough	O
to	O
discourage	O
the	O
use	O
of	O
SSRIs	O
during	O
human	O
pregnancy	O
[	O
66	O
].	O

Therefore	O
glyburide	O
has	O
the	O
potential	O
to	O
result	O
in	O
earlier	O
development	O
of	O
maternal	O
diabetes	O
,	O
and	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
the	O
mothers	O
are	B
needed	I
to	O
alleviate	O
this	O
concern	O
.	O

(	O
2012b	O
)*	O
Li	O
et	O
al	O
.	O

Mothers	O
are	O
asked	O
how	O
soon	O
after	O
birth	O
the	O
infant	O
was	O
breastfed	O
,	O
if	O
the	O
infant	O
is	O
currently	O
being	O
breastfed	O
and	O
if	O
not	O
,	O
the	O
duration	O
of	O
breastfeeding	O
.	O

The	O
highest	O
profit	O
in	O
this	O
steer	O
group	O
was	O
for	O
a	O
slaughter	O
age	O
of	O
31	O
months	O
.	O

The	O
DVD	O
adult	O
rat	O
is	O
also	O
more	O
sensitive	O
to	O
haloperidol	O
,	O
a	O
dopamine	O
(	O
DA	O
)	O
D2	O
receptor	O
antagonist	O
[	O
10	O
],	O
that	O
is	O
a	O
widely	O
used	O
antipsychotic	O
medication	O
used	O
to	O
treat	O
schizophrenia	O
.	O

They	O
were	O
originally	O
thought	O
to	O
be	O
factors	O
inducing	O
bone	O
formation	O
,	O
but	O
were	O
then	O
described	O
to	O
be	O
involved	O
in	O
the	O
development	O
and	O
function	O
of	O
many	O
tissues	O
,	O
such	O
as	O
the	O
intestine	O
,	O
brain	O
and	O
WAT	O
(	O
Hogan	O
,	O
1996	O
).	O

The	O
emulsifier	O
PROSOL	O
(	O
sodium	O
stearoyl	O
-	O
2	O
-	O
lactylate	O
)	O
increases	O
IMF	O
deposition	O
and	O
QG	O
in	O
Korean	O
cattle	O
[	O
108	O
].	O

The	O
lab	O
technicians	O
were	O
blind	O
to	O
group	O
allocations	O
.	O

During	O
the	O
final	O
stage	O
,	O
from	O
18	O
months	O
to	O
slaughter	O
(	O
28	O
to	O
30	O
months	O
of	O
age	O
),	O
the	O
concentrate	O
is	O
84	O
.	O
2	O
%	O
to	O
86	O
.	O
4	O
%	O
of	O
feed	O
,	O
and	O
the	O
rest	O
is	O
roughage	O
(	O
rice	O
straw	O
).	O

Briefly	O
,	O
0	O
.	O
04	O
g	O
–	O
0	O
.	O
07	O
g	O
of	O
crude	O
fresh	O
frozen	O
NAc	O
tissue	O
was	O
placed	O
in	O
Buffer	O
1	O
(	O
7M	O
Urea	O
,	O
2M	O
Thiourea	O
,	O
1	O
%	O
C7bZO	O
,	O
40	O
mM	O
Tris	O
).	O

The	O
researcher	O
took	O
non	O
-	O
fasting	O
venous	O
blood	O
samples	O
from	O
mothers	O
during	O
6	O
-	O
12	O
and	O
15	O
-	O
20	O
gestational	O
weeks	O
between	O
09	O
:	O
00	O
and	O
11	O
:	O
00	O
am	O
.	O

It	O
was	O
hypothesized	O
that	O
(	O
1	O
)	O
total	O
current	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
would	O
be	O
positively	O
correlated	O
with	O
cathelicidin	O
in	O
children	O
;	O
(	O
2	O
)	O
children	O
with	O
higher	O
plasma	O
cathelicidin	O
concentrations	O
would	O
have	O
had	O
fewer	O
infections	O
than	O
children	O
with	O
lower	O
cathelicidin	O
concentrations	O
;	O
and	O
(	O
3	O
)	O
cathelicidin	O
concentration	O
would	O
increase	O
with	O
advancing	O
age	O
.	O

One	O
earlier	O
study	O
,	O
from	O
Denmark	O
,	O
found	O
that	O
lower	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
was	O
associated	O
with	O
pregnancy	O
loss	O
in	O
the	O
first	O
trimester	O
[	O
24	O
].	O

These	O
changes	O
include	O
increased	O
total	O
circulatory	O
volume	O
,	O
increased	O
systemic	O
blood	O
pressure	O
,	O
and	O
structural	O
changes	O
in	O
the	O
aortic	O
wall	O
secondary	O
to	O
the	O
hormonal	O
effects	O
of	O
estrogen	O
and	O
progesterone	O
[	O
4	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Sociodemographic	O
and	O
other	O
characteristics	O
of	O
the	O
study	O
subjects	O
,	O
Seattle	O
,	O
Washington	O
,	O
USA	O
2003	O
-	O
2006Gestational	O
Diabetes	O
MellitusEntire	O
Study	O
CohortN	O
=	O
1290NoN	O
=	O
1222YesN	O
=	O
68Characteristicsn	O
(%)	O
n	O
(%)	O
n	O
(%)	O
Maternal	O
age	O
at	O
Interview	O
(	O
years	O
)*	O
33	O
.	O
3	O
±	O
4	O
.	O
433	O
.	O
2	O
±	O
4	O
.	O
335	O
.	O
2	O
±	O
5	O
.	O
0	O
<	O
35	O
years772	O
(	O
59	O
.	O
8	O
)	O
746	O
(	O
61	O
.	O
0	O
)	O
26	O
(	O
38	O
.	O
2	O
)	O
≥	O
35	O
years518	O
(	O
40	O
.	O
2	O
)	O
476	O
(	O
39	O
.	O
0	O
)	O
42	O
(	O
61	O
.	O
8	O
)	O
Maternal	O
race	O
/	O
ethnicity	O
*	O
Non	O
-	O
Hispanic	O
White1133	O
(	O
87	O
.	O
8	O
)	O
1080	O
(	O
88	O
.	O
4	O
)	O
53	O
(	O
77	O
.	O
9	O
)	O
Other157	O
(	O
12	O
.	O
2	O
)	O
141	O
(	O
11	O
.	O
5	O
)	O
15	O
(	O
22	O
.	O
1	O
)	O
Medical	O
bill	O
payment	O
status	O
Insurance1239	O
(	O
96	O
.	O
1	O
)	O
1173	O
(	O
96	O
.	O
0	O
)	O
66	O
(	O
97	O
.	O
1	O
)	O
Medicaid26	O
(	O
2	O
.	O
0	O
)	O
24	O
(	O
2	O
.	O
0	O
)	O
2	O
(	O
2	O
.	O
9	O
)	O
unknown25	O
(	O
1	O
.	O
9	O
)	O
25	O
(	O
2	O
.	O
0	O
)	O
0	O
(	O
0	O
)	O
Nulliparous768	O
(	O
59	O
.	O
5	O
)	O
727	O
(	O
59	O
.	O
5	O
)	O
41	O
(	O
60	O
.	O
3	O
)≤	O
High	O
school	O
education37	O
(	O
2	O
.	O
9	O
)	O
33	O
(	O
2	O
.	O
7	O
)	O
4	O
(	O
5	O
.	O
9	O
)	O
Unmarried106	O
(	O
8	O
.	O
2	O
)	O
98	O
(	O
8	O
.	O
0	O
)	O
8	O
(	O
11	O
.	O
8	O
)	O
Smoked	O
during	O
pregnancy67	O
(	O
5	O
.	O
2	O
)	O
65	O
(	O
5	O
.	O
3	O
)	O
2	O
(	O
2	O
.	O
9	O
)	O
No	O
prenatal	O
vitamins32	O
(	O
2	O
.	O
5	O
)	O
30	O
(	O
2	O
.	O
5	O
)	O
2	O
(	O
2	O
.	O
9	O
)	O
Pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
kg	O
/	O
m2	O
)*	O
23	O
.	O
5	O
±	O
4	O
.	O
523	O
.	O
3	O
±	O
4	O
.	O
426	O
.	O
6	O
±	O
6	O
.	O
3	O
Lean	O
(<	O
18	O
.	O
5	O
)	O
58	O
(	O
4	O
.	O
5	O
)	O
57	O
(	O
4	O
.	O
7	O
)	O
1	O
(	O
1	O
.	O
5	O
)	O
Normal	O
(	O
18	O
.	O
5	O
-	O
24	O
.	O
9	O
)	O
908	O
(	O
70	O
.	O
4	O
)	O
876	O
(	O
71	O
.	O
7	O
)	O
32	O
(	O
47	O
.	O
1	O
)	O
Overweight	O
(	O
25	O
-	O
29	O
.	O
9	O
)	O
229	O
(	O
17	O
.	O
7	O
)	O
208	O
(	O
17	O
.	O
0	O
)	O
21	O
(	O
30	O
.	O
9	O
)	O
Obese	O
(≥	O
30	O
)	O
95	O
(	O
7	O
.	O
4	O
)	O
81	O
(	O
6	O
.	O
6	O
)	O
14	O
(	O
20	O
.	O
4	O
)	O
Mean	O
±	O
standard	O
deviation	O
(	O
SD	O
).	O

In	O
general	O
,	O
the	O
term	O
obesity	O
applies	O
to	O
both	O
the	O
obese	O
and	O
the	O
overweight	O
subjects	O
.	O

Autism	O
and	O
autism	O
spectrum	O
disorders	O
(	O
ASDs	O
),	O
including	O
Asperger	O
'	O
s	O
syndrome	O
and	O
pervasive	O
developmental	O
disorder	O
,	O
have	O
become	O
increasingly	O
diagnosed	O
over	O
the	O
past	O
decade	O
.	O

Thus	O
,	O
optimal	O
asthma	O
treatment	O
is	O
crucial	O
,	O
as	O
the	O
risk	O
of	O
preeclampsia	O
,	O
premature	O
birth	O
,	O
low	O
birth	O
weight	O
,[	O
19	O
]	O
and	O
maternal	O
and	O
neonatal	O
hypoxia	O
and	O
morbidity	O
[	O
10	O
,	O
20	O
]	O
posed	O
by	O
undertreated	O
asthma	O
may	O
be	O
greater	O
than	O
that	O
from	O
the	O
use	O
of	O
oral	O
steroids	O
for	O
the	O
treatment	O
of	O
asthma	O
.	O

Additionally	O
,	O
the	O
diagnosis	O
of	O
GDM	O
indicates	O
that	O
the	O
mother	O
has	O
a	O
predisposition	O
to	O
diabetes	O
.	O

Our	O
results	O
indicates	O
that	O
25OHD	O
at	O
T3	O
but	O
not	O
at	O
T1	O
is	O
associated	O
with	O
SGA	O
and	O
LBW	O
,	O
despite	O
better	O
statistical	O
power	O
at	O
T1	O
due	O
to	O
more	O
25OHD	O
samples	O
and	O
subsequently	O
more	O
cases	O
of	O
SGA	O
,	O
LBW	O
and	O
preterm	O
birth	O
.	O

This	O
study	O
demonstrated	O
a	O
significant	O
association	O
between	O
high	O
adherences	O
to	O
western	O
dietary	O
pattern	O
and	O
chance	O
of	O
having	O
low	O
birth	O
weight	O
infant	O
.	O

Impact	O
of	O
perinatal	O
nutritional	O
changes	O
Epidemiological	O
evidence	O
in	O
humans	O
strongly	O
suggests	O
that	O
the	O
intrauterine	O
and	O
early	O
postnatal	O
environments	O
have	O
a	O
significant	O
long	O
-	O
term	O
influence	O
on	O
body	O
weight	O
and	O
energy	O
homeostasis	O
in	O
offspring	O
(	O
for	O
rev	O
.,	O
see	O
Breton	O
,	O
2013	O
).	O

Lastly	O
,	O
the	O
environmental	O
impact	O
of	O
perinatal	O
air	O
pollutants	O
has	O
also	O
been	O
observed	O
[	O
20	O
,	O
21	O
].	O

Our	O
secondary	O
hypotheses	O
were	O
that	O
supplementation	O
would	O
reduce	O
all	O
pneumonias	O
(	O
radiologically	O
confirmed	O
or	O
clinically	O
defined	O
),	O
repeat	O
episodes	O
of	O
pneumonia	O
,	O
hospital	O
admissions	O
,	O
and	O
all	O
cause	O
mortality	O
.	O

Also	O
,	O
58	O
(	O
2	O
.	O
8	O
%)	O
infants	O
had	O
LBW	O
,	O
while	O
78	O
(	O
3	O
.	O
8	O
%)	O
infants	O
were	O
delivered	O
preterm	O
(	O
Table1	O
).	O

However	O
,	O
we	O
plan	B
to	I
re	O
-	O
examine	O
this	O
hypothesis	O
in	O
another	O
birth	O
cohort	O
to	O
see	O
if	O
we	O
can	O
replicate	O
the	O
main	O
findings	O
.	O

To	O
further	O
evaluate	O
the	O
association	O
between	O
infant	O
birth	O
weight	O
and	O
repetitive	O
element	O
methylation	O
identified	O
in	O
the	O
univariate	O
analyses	O
,	O
controlled	O
for	O
confounders	O
,	O
we	O
used	O
multiple	O
linear	O
regression	O
.	O

Mitotic	O
cyclins	O
interact	O
with	O
Polo	O
-	O
like	O
kinases	O
(	O
PLK	O
),	O
an	O
evolutionary	O
conserved	O
family	O
of	O
essential	O
cell	O
cycle	O
regulators	O
,	O
which	O
are	O
required	O
at	O
several	O
key	O
points	O
within	O
mitosis	O
,	O
including	O
entry	O
into	O
and	O
exit	O
from	O
mitosis	O
[	O
23	O
,	O
24	O
].	O

Disordered	O
regulation	O
of	O
feeding	O
pathways	O
can	O
affect	O
growth	O
and	O
metabolism	O
,	O
consequently	O
driving	O
the	O
appearance	O
of	O
metabolic	O
syndrome	O
later	O
in	O
life	O
.	O
7	O
,	O
8	O
An	O
extension	O
of	O
the	O
concept	O
that	O
early	O
life	O
factors	O
contribute	O
to	O
chronic	O
diseases	O
is	O
described	O
by	O
the	O
predictive	O
adaptive	O
response	O
(	O
PAR	O
)	O
hypothesis	O
,	O
which	O
suggests	O
that	O
a	O
mismatch	O
between	O
in	O
utero	O
and	O
postnatal	O
environment	O
increases	O
the	O
risk	O
of	O
developing	O
disease	O
in	O
adulthood	O
.	O
9	O
,	O
10It	O
has	O
been	O
proposed	O
that	O
the	O
offspring	O
modify	O
their	O
phenotype	O
based	O
on	O
their	O
in	O
utero	O
environment	O
in	O
order	O
to	O
adapt	O
to	O
the	O
predicted	O
postnatal	O
setting	O
.	O

Those	O
who	O
consented	O
and	O
signed	O
the	O
content	O
form	O
were	O
enrolled	O
into	O
the	O
study	O
.	O

A	O
putative	O
decrease	O
in	O
hypothalamic	O
sensitivity	O
to	O
leptin	O
may	O
result	O
in	O
an	O
inability	O
to	O
detect	O
satiety	O
despite	O
the	O
fat	O
stores	O
,	O
which	O
finally	O
develop	O
to	O
obesity	O
(	O
Sasaki	O
,	O
2015	O
).	O

Most	O
pregnant	O
mothers	O
tolerated	O
the	O
2000	O
IU	O
well	O
without	O
any	O
adverse	O
effects	O
and	O
just	O
a	O
few	O
of	O
them	O
temporarily	O
complained	O
about	O
nausea	O
.	O

Some	O
data	O
suggest	O
the	O
importance	O
of	O
growth	O
factors	O
(	O
mainly	O
TSH	O
,	O
but	O
also	O
HCG	O
)	O
in	O
growth	O
,	O
progression	O
and	O
spread	O
of	O
papillary	O
tumours	O
.	O

Of	O
those	O
invited	O
,	O
over	O
half	O
decided	O
to	O
participate	O
.	O

Allergy	O
diagnosis	O
during	O
pregnancy	O
should	B
preferentially	O
consist	O
of	O
recording	O
the	O
patient	O
'	O
s	O
history	O
for	O
precise	O
recommendation	B
of	O
allergen	O
avoidance	O
and	O
in	O
vitro	O
testing	O
only	O
.	O

Researchers	O
have	O
studied	O
the	O
relationship	O
between	O
low	O
serum	O
vitamin	O
D	O
concentration	O
and	O
perinatal	O
depression	O
,	O
although	O
no	O
clinical	O
trial	O
has	O
been	O
conducted	O
on	O
vitamin	O
D	O
’	O
s	O
effects	O
on	O
depression	O
related	O
to	O
childbirth	O
.	O

In	O
human	O
body	O
,	O
the	O
most	O
important	O
source	O
of	O
vitamin	O
D	O
is	O
the	O
skin	O
where	O
7	O
-	O
dehydrocholesterol	O
is	O
converted	O
to	O
vitamin	O
D3in	O
response	O
to	O
UV	O
exposure	O
.	O

Eligible	O
studies	O
included	O
those	O
of	O
healthy	O
pregnant	O
women	O
who	O
had	O
experienced	O
full	O
term	O
births	O
and	O
those	O
that	O
had	O
measured	O
fish	O
or	O
seafood	O
intake	O
and	O
assessed	O
neurodevelopmental	O
outcomes	O
in	O
offspring	O
.	O

However	O
,	O
such	O
associations	O
were	O
not	O
seen	O
with	O
healthy	O
and	O
traditional	O
dietary	O
pattern	O
.	O

The	O
most	O
popular	O
vitamin	O
and	O
mineral	O
supplements	O
contain	O
iron	O
,	O
folic	O
acid	O
and	O
vitamin	O
D	O
[	O
12	O
,	O
28	O
].	O

She	O
had	O
no	O
palpable	O
pedal	O
pulses	O
and	O
bilateral	O
1	O
+	O
edema	O
of	O
her	O
lower	O
extremities	O
.	O

This	O
was	O
mediated	O
by	O
phosphorylation	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
3	O
(	O
pSTAT3	O
).	O

Evaluation	O
of	O
the	O
reasons	O
why	O
55	O
.	O
2	O
%	O
of	O
respondents	O
changed	O
their	O
ANC	O
site	O
,	O
revealed	O
that	O
the	O
change	O
of	O
residence	O
,	O
closeness	O
to	O
the	O
health	O
facility	O
and	O
the	O
quality	O
of	O
care	O
offered	O
at	O
the	O
previous	O
site	O
were	O
the	O
predominant	O
reasons	O
.	O

The	O
selective	O
knock	O
-	O
out	O
of	O
SIRT1	O
in	O
hypothalamic	O
AgRP	O
neurons	O
diminished	O
response	O
to	O
hunger	O
-	O
inducing	O
hormone	O
ghrelin	O
,	O
reduced	O
food	O
intake	O
,	O
consequently	O
causing	O
decreased	O
lean	O
mass	O
and	O
body	O
weight	O
(	O
23	O
).	O

Although	O
farm	O
children	O
are	O
exposed	O
to	O
higher	O
concentrations	O
of	O
airborne	O
allergens	O
,	O
paradoxically	O
they	O
become	O
sensitized	O
less	O
often	O
and	O
manifest	O
a	O
weaker	O
sensitization	O
response	O
than	O
non	O
-	O
farm	O
controls	O
[	O
113	O
].	O

Currently	O
,	O
the	O
ICDS	O
scheme	O
symbolizes	O
one	O
of	O
the	O
most	O
extensive	O
and	O
the	O
unique	O
initiative	O
for	O
safeguarding	O
early	O
childhood	O
development	O
,	O
catering	O
to	O
more	O
than	O
100	O
million	O
under	O
-	O
six	O
year	O
children	O
under	O
the	O
different	O
provisions	O
available	O
in	O
the	O
scheme	O
(	O
2	O
).	O

In	O
the	O
entire	O
country	O
,	O
by	O
the	O
end	O
of	O
June	O
2013	O
,	O
1373349	O
AWCs	O
/	O
mini	O
-	O
AWCs	O
have	O
been	O
sanctioned	O
,	O
of	O
which	O
around	O
1339410	O
(	O
97	O
.	O
5	O
%)	O
are	O
operational	O
.	O

The	O
importance	O
of	O
an	O
exacerbation	O
of	O
eczema	O
and	O
dermatitis	O
during	O
pregnancy	O
should	B
not	I
be	I
underestimated	O
as	O
readout	O
of	O
the	O
atopic	O
state	O
,	O
being	O
of	O
interest	O
for	O
the	O
genetic	O
predisposition	O
of	O
the	O
newborn	O
[	O
42	O
].	O

The	O
benefits	O
of	O
such	O
inheritance	O
are	O
obvious	O
and	O
even	O
Darwin	O
himself	O
proposed	O
a	O
hypothetical	O
mechanism	O
for	O
the	O
transmission	O
of	O
somatic	O
tissue	O
characteristics	O
via	O
the	O
germ	O
cells	O
to	O
subsequent	O
generations	O
,	O
which	O
he	O
termed	O
pangenesis	O
(	O
Darwin1868	O
).	O

Volunteering	O
women	O
reporting	O
for	O
ANC	O
planned	O
visits	O
at	O
the	O
study	O
sites	O
were	O
sensitized	O
on	O
the	O
purpose	O
and	O
the	O
procedure	O
of	O
the	O
study	O
.	O

One	O
of	O
the	O
reasons	O
for	O
a	O
visfatin	O
effect	O
on	O
fetal	O
development	O
is	O
its	O
effect	O
on	O
sirtuins	O
(	O
SIRT	O
).	O

Epidemiologic	O
evidence	O
in	O
support	O
of	O
a	O
viral	O
or	O
pathogenic	O
etiology	O
for	O
adult	O
brain	O
tumors	O
remains	O
controversial	O
and	O
the	O
windows	O
of	O
interest	O
of	O
these	O
studies	O
have	O
been	O
outside	O
the	O
perinatal	O
period	O
.	O

Maternal	O
household	O
food	O
insufficiency	O
and	O
insecurity	O
The	O
level	O
of	O
the	O
participating	O
women	O
’	O
s	O
household	O
food	O
insufficiency	O
and	O
insecurity	O
is	O
assessed	O
at	O
phase	O
1	O
in	O
pregnancy	O
and	O
again	O
at	O
phases	O
6	O
and	O
8	O
postnatally	O
.	O

Vitamin	O
D	O
deficiency	O
is	O
closely	O
associated	O
with	O
Gestational	O
Diabetes	O
Mellitus	O
(	O
GDM	O
).	O

Furthermore	O
,	O
the	O
common	O
practice	O
of	O
swaddling	O
infants	O
might	O
reduce	O
exposure	O
to	O
sunlight	O
.	O
2Thus	O
young	O
children	O
are	O
at	O
a	O
high	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
.	O

Similarly	O
,	O
left	O
-	O
handedness	O
has	O
been	O
linked	O
to	O
congenital	O
adrenal	O
hyperplasia	O
,	O
a	O
condition	O
characterized	O
by	O
high	O
in	O
utero	O
levels	O
of	O
androgeizing	O
hormones	O
[	O
197	O
].	O

By	O
contrast	O
,	O
in	O
normal	O
weight	O
mothers	O
,	O
lower	O
fat	O
intake	O
(	O
and	O
higher	O
carbohydrate	O
intake	O
)	O
early	O
in	O
pregnancy	O
was	O
a	O
significant	O
predictor	O
of	O
higher	O
offspring	O
weight	O
at	O
6	O
months	O
.	O

Although	O
most	O
of	O
the	O
existing	O
data	O
regarding	O
asthma	O
and	O
allergy	O
medications	O
during	O
pregnancy	O
have	O
not	O
demonstrated	O
adverse	O
effects	O
,	O
data	O
regarding	O
the	O
use	O
of	O
oral	O
corticosteroids	O
have	O
not	O
been	O
totally	O
reassuring	O
.	O

Vitamin	O
D	O
deficiency	O
increases	O
the	O
risk	O
of	O
osteoporosis	O
[	O
3	O
]	O
and	O
fractures	O
[	O
4	O
],	O
while	O
in	O
its	O
most	O
severe	O
form	O
it	O
causes	O
rickets	O
in	O
children	O
[	O
5	O
]	O
and	O
osteomalacia	O
in	O
adults	O
[	O
6	O
].	O

Based	O
on	O
our	O
current	O
information	O
,	O
insulin	O
is	O
still	O
the	O
best	O
option	O
,	O
with	O
the	O
least	O
potential	O
for	O
long	O
-	O
term	O
risk	O
to	O
the	O
mother	O
and	O
child	O
.	O

We	O
consider	B
this	O
risk	O
,	O
and	O
the	O
impact	O
on	O
the	O
validity	O
of	O
our	O
findings	O
to	O
be	O
low	O
.	O

Trunk	O
blood	O
was	O
collected	O
and	O
centrifuged	O
,	O
and	O
plasma	O
samples	O
were	O
added	O
with	O
0	O
.	O
5	O
%	O
ascorbic	O
acid	O
to	O
prevent	O
folate	O
oxidation	O
.	O

Methods	O
Study	O
objects	O
Pregnant	O
women	O
in	O
middle	O
and	O
late	O
pregnancy	O
who	O
were	O
diagnosed	O
with	O
GDM	O
by	O
75	O
-	O
g	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
)	O
at	O
the	O
outpatient	O
nutrition	O
clinic	O
in	O
Peking	O
Union	O
Medical	O
College	O
Hospital	O
from	O
October	O
2013	O
to	O
July	O
2015	O
were	O
enrolled	O
in	O
this	O
study	O
.	O

Peer	O
-	O
reviewed	O
journal	O
articles	O
published	O
between	O
January	O
2000	O
and	O
March	O
2014	O
were	O
included	O
.	O

4	O
.	O

Exclusion	O
Criteria	O
were	O
:	O
the	O
participants	O
with	O
the	O
EPDS	O
baseline	O
scores	O
of	O
>	O
13	O
,	O
not	O
providing	O
blood	O
sample	O
at	O
the	O
onset	O
of	O
the	O
study	O
,	O
and	O
less	O
than	O
8	O
weeks	O
consumption	O
of	O
vitamin	O
D3supplementations	O
(	O
for	O
example	O
due	O
to	O
preterm	O
labor	O
or	O
stopping	O
consumption	O
),	O
irregular	O
consumption	O
(	O
for	O
example	O
every	O
two	O
/	O
three	O
days	O
instead	O
of	O
daily	O
consumption	O
).	O

Maternal	O
serum	O
T1	O
and	O
T3	O
samples	O
were	O
analysed	O
in	O
sequence	O
.	O

This	O
illustrates	O
the	O
importance	O
of	O
previous	O
contact	O
with	O
a	O
facility	O
to	O
determine	O
further	O
use	O
.	O

The	O
dams	O
were	O
housed	O
individually	O
in	O
ventilated	O
plastic	O
transparent	O
cages	O
with	O
bedding	O
in	O
a	O
12	O
:	O
12	O
h	O
light	O
-	O
dark	O
cycle	O
(	O
lights	O
on	O
at	O
0700	O
at	O
22	O
±	O
1	O
°	O
C	O
).	O

Study	O
eligibility	O
criteria	O
for	O
mothers	O
included	O
healthy	O
mothers	O
ranging	O
from	O
18	O
to	O
40	O
years	O
of	O
age	O
,	O
with	O
no	O
history	O
of	O
gestational	O
diabetes	O
,	O
psychological	O
disorders	O
,	O
or	O
genetic	O
disorders	O
.	O

More	O
than	O
the	O
total	O
body	O
weight	O
,	O
the	O
distribution	O
of	O
the	O
stored	O
fat	O
is	O
of	O
importance	O
for	O
the	O
development	O
of	O
obesity	O
and	O
its	O
comorbidities	O
.	O

Children	O
born	O
to	O
mothers	O
with	O
antiphospholipid	O
syndrome	O
were	O
observed	O
to	O
have	O
a	O
higher	O
frequency	O
of	O
autism	O
spectrum	O
disorders	O
in	O
comparison	O
to	O
mothers	O
without	O
antiphospholipid	O
syndrome	O
,	O
which	O
further	O
supports	O
findings	O
that	O
perinatal	O
complications	O
increase	O
the	O
risk	O
of	O
autism	O
in	O
children	O
[	O
28	O
].	O

Results	O
showed	O
that	O
in	O
the	O
vitamin	O
D	O
group	O
the	O
number	O
of	O
participants	O
with	O
depression	O
scores	O
of	O
<	O
9	O
were	O
more	O
than	O
the	O
control	O
group	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
Table	O
3	O
).	O

Change	O
in	O
25OHD	O
during	O
pregnancy	O
was	O
associated	O
with	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
,	O
with	O
the	O
lowest	O
odds	O
for	O
women	O
with	O
an	O
increment	O
in	O
25OHD	O
≥	O
30	O
nmol	O
/	O
L	O
.	O

Kynurenine	O
pathway	O
metabolites	O
(	O
mediates	O
interactions	O
between	O
immunological	O
and	O
neurological	O
function	O
)	O
will	O
be	O
determined	O
using	O
LCMSMS	O
[	O
76	O
].	O

Additionally	O
,	O
differences	O
in	O
breast	O
milk	O
composition	O
due	O
to	O
maternal	O
diet	O
may	O
contribute	O
to	O
the	O
infant	O
gut	O
microbiome	O
in	O
breastfed	O
infants	O
.	O

Both	O
hypotheses	O
would	O
suggest	O
a	O
higher	O
thyroid	O
neoplasm	O
proliferation	O
in	O
stimulated	O
thyroid	O
tissue	O
during	O
pregnancy	O
or	O
adolescence	O
,	O
though	O
even	O
in	O
growing	O
tissues	O
these	O
cancers	O
show	O
a	O
very	O
good	O
prognosis	O
.	O

The	O
median	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
was	O
significantly	O
higher	O
in	O
the	O
first	O
trimester	O
than	O
in	O
the	O
third	O
trimester	O
:	O
20	O
.	O
4	O
ng	O
/	O
mL	O
and	O
22	O
.	O
7	O
ng	O
/	O
mL	O
respectively	O
.	O

However	O
,	O
several	O
limitations	O
merit	O
discussion	O
and	O
consideration	B
.	O

Of	O
total	O
participants	O
92	O
(	O
60	O
.	O
1	O
%)	O
mothers	O
were	O
nulliparous	O
and	O
61	O
(	O
39	O
.	O
9	O
%)	O
were	O
multiparous	O
women	O
.	O

Further	O
,	O
our	O
analysis	O
was	O
limited	O
to	O
prenatal	O
exposure	O
to	O
estrogenic	O
agents	O
.	O

None	O
of	O
these	O
events	O
were	O
adjudged	O
by	O
the	O
data	O
and	O
safety	O
monitoring	O
committee	O
to	O
be	O
treatment	O
related	O
and	O
there	O
were	O
no	O
serious	O
adverse	O
events	O
associated	O
with	O
the	O
use	O
of	O
metformin	O
.	O

The	O
special	O
nuclear	O
receptors	O
for	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
and	O
also	O
essential	O
enzymes	O
for	O
hydroxylation	O
of	O
vitamin	O
D	O
are	O
found	O
in	O
the	O
central	O
nervous	O
system	O
.	O

Our	O
findings	O
of	O
elevated	O
risks	O
of	O
incident	O
GDM	O
among	O
women	O
reporting	O
both	O
long	O
and	O
short	O
sleep	O
durations	O
in	O
early	O
pregnancy	O
are	O
consistent	O
with	O
these	O
earlier	O
reports	O
from	O
men	O
and	O
non	O
pregnant	O
women	O
.	O

No	O
earlier	O
studies	O
that	O
we	O
are	O
aware	O
of	O
have	O
evaluated	O
the	O
relationship	O
between	O
adult	O
vitamin	O
D	O
levels	O
and	O
psychotic	O
symptoms	O
.	O

Several	O
other	O
studies	O
have	O
focused	O
on	O
maternal	O
changes	O
during	O
pregnancy	O
and	O
their	O
association	O
with	O
autism	O
.	O

In	O
addition	O
,	O
it	O
is	O
possible	O
to	O
have	O
adverse	O
outcomes	O
that	O
are	O
reversible	O
.	O

However	O
,	O
by	O
limiting	O
unmeasured	O
confounding	O
due	O
to	O
differences	O
in	O
human	O
microbiomes	O
between	O
populations	O
that	O
may	O
result	O
in	O
erroneous	O
associations	O
with	O
dietary	O
differences	O
,	O
our	O
study	O
also	O
may	O
have	O
greater	O
internal	O
validity	O
.	O

Most	O
sleep	O
studies	O
,	O
however	O
,	O
have	O
excluded	O
pregnant	O
women	O
;	O
hence	O
very	O
little	O
is	O
known	O
about	O
how	O
insufficient	O
sleep	O
and	O
sleep	O
disordered	O
breathing	O
during	O
gestation	O
contribute	O
to	O
increased	O
risks	O
of	O
medical	O
complications	O
of	O
pregnancy	O
including	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
).	O

While	O
shared	O
genes	O
account	O
for	O
some	O
of	O
the	O
similarity	O
in	O
maternal	O
and	O
offspring	O
weight	O
,	O
evidence	O
suggests	O
that	O
exposure	O
to	O
the	O
uterine	O
environment	O
of	O
an	O
obese	O
woman	O
itself	O
may	O
directly	O
program	O
offspring	O
obesity	O
[	O
3	O
].	O

Lower	O
25OHD	O
in	O
early	O
pregnancy	O
was	O
only	O
associated	O
with	O
pregnancy	O
loss	O
.	O

2	O
.	O
3	O
.	O

Vitamin	O
C	O
Vitamin	O
C	O
can	O
be	O
synthesized	O
from	O
glucose	O
in	O
the	O
liver	O
of	O
many	O
mammalian	O
species	O
other	O
than	O
guinea	O
pigs	O
,	O
humans	O
,	O
and	O
other	O
primates	O
[	O
146	O
].	O

The	O
measurement	O
is	O
taken	O
with	O
the	O
infant	O
lying	O
on	O
his	O
/	O
her	O
back	O
on	O
the	O
infantometer	O
,	O
legs	O
extended	O
with	O
the	O
head	O
and	O
foot	O
board	O
making	O
contact	O
with	O
the	O
infant	O
.	O

Although	O
this	O
association	O
became	O
significant	O
even	O
after	O
taking	O
potential	O
confounders	O
into	O
account	O
in	O
model	O
1	O
[	O
OR	O
0	O
.	O
80	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
34	O
-	O
1	O
.	O
93	O
),	O
P	O
<	O
0	O
.	O
01	O
],	O
such	O
association	O
was	O
not	O
seen	O
in	O
models	O
2	O
and	O
3	O
.	O

Dietary	O
therapy	O
It	O
is	O
generally	O
accepted	O
that	O
dietary	O
therapy	O
is	O
the	O
cornerstone	O
of	O
treatment	O
of	O
GDM	O
.	O

Focusing	O
on	O
post	O
-	O
natal	O
issues	O
was	O
not	O
usually	O
appealing	O
to	O
pregnant	O
women	O
who	O
were	O
more	O
eager	O
to	O
learn	O
about	O
labor	O
.	O

Out	O
of	O
which	O
,	O
184	O
qualified	O
mothers	O
were	O
selected	O
who	O
completed	O
the	O
baseline	O
depression	O
questionnaire	O
.	O

For	O
1307	O
women	O
a	O
general	O
questionnaire	O
was	O
available	O
.	O

A	O
smaller	O
(	O
n	O
=	O
498	O
)	O
Japanese	O
study	O
did	O
not	O
demonstrate	O
a	O
positive	O
or	O
negative	O
association	O
between	O
maternal	O
fish	O
intake	O
during	O
pregnancy	O
and	O
neurodevelopment	O
as	O
measured	O
by	O
the	O
Neonatal	O
Behavioural	O
Assessment	O
tool	O
in	O
infants	O
at	O
three	O
days	O
of	O
age	O
[	O
25	O
].	O

Similarly	O
,	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
the	O
two	O
groups	O
with	O
regards	O
to	O
the	O
individual	O
components	O
of	O
the	O
Ages	O
and	O
Stages	O
score	O
(	O
Table	O
3	O
).	O

In	O
addition	O
,	O
brown	O
adipocytes	O
can	O
be	O
found	O
scattered	O
in	O
WAT	O
,	O
especially	O
upon	O
cold	O
exposure	O
(	O
Young	O
et	O
al	O
.,	O
1984	O
;	O
Guerra	O
et	O
al	O
.,	O
1998	O
),	O
treatment	O
with	O
β	O
-	O
adrenergic	O
(	O
Himms	O
-	O
Hagen	O
et	O
al	O
.,	O
2000	O
),	O
or	O
with	O
peroxisome	O
-	O
proliferator	O
-	O
activated	O
receptor	O
-	O
γ	O
(	O
PPAR	O
-	O
γ	O
)	O
agonists	O
(	O
Petrovic	O
et	O
al	O
.,	O
2010	O
).	O

Furthermore	O
,	O
metformin	O
can	O
promote	O
the	O
development	O
of	O
lactic	O
acidosis	O
,	O
which	O
surely	O
must	O
be	O
a	O
concern	O
in	O
situations	O
of	O
fetal	O
distress	O
.	O

There	O
are	O
no	O
indications	O
for	O
termination	O
of	O
pregnancy4	O
.	O

A	O
meta	O
-	O
analysis	O
of	O
starch	O
digestion	O
in	O
dairy	O
cows	O
revealed	O
that	O
the	O
ruminal	O
digestibility	O
of	O
corn	O
was	O
57	O
.	O
4	O
%	O
[	O
112	O
],	O
demonstrating	O
that	O
a	O
substantial	O
portion	O
of	O
corn	O
can	O
be	O
digested	O
in	O
the	O
small	O
intestine	O
.	O

In	O
the	O
studies	O
conducted	O
to	O
date	O
,	O
risk	O
estimates	O
and	O
p	O
-	O
values	O
for	O
the	O
association	O
between	O
season	O
of	O
birth	O
and	O
glioma	O
risk	O
have	O
been	O
nominal	O
to	O
borderline	O
in	O
strength	O
.	O

Peptide	O
mass	O
maps	O
of	O
tryptic	O
peptides	O
were	O
generated	O
by	O
matrix	O
assisted	O
laser	O
desorption	O
/	O
ionisation	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
TOF	O
MS	O
)	O
using	O
an	O
Applied	O
Biosystems	O
Q	O
-	O
STAR	O
Pulsar	O
with	O
MALDI	O
source	O
(	O
APAF	O
,	O
University	O
of	O
Sydney	O
).	O

However	O
,	O
the	O
exact	O
prevalence	O
of	O
allergic	O
forms	O
of	O
dermatitis	O
in	O
the	O
pregnant	O
population	O
is	O
not	O
known	O
.	O

Prenatal	O
vitamin	O
D	O
inadequacy	O
has	O
been	O
hypothesized	O
as	O
a	O
risk	O
factor	O
for	O
pediatric	O
atopy	O
and	O
asthma	O
.	O

Models	O
will	O
include	O
treatment	O
group	O
as	O
a	O
fixed	O
effect	O
,	O
community	O
-	O
cluster	O
as	O
a	O
random	O
effect	O
to	O
account	O
for	O
the	O
cluster	O
effect	O
.	O

This	O
was	O
independent	O
of	O
diet	O
and	O
lifestyles	O
factors	O
including	O
BMI	O
and	O
SEI	O
and	O
highlights	O
the	O
difficulty	O
in	O
understanding	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
in	O
human	O
cohort	O
studies	O
.	O

A	O
similar	O
process	O
was	O
used	O
to	O
identify	O
papers	O
on	O
risk	O
factors	O
related	O
to	O
season	O
of	O
birth	O
.	O

Funding	O
Wellcome	O
Trust	O
and	O
British	O
Council	O
.	O

The	O
CAPE	O
measures	O
of	O
psychosis	O
are	O
strongly	O
correlated	O
with	O
measures	O
of	O
general	O
psychopathology	O
,	O
including	O
depression	O
.	O

Furthermore	O
,	O
the	O
diet	O
-	O
dependent	O
transcriptional	O
excursions	O
revealed	O
an	O
impact	O
on	O
N	O
-	O
metabolism	O
.	O

3	O
.	O
4	O
.	O
2	O
.	O

Results	O
:	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
levels	O
were	O
found	O
to	O
be	O
significantly	O
positively	O
associated	O
with	O
birth	O
weight	O
percentile	O
(	O
p	O
=	O
0	O
.	O
01	O
and	O
p	O
<	O
0	O
.	O
0001	O
,	O
respectively	O
)	O
and	O
were	O
found	O
to	O
differ	O
significantly	O
among	O
infants	O
exposed	O
to	O
tobacco	O
smoke	O
and	O
alcohol	O
.	O

The	O
decision	O
whether	O
to	O
use	O
a	O
first	O
-	O
generation	O
or	O
second	O
-	O
generation	O
antihistamine	O
for	O
a	O
particular	O
patient	O
must	O
be	O
individualized	O
.	O

Proportion	O
(%)	O
of	O
women	O
with	O
1	O
-	O
hour	O
glucose	O
concentrations	O
≥	O
140	O
mg	O
/	O
dl	O
(	O
b	O
).	O

The	O
UPBEAT	O
trial	O
evaluated	O
the	O
effect	O
of	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
among	O
obese	O
women	O
,	O
with	O
no	O
impact	O
on	O
infant	O
birth	O
weight	O
demonstrated	O
[	O
17	O
].	O

In	O
the	O
same	O
report	O
[	O
68	O
],	O
the	O
MS	O
in	O
5	O
,	O
826	O
Korean	O
cattle	O
steers	O
from	O
several	O
farms	O
in	O
Gangwon	O
Province	O
was	O
analyzed	O
in	O
2010	O
to	O
2012	O
;	O
MS	O
increased	O
from	O
4	O
.	O
9	O
to	O
5	O
.	O
7	O
as	O
slaughter	O
age	O
increased	O
from	O
26	O
to	O
35	O
months	O
.	O

All	O
the	O
microarray	O
data	O
is	O
MIAME	O
compliant	O
and	O
the	O
raw	O
data	O
has	O
been	O
deposited	O
in	O
a	O
MIAME	O
compliant	O
database	O
,	O
the	O
National	O
Center	O
for	O
Biotechnology	O
Information	O
Gene	O
Expression	O
Omnibushttp	O
://	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
geo	O
(	O
accession	O
numbers	O
:	O
GSE25482	O
and	O
GSE31191	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
asthma	O
,	O
wheeze	O
,	O
eczema	O
,	O
hay	O
fever	O
and	O
atopy	O
in	O
the	O
offspringMaternal	O
free	O
sugar	O
intake	O
during	O
pregnancyp	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAsthma	O
n	O
=	O
7677	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
14	O
(	O
0	O
.	O
91	O
–	O
1	O
.	O
41	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
77	O
–	O
1	O
.	O
23	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
56	O
)	O
1	O
.	O
37	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
81	O
)	O
1	O
.	O
07	O
(	O
1	O
.	O
00	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
04	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
18	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
29	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
58	O
)	O
1	O
.	O
31	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
75	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
09	O
Wheeze	O
n	O
=	O
7762	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
21	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
52	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
35	O
)	O
1	O
.	O
19	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
54	O
)	O
1	O
.	O
38	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
85	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
09	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
25	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
58	O
)	O
1	O
.	O
11	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
42	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
42	O
(	O
1	O
.	O
05	O
–	O
1	O
.	O
92	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
08	O
Eczema	O
n	O
=	O
7748	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
19	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
44	O
)	O
1	O
.	O
13	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
30	O
)	O
0	O
.	O
91	O
(	O
0	O
.	O
70	O
–	O
1	O
.	O
17	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
03	O
)	O
0	O
.	O
33	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
17	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
42	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
41	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
33	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
74	O
–	O
1	O
.	O
26	O
)	O
0	O
.	O
99	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
05	O
)	O
0	O
.	O
70	O
Hay	O
fever	O
n	O
=	O
7728	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
07	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
88	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
13	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
03	O
(	O
0	O
.	O
79	O
–	O
1	O
.	O
33	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
21	O
(	O
0	O
.	O
91	O
–	O
1	O
.	O
60	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
75	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
10	O
Atopy	O
n	O
=	O
6117	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
99	O
(	O
0	O
.	O
81	O
–	O
1	O
.	O
21	O
)	O
1	O
.	O
09	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
34	O
)	O
1	O
.	O
19	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
60	O
)	O
1	O
.	O
06	O
(	O
1	O
.	O
01	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
03	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
98	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
20	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
35	O
)	O
1	O
.	O
20	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
49	O
)	O
1	O
.	O
38	O
(	O
1	O
.	O
06	O
–	O
1	O
.	O
78	O
)	O
1	O
.	O
09	O
(	O
1	O
.	O
02	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
006	O
#:	O
controlling	O
for	O
energy	O
intake	O
;¶:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

The	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
exhibited	O
higher	O
plasma	O
levels	O
of	O
LDL	O
and	O
glucose	O
as	O
well	O
as	O
a	O
reduction	O
in	O
chocolate	O
and	O
caloric	O
intake	O
at	O
post	O
-	O
weaning	O
periods	O
in	O
the	O
feeding	O
tests	O
.	O

Overall	O
,	O
the	O
current	O
study	O
extends	O
existing	O
work	O
by	O
suggesting	O
that	O
exposure	O
to	O
foods	O
or	O
drinks	O
high	O
in	O
sugar	O
content	O
early	O
in	O
gestation	O
may	O
predispose	O
offspring	O
to	O
higher	O
weight	O
status	O
early	O
in	O
infancy	O
,	O
independent	O
of	O
maternal	O
GWG	O
.	O

Post	O
-	O
intervention	O
,	O
significantly	O
more	O
women	O
(	O
50	O
.	O
6	O
%)	O
received	O
best	O
-	O
practice	O
care	O
(	O
2	O
+	O
reviews	O
)	O
(	O
p	O
=	O
0	O
.	O
02	O
).	O

Regarding	O
the	O
fate	O
of	O
glucose	O
in	O
brown	O
adipocytes	O
under	O
anabolic	O
conditions	O
characterized	O
by	O
high	O
insulin	O
levels	O
,	O
it	O
is	O
essentially	O
metabolized	O
to	O
provide	O
glycerol	O
-	O
3	O
-	O
phosphate	O
for	O
triglyceride	O
synthesis	O
or	O
acetyl	O
-	O
CoA	O
for	O
de	O
novo	O
fatty	O
acid	O
synthesis	O
(	O
Cannon	O
and	O
Nedergaard	O
,	O
2004	O
).	O

The	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
.	O
Visfatin	O
has	O
extensive	O
effects	O
on	O
pregnancy	O
physiology	O
and	O
pathology	O
,	O
maternal	O
and	O
especially	O
neonatal	O
outcomes	O
,	O
and	O
its	O
effect	O
is	O
different	O
in	O
normal	O
weight	O
and	O
overweight	O
women	O
.	O

With	O
1	O
ng	O
/	O
mL	O
reduction	O
in	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
,	O
the	O
anxiety	O
and	O
depression	O
levels	O
increased	O
0	O
.	O
043	O
and	O
0	O
.	O
040	O
,	O
respectively	O
[	O
64	O
].	O

Nutrient	O
density	O
was	O
calculated	O
by	O
dividing	O
the	O
estimated	O
intake	O
of	O
fatty	O
acids	O
,	O
vitamin	O
D	O
and	O
other	O
nutrients	O
by	O
the	O
total	O
energy	O
intake	O
(	O
i	O
.	O
e	O
.,	O
the	O
multivariate	O
nutrient	O
density	O
model	O
)	O
[	O
28	O
].	O

All	O
RNA	O
samples	O
were	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
downstream	O
analysis	O
was	O
performed	O
.	O

*	O
Studies	O
demonstrating	O
environmentally	O
-	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
were	O
reversed	O
by	O
an	O
inhibitor	O
/	O
treatment	O
,	O
absent	O
in	O
a	O
knock	O
out	O
/	O
down	O
model	O
,	O
and	O
/	O
or	O
mechanistically	O
linked	O
in	O
a	O
relevant	O
in	O
vitro	O
system	O
.	O

At	O
minimum	O
,	O
if	O
a	O
causal	O
relationship	O
exists	O
,	O
season	O
of	O
birth	O
meets	O
the	O
criteria	O
of	O
temporality	O
as	O
the	O
period	O
surrounding	O
birth	O
clearly	O
predates	O
disease	O
occurrence	O
.	O

Even	O
so	O
,	O
this	O
study	O
will	O
provide	O
a	O
comprehensive	O
and	O
unique	O
database	O
from	O
an	O
urban	O
South	O
African	O
setting	O
which	O
will	O
allow	O
for	O
cross	O
-	O
sectional	O
,	O
prospective	O
and	O
retrospective	O
analyses	O
to	O
describe	O
the	O
nutritional	O
status	O
and	O
dietary	O
intake	O
of	O
pregnant	O
women	O
,	O
and	O
to	O
determine	O
associations	O
with	O
health	O
outcome	O
measures	O
.	O

At	O
the	O
first	O
postnatal	O
visit	O
(	O
phase	O
6	O
)	O
a	O
follow	O
-	O
up	O
is	O
made	O
on	O
the	O
maternal	O
medical	O
history	O
at	O
birth	O
.	O

Multiple	O
linear	O
regression	O
was	O
then	O
used	O
to	O
evaluate	O
the	O
association	O
between	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
levels	O
and	O
continuous	O
birth	O
weight	O
percentile	O
.	O

1998	O
).	O

Of	O
those	O
who	O
delivered	O
preterm	O
,	O
10	O
delivered	O
before	O
gestational	O
week	O
31	O
and	O
thus	O
before	O
the	O
T3	O
blood	O
sample	O
could	O
be	O
drawn	O
.	O

Introduction	O
Thyroid	O
cancer	O
,	O
the	O
most	O
common	O
endocrine	O
malignancy	O
,	O
is	O
often	O
detected	O
in	O
young	O
patients	O
and	O
is	O
more	O
frequently	O
diagnosed	O
in	O
women	O
.	O

Experts	O
have	O
decried	O
the	O
lack	O
of	O
trustworthy	O
statistics	O
on	O
the	O
sources	O
and	O
extent	O
of	O
pollution	O
and	O
the	O
number	O
of	O
remediation	O
facilities	O
.	O

Furthermore	O
,	O
studies	O
have	O
focussed	O
predominantly	O
on	O
measures	O
of	O
adiposity	O
,	O
and	O
have	O
not	O
reported	O
other	O
clinically	O
relevant	O
infant	O
outcomes	O
[	O
18	O
,	O
20	O
],	O
or	O
specifically	O
reported	O
infant	O
outcomes	O
among	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
[	O
19	O
].	O

of	O
expressed	O
probe	O
-	O
setsNo	O
.	O

In	O
such	O
patients	O
,	O
IL	O
-	O
6	O
is	O
preferentially	O
secreted	O
from	O
visceral	O
rather	O
than	O
from	O
subcutaneous	O
adipocytes	O
and	O
may	O
participate	O
in	O
the	O
prevailing	O
increase	O
in	O
sympathetic	O
outflow	O
by	O
exerting	O
central	O
effects	O
(	O
Wallenius	O
et	O
al	O
.,	O
2002	O
;	O
Fain	O
et	O
al	O
.,	O
2004	O
).	O

Cancer	O
Causes	O
Control	O
15	O
(	O
6	O
):	O
559	O
–	O
570	O
.	O

The	O
relatively	O
high	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
may	O
have	O
important	O
health	O
implications	O
for	O
Thai	O
people	O
as	O
the	O
science	O
of	O
vitamin	O
D	O
continues	O
to	O
be	O
unraveled	O
.	O

Future	B
research	I
is	I
needed	I
to	O
determine	O
whether	O
differences	O
in	O
postnatal	O
feeding	O
behaviors	O
might	O
explain	O
differential	O
growth	O
rates	O
in	O
offspring	O
of	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
mothers	O
.	O

N	O
-	O
nitroso	O
compounds	O
are	O
a	O
potent	O
inducer	O
of	O
cancer	O
and	O
brain	O
tumors	O
in	O
various	O
animal	O
species	O
[	O
159	O
,	O
160	O
],	O
and	O
fetal	O
exposure	O
produces	O
more	O
tumors	O
than	O
postnatal	O
exposure	O
[	O
161	O
].	O

*/***	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
control	O
dams	O
.	O

Alternatively	O
,	O
higher	O
eggs	O
and	O
poultry	O
consumption	O
may	O
also	O
explain	O
the	O
high	O
detection	O
rate	O
.	O

The	O
IMF	O
of	O
Angus	O
steers	O
grown	O
in	O
South	O
Dakota	O
(	O
USA	O
)	O
increased	O
linearly	O
with	O
increasing	O
HCW	O
from	O
189	O
to	O
368	O
kg	O
(	O
live	O
weight	O
from	O
340	O
to	O
591	O
kg	O
)	O
[	O
73	O
].	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

Moreover	O
,	O
we	O
observed	O
a	O
sex	O
effect	O
on	O
perirenal	O
,	O
perigonadal	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perigonadal	O
fat	O
relative	O
to	O
body	O
weight	O
.	O

The	O
rats	O
were	O
fasted	O
overnight	O
for	O
10	O
h	O
before	O
glucose	O
gavage	O
.	O

Romanian	O
recommendations	B
stipulate	O
that	O
women	O
with	O
a	O
haemoglobin	O
higher	O
than	O
11	O
g	O
/	O
dl	O
should	B
take	O
60	O
mg	O
of	O
iron	O
and	O
350	O
μg	O
of	O
folic	O
acid	O
from	O
the	O
16thweek	O
of	O
pregnancy	O
to	O
prevent	O
anaemia	O
,	O
but	O
only	O
iron	O
products	O
are	O
reimbursed	O
by	O
the	O
health	O
insurance	O
system	O
.	O

The	O
latter	O
tend	O
to	O
live	O
and	O
work	O
in	O
a	O
more	O
closed	O
indoor	O
environment	O
and	O
thus	O
suffer	O
greater	O
exposure	O
to	O
indoor	O
pollutants	O
(	O
e	O
.	O
g	O
.,	O
polychlorinated	O
biphenyls	O
,	O
phthalates	O
,	O
phenols	O
,	O
flame	O
retardants	O
)	O
[	O
29	O
].	O

The	O
WHO	O
technical	O
working	O
group	O
on	O
the	O
prevention	O
and	O
the	O
treatment	O
of	O
severe	O
anaemia	O
has	O
documented	O
that	O
parenteral	O
iron	O
therapy	O
produces	O
a	O
rapid	O
and	O
complete	O
correction	O
of	O
iron	O
deficiency	O
,	O
including	O
replacement	O
of	O
iron	O
stores	O
;	O
thereby	O
producing	O
a	O
more	O
rapid	O
erythropoietic	O
response	O
than	O
oral	O
iron	O
replacement	O
[	O
39	O
].	O

Potential	O
confounders	O
for	O
vitamin	O
D	O
status	O
were	O
assessed	O
using	O
linear	O
modelling	O
.	O

(	O
2008	O
)*	O
NicotineRatInjection	O
(	O
sc	O
)	O
(	O
1	O
mg	O
/	O
kg	O
twice	O
/	O
d	O
)	O
Implant	O
(	O
sc	O
)	O
(	O
4	O
µg	O
/	O
kg	O
/	O
min	O
)	O
Combinations	O
of	O
:	O
In	O
utero	O
Neonatal	O
In	O
utero	O
Neonatal	O
F0	O
-	O
F1generationsGrowth	O
retardation	O
Neurological	O
and	O
adrenal	O
abnormalitiesHistone	O
modification	O
DNA	O
methylation	O
Epigenetic	O
machineryLi	O
et	O
al	O
.	O

In	O
univariate	O
analyses	O
,	O
thyroxine	O
therapy	O
apparently	O
helps	O
decrease	O
cancer	O
-	O
related	O
death	O
rates	O
among	O
patients	O
with	O
PTC	O
.	O

In	O
juvenile	O
LP	O
offspring	O
,	O
mRNA	O
expression	O
profiles	O
were	O
moderately	O
altered	O
compared	O
to	O
AP	O
offspring	O
.	O

Birth	O
weight	O
percentile	O
was	O
stratified	O
into	O
three	O
clinically	O
meaningful	O
categories	O
to	O
create	O
birth	O
weight	O
status	O
:	O
SGA	O
babies	O
,	O
defined	O
as	O
babies	O
whose	O
birth	O
weight	O
lies	O
below	O
the	O
10th	O
percentile	O
for	O
that	O
gestational	O
age	O
;	O
appropriate	O
for	O
gestational	O
age	O
(	O
AGA	O
)	O
babies	O
,	O
defined	O
as	O
babies	O
whose	O
birth	O
weight	O
lies	O
above	O
the	O
10th	O
percentile	O
for	O
that	O
gestational	O
age	O
and	O
below	O
the	O
90th	O
percentile	O
for	O
that	O
gestational	O
age	O
;	O
and	O
large	O
for	O
gestational	O
age	O
(	O
LGA	O
)	O
babies	O
,	O
defined	O
as	O
babies	O
whose	O
birth	O
weight	O
lies	O
above	O
the	O
90th	O
percentile	O
for	O
that	O
gestational	O
age	O
.	O

Greenwood	O
et	O
al	O
[	O
30	O
]	O
conducted	O
a	O
study	O
to	O
test	O
effects	O
of	O
genotypes	O
and	O
nutrition	O
during	O
the	O
immediate	O
postweaning	O
period	O
on	O
IMF	O
contents	O
in	O
5	O
muscles	O
,	O
marbling	O
,	O
and	O
subcutaneous	O
fat	O
(	O
rib	O
fat	O
or	O
P8	O
rump	O
fat	O
)	O
in	O
Bos	O
Taurus	O
steers	O
.	O

Furthermore	O
,	O
mean	O
LINE	O
-	O
1	O
methylation	O
levels	O
were	O
significantly	O
different	O
by	O
maternal	O
alcohol	O
use	O
during	O
pregnancy	O
;	O
however	O
,	O
limited	O
numbers	O
may	O
affect	O
our	O
precision	O
,	O
so	O
this	O
result	O
should	B
be	I
confirmed	I
in	I
further	I
analyses	I
.	O

[	O
5	O
]	O
The	O
above	O
observations	O
highlight	O
the	O
fact	O
that	O
vitamin	O
D	O
has	O
a	O
key	O
role	O
to	O
play	O
in	O
the	O
pathogenesis	O
of	O
wheezing	O
/	O
asthma	O
.	O

The	O
TSH	O
concentration	O
generally	O
lies	O
within	O
the	O
normal	O
range	O
after	O
the	O
16th	O
to	O
18th	O
week11171920	O
.	O

In	O
response	O
,	O
the	O
Chinese	O
government	O
invested	O
US	O
$	O
100	O
million	O
in	O
2007	O
to	O
launch	O
the	O
collection	O
of	O
data	O
from	O
industrial	O
,	O
agricultural	O
,	O
and	O
residential	O
sources	O
at	O
sites	O
throughout	O
China	O
,	O
beginning	O
in	O
February	O
2008	O
.	O

A	O
meta	O
-	O
analysis	O
which	O
included	O
the	O
above	O
studies	O
as	O
well	O
as	O
others	O
examining	O
women	O
with	O
pre	O
-	O
existing	O
diabetes	O
,	O
with	O
745	O
glyburide	O
exposed	O
pregnancies	O
and	O
637	O
treated	O
with	O
insulin	O
,	O
has	O
been	O
performed	O
.	O
65This	O
study	O
found	O
that	O
glyburide	O
did	O
not	O
increase	O
the	O
risk	O
of	O
macrosomia	O
,	O
large	O
for	O
gestational	O
age	O
,	O
or	O
neonatal	O
hypoglycemia	O
,	O
but	O
did	O
not	O
examine	O
more	O
serious	O
consequences	O
such	O
as	O
perinatal	O
mortality	O
or	O
congenital	O
anomalies	O
.	O

The	O
validity	O
of	O
PUFA	O
estimated	O
by	O
means	O
of	O
the	O
FFQ	O
was	O
r	O
=	O
0	O
.	O
5	O
in	O
comparison	O
to	O
adipose	O
tissue	O
composition	O
[	O
26	O
].	O

Data	O
from	O
gene	O
expression	O
were	O
analyzed	O
by	O
two	O
-	O
way	O
ANOVA	O
with	O
diet	O
and	O
sex	O
as	O
factors	O
.	O

Standard	O
measuring	O
equipment	O
,	O
common	O
size	O
containers	O
(	O
e	O
.	O
g	O
.	O

The	O
HFol	O
pup	O
diet	O
reduced	O
SeroR2A	O
expression	O
in	O
mature	O
offspring	O
of	O
the	O
dams	O
fed	O
the	O
HV	O
diet	O
,	O
but	O
not	O
by	O
the	O
HV	O
pup	O
diet	O
(	O
Figure	O
5b	O
).	O

They	O
drink	O
more	O
water	O
and	O
eat	O
more	O
foods	O
per	O
unit	O
of	O
body	O
weight	O
than	O
adults	O
and	O
will	O
therefore	O
ingest	O
more	O
toxins	O
from	O
well	O
water	O
and	O
agriculturally	O
treated	O
foods	O
[	O
33	O
,	O
34	O
].	O

Some	O
ncRNAs	O
can	O
also	O
promote	O
changes	O
in	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
,	O
and	O
/	O
or	O
the	O
expression	O
of	O
other	O
ncRNAs	O
.	O

From	O
third	O
day	O
of	O
pregnancy	O
to	O
term	O
,	O
dams	O
(	O
n	O
=	O
10	O
per	O
gestational	O
diet	O
group	O
)	O
were	O
fed	O
the	O
AIN	O
-	O
93G	O
diet13containing	O
either	O
the	O
RV	O
or	O
HV	O
amount	O
of	O
the	O
multivitamin	O
mix	O
.	O

Spearman	O
correlations	O
(	O
ρ	O
)	O
were	O
used	O
to	O
assess	O
the	O
association	O
between	O
each	O
child	O
’	O
s	O
cathelicidin	O
concentration	O
and	O
the	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
obtained	O
at	O
various	O
time	O
points	O
:	O
(	O
1	O
)	O
at	O
the	O
corresponding	O
follow	O
-	O
up	O
visit	O
;	O
(	O
2	O
)	O
at	O
delivery	O
;	O
(	O
3	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
(	O
using	O
the	O
area	O
under	O
the	O
curve	O
from	O
visit	O
3	O
to	O
visit	O
7	O
);	O
and	O
(	O
4	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
of	O
delivery	O
.	O

The	O
system	O
will	O
also	O
generate	O
daily	O
reports	O
of	O
the	O
completed	O
interviews	O
and	O
enrolment	O
and	O
make	O
them	O
available	O
on	O
the	O
online	O
monitoring	O
interface	O
(	O
in	O
real	O
time	O
).	O

Weight	O
,	O
length	O
,	O
BMI	O
,	O
weight	O
-	O
for	O
-	O
length	O
,	O
and	O
head	O
circumference	O
measures	O
were	O
converted	O
to	O
z	O
-	O
scores	O
for	O
age	O
and	O
gender	O
,	O
using	O
WHO	O
standards	O
[	O
27	O
,	O
30	O
].	O

The	O
fieldworkers	O
obtained	O
written	O
informed	O
consent	O
from	O
the	O
mother	O
,	O
father	O
,	O
or	O
another	O
senior	O
family	O
member	O
before	O
recruitment	O
;	O
allocated	O
the	O
unique	O
identification	O
number	O
(	O
sequentially	O
);	O
and	O
gave	O
the	O
first	O
dose	O
of	O
vitamin	O
D3or	O
placebo	O
.	O

Particularly	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
males	O
and	O
RC	O
females	O
did	O
not	O
displayed	O
higher	O
caloric	O
intake	O
compared	O
to	O
the	O
respective	O
CC	O
males	O
and	O
CC	O
females	O
.	O

Points	O
are	O
colored	O
by	O
taxonomy	O
represented	O
heavily	O
in	O
top	O
results	O
,	O
for	O
p	O
<	O
0	O
.	O
10	O
.	O

Participants	O
took	O
a	O
survey	O
about	O
their	O
Vitamin	O
D	O
supplement	O
intake	O
history	O
,	O
including	O
brand	O
,	O
gestational	O
week	O
when	O
starting	O
the	O
intake	O
,	O
frequency	O
and	O
dose	O
,	O
and	O
calculation	O
of	O
non	O
-	O
dietary	O
Vitamin	O
D	O
daily	O
intake	O
.	O

All	O
the	O
studies	O
shown	O
here	O
demonstrated	O
associations	O
among	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

All	O
whole	O
body	O
DEXA	O
scans	O
were	O
done	O
by	O
the	O
same	O
technologist	O
on	O
a	O
Hologic	O
Discovery	O
A	O
densitometer	O
(	O
Bedford	O
,	O
MA	O
,	O
USA	O
).	O

A	O
deeper	O
shave	O
removal	O
was	O
performed	O
with	O
aggressive	O
electrodessication	O
of	O
the	O
base	O
to	O
minimize	O
risk	O
of	O
recurrence	O
.	O

This	O
correlation	O
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

Spearman	O
Rank	O
correlation	O
test	O
showed	O
a	O
negative	O
significant	O
relationship	O
between	O
second	O
trimester	O
visfatin	O
level	O
and	O
birth	O
height	O
(	O
p	O
=	O
0	O
.	O
015	O
,	O
r	O
=-	O
0	O
.	O
523	O
)	O
in	O
group	O
B	O
(	O
Table	O
2	O
).	O

The	O
vast	O
majority	O
of	O
the	O
mammalian	O
genome	O
is	O
composed	O
of	O
so	O
-	O
called	O
non	O
-	O
coding	O
DNA	O
(	O
ncDNA	O
),	O
with	O
only	O
1	O
–	O
5	O
%	O
coding	O
for	O
proteins	O
.	O

Dietary	O
intake	O
of	O
fish	O
,	O
omega	O
-	O
3	O
,	O
omega	O
-	O
6	O
polyunsaturated	O
fatty	O
acids	O
and	O
vitamin	O
D	O
and	O
the	O
prevalence	O
of	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
cohort	O
of	O
33	O
000	O
women	O
from	O
the	O
general	O
population	O
Abstract	O
Background	O
Low	O
intake	O
of	O
fish	O
,	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
)	O
and	O
vitamin	O
D	O
deficiency	O
has	O
been	O
suggested	O
to	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
schizophrenia	O
.	O

The	O
Projahnmo	O
trial	O
demonstrated	O
improved	O
IFA	O
supplements	O
as	O
84	O
%	O
of	O
pregnant	O
women	O
in	O
the	O
home	O
-	O
care	O
treatment	O
arm	O
reported	O
IFA	O
supplements	O
use	O
in	O
pregnancy	O
[	O
18	O
].	O

In	O
the	O
February	O
2008	O
issue	O
of	O
Food	O
and	O
Chemical	O
Toxicology	O
,	O
researchers	O
from	O
India	O
report	O
that	O
aqueous	O
garlic	O
extract	O
(	O
AGE	O
)	O
fed	O
to	O
at	O
-	O
risk	O
individuals	O
may	O
reduce	O
the	O
toxic	O
effects	O
of	O
arsenic	O
.	O

The	O
results	O
of	O
the	O
Behavioural	O
Risk	O
Factor	O
Surveillance	O
System	O
(	O
BRFSS	O
)	O
also	O
emphasize	O
the	O
role	O
of	O
income	O
and	O
marital	O
status	O
in	O
the	O
use	O
of	O
vitamin	O
and	O
mineral	O
supplements	O
[	O
40	O
].	O

We	O
conducted	O
the	O
key	O
informant	O
interviews	O
to	O
understand	O
the	O
community	O
norms	O
around	O
IFA	O
supplementation	O
,	O
and	O
challenges	O
and	O
successes	O
of	O
the	O
existing	O
programme	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Maternal	O
mean	O
plasma	O
glucose	O
concentrations	O
after	O
a	O
50	O
-	O
g	O
glucose	O
challenge	O
.	O

However	O
,	O
a	O
woman	O
with	O
GDM	O
is	O
a	O
woman	O
at	O
high	O
risk	O
of	O
future	O
diabetes	O
.	O

Kawachi	O
[	O
137	O
]	O
described	O
that	O
the	O
plasma	O
retinol	O
level	O
in	O
Japanese	O
fattening	O
cattle	O
is	O
about	O
300	O
μg	O
/	O
L	O
(	O
100	O
IU	O
/	O
dL	O
)	O
and	O
that	O
a	O
vitamin	O
A	O
-	O
deficient	O
diet	O
decreases	O
the	O
plasma	O
concentration	O
to	O
<	O
90	O
μg	O
/	O
L	O
(	O
30	O
IU	O
/	O
dL	O
).	O

Radioimmunoassay	O
and	O
ELISA	O
were	O
performed	O
to	O
analyze	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
,	O
respectively	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

In	O
addition	O
to	O
the	O
previously	O
mentioned	O
soluble	O
factors	O
,	O
also	O
cells	O
are	O
transferred	O
in	O
utero	O
,	O
for	O
instance	O
,	O
leukocytes	O
pass	O
from	O
mother	O
to	O
fetus	O
.	O

We	O
have	O
utilised	O
robust	O
methodology	O
in	O
terms	O
of	O
obtaining	O
accurate	O
measurement	O
of	O
early	O
pregnancy	O
weight	O
,	O
height	O
,	O
and	O
BMI	O
;	O
detailed	O
maternal	O
dietary	O
and	O
physical	O
activity	O
history	O
;	O
and	O
have	O
delivered	O
the	O
antenatal	O
intervention	O
in	O
a	O
consistent	O
manner	O
to	O
participants	O
.	O

DNA	O
is	O
methylated	O
by	O
a	O
family	O
of	O
DNA	O
methyltransferases	O
(	O
DNMTs	O
)	O
(	O
Bestor	O
&	O
Ingram1983	O
;	O
Li	O
et	O
al	O
.	O
1992	O
,	O
1996	O
;	O
Okano	O
et	O
al	O
.	O
1998	O
,	O
1999	O
;	O
Aapola	O
et	O
al	O
.	O
2000	O
;	O
Gowher	O
et	O
al	O
.	O
2005	O
).	O

Blood	O
samples	O
were	O
obtained	O
during	O
yearly	O
visits	O
from	O
133	O
children	O
,	O
ages	O
2	O
–	O
7	O
,	O
whose	O
mothers	O
had	O
participated	O
in	O
a	O
pregnancy	O
vitamin	O
D	O
supplementation	O
RCT	O
.	O

Indeed	O
,	O
PGCs	O
,	O
which	O
represent	O
an	O
interim	O
stage	O
of	O
the	O
developing	O
germ	O
line	O
that	O
requires	O
miRNA	O
-	O
mediated	O
proliferation	O
and	O
differentiation	O
with	O
some	O
pi	O
/	O
esiRNA	O
-	O
mediated	O
genome	O
protection	O
,	O
express	O
greater	O
levels	O
of	O
miRNAs	O
and	O
reduced	O
levels	O
of	O
piRNAs	O
and	O
esiRNAs	O
compared	O
with	O
the	O
mature	O
gametes	O
and	O
early	O
zygote	O
(	O
Garcia	O
-	O
Lopez	O
et	O
al	O
.	O
2015	O
).	O

),	O
overweight	O
or	O
obesity	O
,	O
excessive	O
gestational	O
weight	O
gain	O
,	O
excessive	O
central	O
body	O
fat	O
deposition	O
,	O
family	O
history	O
of	O
diabetes	O
,	O
short	O
stature	O
(<	O
1	O
.	O
50	O
m	O
),	O
excessive	O
fetal	O
growth	O
,	O
polyhydramnios	O
,	O
hypertension	O
or	O
preeclampsia	O
in	O
the	O
current	O
pregnancy	O
,	O
history	O
of	O
recurrent	O
miscarriage	O
,	O
offspring	O
malformation	O
,	O
fetal	O
or	O
neonatal	O
death	O
,	O
macrosomia	O
,	O
GDM	O
during	O
prior	O
pregnancies	O
and	O
polycystic	O
ovary	O
syndrome	O
.	O

Constraints	O
to	O
Successful	O
Preventive	O
Treatments	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
3	O
.	O
4	O
.	O
1	O
.	O

HELLP	O
syndrome	O
is	O
considered	O
a	O
spectrum	O
of	O
preeclampsia	O
.	O

Pethick	O
et	O
al	O
[	O
69	O
]	O
suggested	O
that	O
feed	O
that	O
has	O
a	O
high	O
glycemic	O
index	O
to	O
allow	O
rapid	O
glucose	O
absorption	O
and	O
concomitant	O
high	O
insulin	O
levels	O
through	O
either	O
grain	O
feeding	O
instead	O
of	O
grass	O
finishing	O
or	O
grain	O
processing	O
provides	O
increased	O
net	O
energy	O
levels	O
for	O
FA	O
synthesis	O
.	O

This	O
was	O
largely	O
driven	O
by	O
a	O
55	O
%	O
decreased	O
risk	O
of	O
GDM	O
in	O
women	O
with	O
a	O
male	O
fetus	O
with	O
high	O
standardised	O
serum	O
25	O
(	O
OH	O
)	O
D	O
when	O
compared	O
to	O
those	O
carrying	O
a	O
male	O
fetus	O
with	O
moderate	O
-	O
high	O
serum	O
25	O
(	O
OH	O
)	O
D	O
(	O
aRR	O
:	O
0	O
.	O
45	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
15	O
,	O
1	O
.	O
38	O
).	O

Methods	O
We	O
interviewed	O
women	O
from	O
the	O
inpatient	O
post	O
-	O
natal	O
unit	O
at	O
BMC	O
about	O
what	O
herbs	O
they	O
used	O
during	O
pregnancy	O
,	O
socioeconomic	O
factors	O
,	O
changes	O
to	O
diet	O
,	O
and	O
use	O
of	O
prenatal	O
vitamins	O
.	O

Using	O
data	O
from	O
the	O
general	O
Australian	O
population	O
,	O
we	O
anticipated	O
a	O
minimum	O
incidence	O
in	O
the	O
standard	O
care	O
group	O
of	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
of	O
approximately	O
25	O
%	O
[	O
35	O
].	O

For	O
these	O
reasons	O
,	O
differentiated	O
thyroid	O
cancer	O
(	O
DTC	O
)	O
is	O
one	O
of	O
the	O
most	O
common	O
cancers	O
in	O
women	O
in	O
the	O
reproductive	O
age	O
.	O

We	O
aimed	O
to	O
examine	O
the	O
association	O
of	O
maternal	O
diet	O
during	O
pregnancy	O
with	O
the	O
infant	O
gut	O
microbiome	O
6	O
weeks	O
post	O
-	O
delivery	O
in	O
mother	O
-	O
infant	O
dyads	O
enrolled	O
in	O
the	O
New	O
Hampshire	O
Birth	O
Cohort	O
Study	O
.	O

Considering	O
the	O
possible	O
losses	O
,	O
the	O
sample	O
size	O
was	O
set	O
at	O
74	O
people	O
in	O
each	O
group	O
finally	O
.	O

The	O
timing	O
and	O
dosage	O
of	O
oral	O
iron	O
are	O
also	O
controversial	O
as	O
most	O
studies	O
have	O
focused	O
on	O
preventive	O
treatment	O
from	O
midpregnancy	O
,	O
at	O
or	O
before	O
20	O
weeks	O
gestation	O
[	O
4	O
].	O

As	O
a	O
result	O
of	O
this	O
improvement	O
,	O
physical	O
activity	O
increases	O
and	O
this	O
have	O
positive	O
effects	O
on	O
health	O
.	O

Some	O
evidence	O
suggests	O
that	O
maternal	O
prenatal	O
intake	O
of	O
protein	O
and	O
fat	O
[	O
7	O
–	O
9	O
]	O
may	O
be	O
positively	O
associated	O
with	O
birth	O
weight	O
.	O

Change	O
in	O
25OHD	O
was	O
calculated	O
as	O
the	O
difference	O
between	O
T3	O
and	O
T1	O
(	O
T3	O
-	O
T1	O
)	O
and	O
was	O
coded	O
into	O
3	O
groups	O
:	O
decrease	O
in	O
25OHD	O
(≤	O
0	O
nmol	O
/	O
L	O
),	O
small	O
increase	O
(	O
0	O
.	O
1	O
–	O
29	O
.	O
99	O
nmol	O
/	O
L	O
)	O
or	O
large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
).	O

The	O
left	O
side	O
of	O
the	O
remaining	O
brain	O
was	O
used	O
for	O
folate	O
concentration	O
measurement	O
.	O

In	O
total	O
,	O
28	O
individual	O
liver	O
mRNA	O
samples	O
were	O
analyzed	O
in	O
duplicate	O
per	O
stage	O
.	O

Conclusion	O
Providing	O
pregnant	O
women	O
who	O
were	O
overweight	O
or	O
obese	O
with	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
did	O
not	O
alter	O
6	O
-	O
month	O
infant	O
growth	O
and	O
adiposity	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Summary	O
of	O
vitamin	O
D	O
status	O
in	O
Thai	O
peopleStudyChailurkit	O
et	O
al	O
.	O

Two	O
-	O
way	O
ANOVA	O
showed	O
a	O
main	O
effect	O
of	O
the	O
diet	O
on	O
the	O
gene	O
expression	O
of	O
Cnr1	O
in	O
hypothalamus	O
and	O
liver	O
,	O
Cnr2	O
in	O
hypothalamus	O
and	O
PAT	O
,	O
Napepld	O
,	O
Faah	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
liver	O
and	O
PAT	O
,	O
and	O
Dagl	O
α	O
in	O
PAT	O
(	O
see	O
TableS2for	O
statistical	O
values	O
).	O

It	O
will	O
also	O
provide	O
valuable	O
evidence	O
about	O
the	O
role	O
of	O
groundwater	O
iron	O
level	O
in	O
modifying	O
the	O
responses	O
of	O
antenatal	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
since	O
there	O
is	O
already	O
some	O
evidence	O
which	O
suggests	O
a	O
positive	O
,	O
dose	O
-	O
response	O
association	O
between	O
natural	O
iron	O
in	O
groundwater	O
and	O
the	O
iron	O
status	O
of	O
women	O
[	O
6	O
].	O

The	O
spicules	O
of	O
bone	O
contained	O
osteocytes	O
and	O
were	O
lined	O
by	O
benign	O
-	O
appearing	O
osteoblasts	O
(	O
Fig	O
3	O
).	O

Several	O
modifications	O
of	O
vitamin	O
D	O
metabolism	O
occur	O
during	O
pregnancy	O
.	O

But	O
,	O
adjustment	O
for	O
multivitamin	O
supplement	O
intake	O
,	O
containing	O
vitamin	O
D	O
,	O
did	O
not	O
change	O
the	O
estimates	O
.	O

There	O
is	O
now	O
increasing	O
evidence	O
that	O
the	O
newer	O
rapid	O
acting	O
insulin	O
analogs	O
lispro	O
and	O
aspart	O
are	O
also	O
safe	O
in	O
pregnancy	O
,	O
and	O
indeed	O
,	O
they	O
are	O
commonly	O
used	O
.	O

We	O
analysed	O
free	O
sugar	O
intake	O
in	O
quintiles	O
:	O
1	O
)	O
as	O
a	O
categorical	O
variable	O
using	O
the	O
lowest	O
quintile	O
as	O
reference	O
to	O
allow	O
for	O
a	O
nonlinear	O
pattern	O
of	O
association	O
and	O
2	O
)	O
as	O
a	O
continuous	O
variable	O
to	O
test	O
for	O
linear	O
trend	O
(	O
i	O
.	O
e	O
.	O

Although	O
potentially	O
complex	O
,	O
the	O
use	O
of	O
a	O
systems	O
biology	O
approach	O
,	O
incorporating	O
genome	O
-	O
wide	O
analysis	O
at	O
multiple	O
levels	O
(	O
histone	O
code	O
,	O
methylome	O
,	O
non	O
-	O
coding	O
RNA	O
expression	O
,	O
transcriptome	O
,	O
proteome	O
and	O
metabolome	O
)	O
would	O
provide	O
comprehensive	O
analysis	O
of	O
epigenetic	O
changes	O
and	O
associated	O
phenotypic	O
outcomes	O
.	O

Also	O
,	O
since	O
more	O
than	O
95	O
%	O
of	O
the	O
mothers	O
had	O
lower	O
than	O
30	O
ng	O
/	O
mL	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
,	O
it	O
is	O
not	O
clear	O
if	O
the	O
same	O
results	O
would	O
be	O
observed	O
in	O
mothers	O
with	O
higher	O
levels	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
.	O
Therefore	O
,	O
we	O
suggest	O
further	B
clinical	O-
trials	I
,	O
using	O
2000	O
IU	O
vitamin	O
D	O
on	O
a	O
larger	O
population	O
,	O
mothers	O
with	O
high	O
levels	O
of	O
depression	O
,	O
and	O
high	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

While	O
a	O
particular	O
low	O
-	O
level	O
exposure	O
may	O
have	O
no	O
adverse	O
effects	O
,	O
multiple	O
low	O
-	O
level	O
exposures	O
over	O
multiple	O
stages	O
of	O
life	O
may	O
induce	O
adverse	O
phenotypes	O
.	O

The	O
standard	O
chow	O
(	O
Standard	O
Chow	O
SAFE	O
A04	O
,	O
Panlab	O
,	O
Barcelona	O
,	O
Spain	O
)	O
contained	O
16	O
.	O
1	O
%	O
of	O
protein	O
,	O
60	O
%	O
carbohydrate	O
,	O
3	O
.	O
1	O
%	O
fat	O
,	O
4	O
%	O
fiber	O
,	O
and	O
0	O
.	O
0025	O
%	O
sodium	O
,	O
resulting	O
in	O
a	O
2	O
.	O
9	O
kcal	O
/	O
g	O
as	O
energy	O
.	O

The	O
maternal	O
baseline	O
depression	O
levels	O
were	O
evaluated	O
.	O

Sample	O
size	O
The	O
available	O
sample	O
size	O
for	O
follow	O
-	O
up	O
assessment	O
at	O
6	O
-	O
months	O
of	O
age	O
was	O
predetermined	O
by	O
the	O
LIMIT	O
trial	O
,	O
which	O
was	O
powered	O
on	O
the	O
primary	O
outcome	O
of	O
large	O
for	O
gestational	O
age	O
,	O
with	O
2212	O
women	O
randomised	O
[	O
22	O
].	O

Briefly	O
,	O
vitamin	O
D	O
concentrations	O
were	O
standardized	O
by	O
taking	O
the	O
difference	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
to	O
the	O
average	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
the	O
corresponding	O
month	O
.	O

To	O
arrive	O
at	O
a	O
final	O
regression	O
model	O
,	O
stepwise	O
analyses	O
were	O
first	O
conducted	O
within	O
predefined	O
categories	O
(	O
i	O
.	O
e	O
.,	O
demographic	O
(	O
age	O
,	O
parity	O
,	O
race	O
,	O
marital	O
status	O
,	O
education	O
,	O
prepregnancy	O
BMI	O
),	O
physical	O
activity	O
(	O
calories	O
expended	O
per	O
week	O
in	O
moderate	O
physical	O
activity	O
TV	O
hours	O
per	O
day	O
),	O
macronutrient	O
(%	O
of	O
calories	O
from	O
fat	O
,	O
carbohydrates	O
,	O
protein	O
,	O
sweets	O
,	O
and	O
total	O
calories	O
),	O
dietary	O
components	O
(	O
fast	O
food	O
and	O
sugar	O
-	O
sweetened	O
soft	O
drinks	O
)	O
psychosocial	O
variables	O
(	O
mood	O
,	O
restraint	O
,	O
disinhibition	O
,	O
and	O
stress	O
),	O
and	O
sleep	O
.	O

The	O
pathogenesis	O
of	O
AAOC	O
remains	O
unclear	O
.	O

Applying	O
a	O
single	O
factor	O
(	O
e	O
.	O
g	O
.,	O
nutritional	O
or	O
genetic	O
)	O
may	O
not	O
be	O
adequate	O
to	O
increase	O
IMF	O
deposition	O
.	O

Her	O
serum	O
antidiuretic	O
hormone	O
level	O
,	O
at	O
the	O
time	O
of	O
birth	O
,	O
was	O
<	O
0	O
.	O
5	O
pg	O
/	O
mL	O
(	O
Normal	O
0	O
.	O
0	O
–	O
4	O
.	O
7	O
pg	O
/	O
mL	O
).	O

The	O
infant	O
received	O
2	O
boluses	O
of	O
10	O
%	O
Dextrose	O
for	O
hypoglycemia	O
and	O
was	O
then	O
placed	O
on	O
Dextrose	O
10	O
%	O
in	O
water	O
at	O
6	O
mL	O
/	O
hour	O
with	O
normal	O
saline	O
at	O
1	O
mL	O
/	O
hour	O
via	O
umbilical	O
vein	O
.	O

Normal	O
embryo	O
development	O
requires	O
a	O
maternal	O
and	O
paternal	O
contribution	O
,	O
generation	O
of	O
uniparental	O
embryos	O
by	O
pronuclear	O
transplantation	O
results	O
in	O
developmental	O
failure	O
(	O
Barton	O
et	O
al	O
.	O
1984	O
;	O
McGrath	O
&	O
Solter1984	O
).	O

Of	O
all	O
women	O
,	O
74	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
71	O
.	O
8	O
–	O
76	O
.	O
5	O
%)	O
were	O
vitamin	O
D	O
insufficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
30	O
ng	O
/	O
ml	O
)	O
and	O
44	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
=	O
41	O
.	O
9	O
–	O
47	O
.	O
3	O
%)	O
of	O
the	O
pregnant	O
women	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
20	O
ng	O
/	O
ml	O
),	O
while	O
12	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
10	O
.	O
3	O
–	O
13	O
.	O
8	O
%)	O
of	O
the	O
women	O
were	O
severely	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
10	O
ng	O
/	O
ml	O
).	O

Railroad	O
jobs	O
were	O
available	O
only	O
far	O
off	O
like	O
Denver	O
.	O

High	O
birth	O
weight	O
is	O
an	O
important	O
predictor	O
of	O
adult	O
obesity	O
[	O
171	O
],	O
and	O
a	O
higher	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
has	O
been	O
linked	O
to	O
greater	O
risk	O
for	O
adult	O
-	O
onset	O
glioma	O
[	O
172	O
].	O

When	O
dividing	O
the	O
cohort	O
by	O
vitamin	O
D	O
sufficiency	O
status	O
for	O
additional	O
analyses	O
,	O
vitamin	O
D	O
deficiency	O
was	O
defined	O
as	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
)).	O

Additionally	O
,	O
a	O
main	O
effect	O
of	O
sex	O
was	O
also	O
detected	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
in	O
liver	O
.	O

Thus	O
,	O
the	O
impact	O
of	O
early	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
needs	B
confirmation	I
in	O
a	O
larger	O
scale	O
trial	O
.	O

Maternal	O
obesity	O
significantly	O
predicts	O
child	O
and	O
adult	O
obesity	O
in	O
her	O
offspring	O
[	O
4	O
,	O
5	O
],	O
and	O
associated	O
cardio	O
-	O
metabolic	O
risk	O
factors	O
,	O
including	O
hypertension	O
,	O
hyperlipidaemia	O
,	O
diabetes	O
,	O
and	O
cardiovascular	O
disease	O
[	O
6	O
–	O
8	O
].	O

These	O
findings	O
suggest	O
that	O
pathways	O
involved	O
in	O
calcium	O
binding	O
and	O
mitochondrial	O
function	O
may	O
underpin	O
the	O
behavioural	O
features	O
associated	O
with	O
this	O
particular	O
animal	O
model	O
of	O
schizophrenia	O
.	O

Two	O
-	O
way	O
ANOVA	O
and	O
Bonferrroni	O
post	O
-	O
hoc	O
test	O
:	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
RC	O
males	O
;	O
ns	O
,	O
non	O
-	O
significant	O
.	O

She	O
recently	O
presented	O
findings	O
showing	O
an	O
association	O
between	O
increased	O
levels	O
of	O
activated	O
T	O
cells	O
in	O
DiNEH	O
Project	O
participants	O
and	O
greater	O
residential	O
proximity	O
to	O
mine	O
waste	O
sites	O
.	O
36	O
“	O
If	O
we	O
see	O
any	O
of	O
these	O
activated	O
T	O
cells	O
,	O
we	O
know	O
that	O
the	O
immune	O
system	O
is	O
highly	O
reacting	O
to	O
something	O
,”	O
Erdei	O
says	O
.	O

Those	O
receiving	O
standard	O
care	O
were	O
unaware	O
that	O
they	O
had	O
GDM	O
.	O

Phase	O
2	O
data	O
are	O
collected	O
at	O
22	O
weeks	O
’	O
gestation	O
(	O
window	O
±	O
12	O
days	O
)	O
when	O
anomaly	O
ultrasounds	O
are	O
typically	O
scheduled	O
.	O

Four	O
major	O
adipose	O
tissue	O
depots	O
exist	O
in	O
animals	O
:	O
ab	O
dominal	O
,	O
subcutaneous	O
,	O
intermuscular	O
,	O
and	O
intramuscular	O
.	O

Nimitphong	O
et	O
al	O
.	O

During	O
lactation	O
,	O
a	O
special	O
diet	O
for	O
the	O
mother	O
(	O
or	O
,	O
if	O
not	O
breast	O
-	O
feeding	O
,	O
hypoallergenic	O
formula	O
nutrition	O
for	O
the	O
infant	O
)	O
should	B
be	I
considered	B
only	O
in	O
individuals	O
with	O
an	O
established	O
atopy	O
risk	O
or	O
existing	O
allergy	O
[	O
82	O
,	O
115	O
].	O

Between	O
birth	O
and	O
6	O
months	O
,	O
the	O
percentage	O
of	O
children	O
with	O
WFA	O
>	O
90th	O
percentile	O
declined	O
slightly	O
in	O
overweight	O
/	O
obese	O
mothers	O
(	O
from	O
19	O
.	O
6	O
%	O
to	O
17	O
.	O
6	O
%)	O
but	O
increased	O
from	O
7	O
%	O
to	O
15	O
%	O
in	O
the	O
offspring	O
of	O
normal	O
weight	O
mothers	O
(	O
Table	O
1	O
).	O

The	O
EPA	O
has	O
mapped	O
521	O
abandoned	O
uranium	O
mines	O
on	O
the	O
reservation	O
,	O
ranging	O
from	O
small	O
holes	O
dug	O
by	O
a	O
single	O
prospector	O
into	O
the	O
side	O
of	O
a	O
mesa	O
to	O
large	O
commercial	O
mining	O
operations	O
.	O
1The	O
Navajo	O
people	O
did	O
not	O
have	O
a	O
word	O
for	O
“	O
radioactivity	O
”	O
when	O
mining	O
outfits	O
looking	O
for	O
vanadium2and	O
uranium3began	O
moving	O
onto	O
their	O
land	O
in	O
the	O
1940s	O
,	O
and	O
they	O
did	O
not	O
understand	O
that	O
radiation	O
could	O
be	O
dangerous	O
.	O

Genetic	O
alterations	O
activating	O
a	O
common	O
pathway	O
of	O
the	O
RET	O
-	O
RAS	O
-	O
BRAF	O
signalling	O
cascade	O
and	O
other	O
chromosomal	O
rearrangements	O
have	O
been	O
identified	O
in	O
most	O
DTC	O
.	O

Data	O
safety	O
and	O
monitoring	O
board	O
The	O
research	O
team	O
will	O
establish	O
an	O
independent	O
data	O
safety	O
and	O
monitoring	O
board	O
(	O
DSMB	O
)	O
consisting	O
of	O
an	O
independent	O
paediatrician	O
,	O
a	O
clinical	O
trial	O
specialist	O
and	O
a	O
biostatistician	O
.	O

Descriptive	O
analysis	O
will	O
be	O
performed	O
to	O
present	O
the	O
cause	O
of	O
death	O
.	O

Her	O
physical	O
examination	O
was	O
significant	O
for	O
confusion	O
,	O
dry	O
oral	O
mucosa	O
,	O
and	O
gravid	O
abdomen	O
.	O

The	O
researchers	O
checked	O
the	O
women	O
’	O
s	O
levels	O
of	O
hemoglobin	O
(	O
which	O
transports	O
oxygen	O
)	O
and	O
ferritin	O
every	O
four	O
weeks	O
through	O
the	O
end	O
of	O
pregnancy	O
.	O

The	O
inclusion	O
criteria	O
were	O
:	O
being	O
18	O
years	O
or	O
older	O
,	O
healthy	O
women	O
means	O
;	O
any	O
one	O
with	O
no	O
history	O
of	O
mental	O
illness	O
and	O
internal	O
diseases	O
such	O
as	O
hyper	O
/	O
hypothyroidism	O
,	O
parathyroid	O
,	O
renal	O
,	O
diabetes	O
and	O
heart	O
diseases	O
,	O
no	O
addiction	O
to	O
any	O
kind	O
of	O
narcotic	O
drugs	O
,	O
living	O
with	O
a	O
husband	O
,	O
a	O
singleton	O
live	O
fetus	O
,	O
without	O
any	O
pregnancy	O
complications	O
such	O
as	O
preeclampsia	O
,	O
gestational	O
diabetes	O
,	O
ruptured	O
membranes	O
and	O
suspicion	O
of	O
preterm	O
birth	O
,	O
no	O
previous	O
cesarean	O
sections	O
,	O
gestational	O
age	O
of	O
26	O
–	O
28	O
weeks	O
based	O
on	O
ultrasound	O
results	O
,	O
and	O
the	O
EPDS	O
baseline	O
scores	O
of	O
0	O
to	O
13	O
.	O

Obviously	O
,	O
at	O
least	O
a	O
part	O
of	O
the	O
innate	O
immune	O
system	O
is	O
impaired	O
when	O
LP	O
offspring	O
is	O
faced	O
with	O
a	O
pre	O
-	O
biotical	O
stress	O
like	O
weaning	O
.	O

Daily	O
use	O
of	O
iron	O
supplements	O
is	O
effective	O
when	O
administered	O
under	O
supervision	O
in	O
clinical	O
interventional	O
trials	O
,	O
but	O
is	O
less	O
so	O
in	O
public	O
health	O
programmes	O
because	O
of	O
difficulty	O
engaging	O
with	O
the	O
target	O
population	O
.	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
.	O

Moreover	O
,	O
males	O
were	O
housed	O
in	O
a	O
separate	O
room	O
.	O

Conclusion	O
To	O
conclude	O
,	O
UCP1	O
is	O
an	O
excellent	O
target	B
to	O
struggle	O
diabetes	O
and	O
decrease	O
body	O
fat	O
mass	O
,	O
improving	O
whole	O
metabolism	O
.	O

As	O
mentioned	O
above	O
,	O
BAT	O
is	O
the	O
effector	O
organ	O
of	O
non	O
-	O
shivering	O
thermogenesis	O
(	O
both	O
cold	O
and	O
diet	O
-	O
induced	O
)	O
that	O
,	O
by	O
utilizing	O
large	O
quantities	O
of	O
glucose	O
and	O
lipids	O
from	O
the	O
circulation	O
,	O
can	O
promote	O
negative	O
energy	O
balance	O
.	O

Introduction	O
Vitamin	O
D	O
status	O
is	O
a	O
well	O
-	O
known	O
determinant	O
of	O
bone	O
health	O
[	O
1	O
],[	O
2	O
].	O

The	O
endocannabinoid	O
system	O
(	O
ECS	O
)	O
is	O
also	O
implicated	O
in	O
metabolic	O
and	O
behavioral	O
mechanisms	O
involved	O
in	O
fetal	O
programming	O
such	O
as	O
leptin	O
signaling	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
)	O
or	O
dopaminergic	O
system	O
(	O
Melis	O
et	O
al	O
.,	O
2004	O
).	O

Study	O
Protocol	O
Health	O
History	O
Information	O
During	O
the	O
yearly	O
visits	O
,	O
5	O
-	O
mL	O
of	O
whole	O
blood	O
were	O
obtained	O
by	O
venous	O
puncture	O
,	O
and	O
the	O
child	O
’	O
s	O
health	O
status	O
,	O
medication	O
usage	O
,	O
and	O
hospitalization	O
history	O
were	O
assessed	O
by	O
both	O
standardized	O
questionnaires	O
completed	O
by	O
a	O
parent	O
of	O
each	O
child	O
and	O
the	O
child	O
’	O
s	O
medical	O
records	O
.	O

In	O
a	O
cross	O
-	O
sectional	O
study	O
of	O
elderly	O
Danish	O
men	O
and	O
women	O
,	O
investigators	O
noted	O
that	O
self	O
-	O
reported	O
snoring	O
was	O
associated	O
with	O
abnormal	O
glucose	O
tolerance	O
test	O
results	O
after	O
control	O
for	O
confounding	O
factors	O
[	O
36	O
].	O

The	O
weights	O
of	O
the	O
individual	O
fat	O
depots	O
were	O
used	O
to	O
determine	O
total	O
body	O
fat	O
mass	O
.	O

2010	O
;	O
Pavanello	O
et	O
al	O
.	O

Once	O
transcription	O
within	O
the	O
embryo	O
genome	O
is	O
activated	O
,	O
however	O
,	O
there	O
is	O
rapid	O
cell	O
proliferation	O
and	O
differentiation	O
,	O
processes	O
for	O
which	O
miRNA	O
-	O
mediated	O
regulation	O
is	O
essential	O
(	O
Ivey	O
&	O
Srivastava2015	O
),	O
hence	O
increased	O
expression	O
of	O
miRNAs	O
.	O

Similarly	O
,	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
1	O
,	O
significantly	O
down	O
-	O
regulated	O
in	O
this	O
study	O
,	O
has	O
been	O
found	O
to	O
be	O
down	O
-	O
regulated	O
at	O
both	O
the	O
mRNA	O
and	O
protein	O
levels	O
in	O
post	O
-	O
mortem	O
schizophrenia	O
brain	O
tissue	O
(	O
thalamus	O
)[	O
48	O
]	O
Like	O
the	O
previous	O
proteomic	O
study	O
[	O
18	O
],	O
we	O
found	O
no	O
alterations	O
in	O
proteins	O
directly	O
associated	O
with	O
DA	O
signaling	O
.	O

We	O
considered	O
p	O
<	O
0	O
.	O
05	O
to	O
be	O
significant	O
.	O

Controls	O
for	O
age	O
can	O
also	O
be	O
accounted	O
for	O
,	O
and	O
adverse	O
effects	O
can	O
be	O
more	B
accurately	O-
studied	I
in	O
the	O
future	B
.	O

In	O
Belgium	O
,	O
pregnant	O
women	O
who	O
reported	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
had	O
a	O
lower	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
and	O
women	O
who	O
reported	O
using	O
sunscreen	O
lotion	O
had	O
a	O
lower	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
.	O

Maternal	O
aMED	O
score	O
was	O
positively	O
associated	O
with	O
OTUs	O
classified	O
to	O
the	O
family	O
Enterobacteriaceae	O
,	O
the	O
genus	O
Streptococcus	O
,	O
and	O
the	O
family	O
Clostridiaceae	O
,	O
and	O
negatively	O
with	O
OTUs	O
classified	O
to	O
the	O
species	O
Bacteroides	O
uniformis	O
,	O
the	O
Enterobacteriaceae	O
family	O
,	O
and	O
the	O
species	O
Escherichia	O
coli	O
and	O
[	O
Ruminococcus	O
]	O
gnavus	O
(	O
Fig	O
.	O

However	O
,	O
such	O
a	O
relation	O
has	O
not	O
yet	O
been	O
confirmed	O
.	O

Marked	O
improvement	O
was	O
seen	O
in	O
the	O
patient	O
'	O
s	O
hypernatremia	O
,	O
in	O
which	O
her	O
serum	O
sodium	O
concentrations	O
decreased	O
from	O
158	O
mEq	O
/	O
L	O
to143	O
mEq	O
/	O
L	O
within	O
30	O
hours	O
from	O
the	O
initial	O
DDAVP	O
dose	O
(	O
Figure	O
1	O
),	O
and	O
normalization	O
of	O
her	O
serum	O
osmolality	O
(	O
Figure	O
2	O
).	O

A	O
rumen	O
-	O
protected	O
form	O
of	O
vitamin	O
C	O
is	O
preferred	O
as	O
a	O
dietary	O
supplement	O
because	O
vitamin	O
C	O
is	O
most	O
likely	O
degraded	O
in	O
the	O
rumen	O
[	O
146	O
].	O

The	O
control	O
group	O
was	O
offspring	O
fed	O
the	O
RV	O
diet	O
and	O
born	O
to	O
dams	O
fed	O
the	O
RV	O
diet	O
.	O

Micelle	O
formation	O
profoundly	O
increases	O
the	O
fraction	O
of	O
lipid	O
molecules	O
accessible	O
to	O
the	O
action	O
of	O
intestinal	O
lipase	O
,	O
aiding	O
fat	O
digestion	O
in	O
the	O
intestine	O
.	O

(	O
2007	O
),	O
and	O
/	O
orSquazzo	O
et	O
al	O
.	O

3	O
.	O

Women	O
in	O
the	O
highest	O
quintile	O
of	O
total	O
sugar	O
intake	O
during	O
pregnancy	O
had	O
a	O
lower	O
pre	O
-	O
pregnancy	O
BMI	O
,	O
higher	O
total	O
energy	O
intake	O
and	O
gained	O
more	O
weight	O
during	O
pregnancy	O
than	O
women	O
in	O
the	O
lowest	O
quintile	O
.	O

At	O
baseline	O
,	O
using	O
Pearson	O
’	O
s	O
correlation	O
coefficient	O
,	O
no	O
relations	O
were	O
observed	O
between	O
the	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
and	O
depression	O
scores	O
(	O
r	O
=	O
0	O
.	O
13	O
,	O
p	O
=	O
0	O
.	O
09	O
).	O

The	O
increase	O
in	O
body	O
weight	O
of	O
RC	O
male	O
offspring	O
is	O
directly	O
associated	O
with	O
an	O
increase	O
in	O
abdominal	O
fat	O
and	O
,	O
particularly	O
,	O
a	O
higher	O
percentage	O
of	O
perirenal	O
adiposity	O
relative	O
to	O
body	O
weight	O
.	O

Carbohydrate	O
should	B
be	I
restricted	O
to	O
35	O
%–	O
40	O
%	O
of	O
calories	O
.	O

2011	O
)	O
and	O
found	O
at	O
times	O
good	O
correlation	O
between	O
the	O
two	O
,	O
our	O
results	O
indicate	O
that	O
array	O
-	O
based	O
methylation	O
level	O
may	O
not	O
be	O
a	O
good	O
predictive	O
marker	O
of	O
repetitive	O
element	O
methylation	O
level	O
in	O
human	O
placenta	O
tissue	O
.	O

This	O
group	O
also	O
received	O
routine	O
prenatal	O
care	O
.	O

Results	O
A	O
total	O
of	O
1754	O
infants	O
were	O
assessed	O
at	O
age	O
6	O
months	O
(	O
Lifestyle	O
Advice	O
n	O
=	O
869	O
;	O
Standard	O
Care	O
n	O
=	O
885	O
),	O
representing	O
82	O
.	O
1	O
%	O
of	O
the	O
eligible	O
sample	O
(	O
n	O
=	O
2136	O
).	O

The	O
effect	O
of	O
pregnancy	O
on	O
cancer	O
:	O
In	O
vitro	O
accelerated	O
cell	O
growth	O
,	O
no	O
effect	O
seen	O
in	O
vivo	O
.	O

An	O
alternative	O
,	O
attribute	O
-	O
driven	O
clustering	O
scheme	O
for	O
the	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
was	O
employed	O
by	O
grouping	O
CpGs	O
by	O
epigenetically	O
relevant	O
bioinformatic	O
attributes	O
:	O
CpG	O
island	O
(	O
CGI	O
)	O
status	O
(	O
Takai	O
and	O
Jones	O
2002	O
),	O
polycomb	O
group	O
(	O
PcG	O
)	O
target	O
status	O
of	O
the	O
associated	O
gene	O
[	O
i	O
.	O
e	O
.,	O
gene	O
was	O
described	O
as	O
a	O
PcG	O
target	O
in	O
at	O
least	O
one	O
ofBracken	O
et	O
al	O
.	O

Infant	O
stool	O
samples	O
were	O
collected	O
from	O
145	O
infants	O
,	O
and	O
maternal	O
prenatal	O
diet	O
was	O
assessed	O
using	O
a	O
food	O
frequency	O
questionnaire	O
.	O

The	O
normality	O
of	O
the	O
data	O
was	O
evaluated	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
.	O

The	O
pellet	O
was	O
air	O
dried	O
for	O
5	O
min	O
and	O
resuspended	O
in	O
Buffer	O
2	O
(	O
7M	O
urea	O
,	O
2M	O
thiourea	O
,	O
1	O
%	O
C7bZO	O
).	O

1	O
Associations	O
between	O
maternal	O
diet	O
and	O
infant	O
gut	O
microbial	O
communities	O
in	O
infants	O
delivered	O
vaginally	O
.	O

Vitamin	O
A	O
(	O
also	O
known	O
as	O
retinol	O
)	O
inhibits	O
adipocyte	O
differentiation	O
[	O
128	O
].	O

Finally	O
,	O
136	O
participants	O
completed	O
the	O
EPDS	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

The	O
quality	O
of	O
clinical	O
assessment	O
in	O
the	O
clinics	O
and	O
during	O
home	O
visits	O
was	O
monitored	O
weekly	O
by	O
study	O
supervisors	O
.	O

String	O
beans	O
and	O
peas	O
also	O
correlated	O
inversely	O
with	O
ALL	O
risk	O
.	O

The	O
higher	O
leptin	O
sensitivity	O
described	O
in	O
females	O
than	O
in	O
males	O
has	O
been	O
associated	O
with	O
gonadal	O
hormones	O
(	O
Clegg	O
et	O
al	O
.,	O
2003	O
,	O
2006	O
)	O
and	O
may	O
explain	O
in	O
part	O
the	O
higher	O
levels	O
of	O
leptin	O
found	O
in	O
the	O
plasma	O
of	O
male	O
offspring	O
.	O

ADP	O
,	O
ON	O
,	O
LM	O
,	O
and	O
MG	O
contributed	O
to	O
the	O
study	O
conceptualization	O
and	O
design	O
,	O
acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
and	O
writing	O
of	O
article	O
.	O

Furthermore	O
,	O
many	O
studies	O
found	O
no	O
benefit	O
of	O
a	O
restricted	O
diet	O
avoiding	O
the	O
consumption	O
of	O
allergy	O
-	O
inducing	O
food	O
during	O
pregnancy	O
[	O
82	O
].	O

Misclassification	O
of	O
fish	O
and	O
PUFA	O
or	O
vitamin	O
D	O
intake	O
due	O
to	O
measurement	O
error	O
associated	O
with	O
the	O
food	O
frequency	O
questionnaire	O
is	O
unavoidable	O
,	O
but	O
given	O
the	O
study	O
design	O
likely	O
non	O
-	O
differential	O
,	O
and	O
thus	O
attenuating	O
any	O
true	O
association	O
.	O

Groups	O
The	O
exogenous	O
Vitamin	O
D	O
came	O
from	O
Vitamin	O
D	O
supplement	O
or	O
Vitamin	O
D	O
rich	O
food	O
.	O

There	O
were	O
no	O
other	O
effects	O
on	O
infant	O
growth	O
,	O
adiposity	O
,	O
or	O
neurodevelopment	O
.	O

Women	O
who	O
were	O
prescribed	O
increased	O
doses	O
of	O
valproic	O
acid	O
showed	O
a	O
twofold	O
increase	O
in	O
risk	O
of	O
developmental	O
malformations	O
and	O
significantly	O
reduced	O
intelligence	O
[	O
30	O
].	O

This	O
is	O
the	O
next	O
step	O
to	O
find	O
out	O
how	O
it	O
’	O
s	O
really	O
happening	O
on	O
the	O
molecular	O
level	O
.”	O
Uranium	O
’	O
s	O
Toxic	O
Legacy	O
Human	O
and	O
animal	O
studies	O
elsewhere	O
have	O
indicated	O
the	O
health	O
legacy	O
of	O
uranium	O
exposure	O
may	O
extend	O
to	O
the	O
children	O
of	O
exposed	O
parents	O
.	O

Articles	O
that	O
investigated	O
the	O
relationship	O
between	O
the	O
maternal	O
consumption	O
of	O
fish	O
or	O
seafood	O
and	O
neurodevelopmental	O
outcomes	O
in	O
offspring	O
were	O
included	O
.	O

Hence	O
,	O
iron	O
supplementation	O
in	O
pregnancy	O
has	O
become	O
a	O
standard	O
and	O
routine	O
practice	O
as	O
a	O
preventive	O
treatment	O
for	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

Rodent	O
models	O
The	O
deleterious	O
effects	O
of	O
exposures	O
to	O
environmental	O
factors	O
in	O
human	O
cohorts	O
have	O
stimulated	B
investigations	I
of	O
environmentally	O
induced	O
toxicity	O
in	O
rodent	O
models	O
.	O

Pregnant	O
women	O
with	O
thyroid	O
cancer	O
have	O
been	O
shown	O
to	O
have	O
favourable	O
outcomes	O
regardless	O
of	O
the	O
timing	O
of	O
diagnosis13233	O
.	O

The	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
study	O
cohort	O
(	O
overall	O
and	O
by	O
GDM	O
status	O
),	O
are	O
presented	O
in	O
Table1	O
.	O

This	O
may	O
have	O
arisen	O
as	O
a	O
consequence	O
of	O
the	O
IOMC	O
study	O
only	O
examining	O
folic	O
acid	O
use	O
during	O
the	O
last	O
trimester	O
of	O
pregnancy	O
[	O
14	O
].	O

Therefore	O
,	O
a	O
cell	O
cycle	O
control	O
system	O
can	O
arrest	O
the	O
cycle	O
at	O
certain	O
checkpoints	O
.	O

2	O
).	O

Given	O
the	O
rarity	O
of	O
some	O
infections	O
and	O
brain	O
tumors	O
,	O
the	O
interpretability	O
of	O
seasonal	O
patterns	O
,	O
or	O
the	O
lack	O
thereof	O
,	O
may	O
be	O
confounded	O
by	O
time	O
-	O
and	O
/	O
or	O
space	O
-	O
dependent	O
factors	O
[	O
126	O
].	O

Interestingly	O
,	O
the	O
ECS	O
is	O
implicated	O
in	O
the	O
intake	O
of	O
palatable	O
food	O
(	O
DiPatrizio	O
and	O
Simansky	O
,	O
2008	O
)	O
and	O
the	O
perception	O
of	O
sweet	O
taste	O
(	O
Niki	O
et	O
al	O
.,	O
2015	O
).	O

This	O
group	O
often	O
uses	O
dietary	O
supplements	O
containing	O
Vitamin	O
D	O
.	O
They	O
also	O
have	O
a	O
Vitamin	O
D2	O
detection	O
rate	O
of	O
19	O
.	O
4	O
%,	O
which	O
can	O
be	O
explained	O
by	O
consuming	O
edible	O
fungi	O
or	O
supplements	O
containing	O
Vitamin	O
D2	O
.	O

Ruth	O
et	O
al	O
.	O

MTRL	O
has	O
been	O
funded	O
by	O
a	O
FPU	O
predoctoral	O
fellowship	O
of	O
the	O
Spanish	O
Ministerio	O
de	O
Educación	O
,	O
Cultura	O
y	O
Deporte	O
(	O
AP	O
-	O
2009	O
-	O
0225	O
);	O
JS	O
holds	O
a	O
“	O
Miguel	O
Servet	O
”	O
research	O
contract	O
from	O
the	O
National	O
System	O
of	O
Health	O
,	O
ISCIII	O
(	O
grant	O
number	O
CP12	O
/	O
03109	O
).	O

An	O
above	O
average	O
level	O
of	O
nutritional	O
knowledge	O
was	O
significantly	O
associated	O
with	O
the	O
use	O
of	O
supplements	O
,	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
consultations	O
,	O
age	O
,	O
area	O
of	O
residence	O
or	O
formal	O
education	O
(	O
Table	O
5	O
),	O
but	O
also	O
when	O
the	O
interaction	O
effect	O
of	O
prenatal	O
care	O
and	O
formal	O
education	O
together	O
was	O
taken	O
into	O
consideration	O
(	O
Table	O
4	O
).	O

More	O
than	O
70	O
%	O
of	O
mothers	O
in	O
the	O
population	O
had	O
at	O
least	O
a	O
college	O
degree	O
,	O
more	O
than	O
90	O
%	O
were	O
married	O
,	O
and	O
most	O
were	O
first	O
-	O
time	O
mothers	O
.	O

The	O
execution	O
of	O
the	O
study	O
is	O
coordinated	O
by	O
the	O
Centre	O
of	O
Excellence	O
for	O
Nutrition	O
of	O
the	O
North	O
-	O
West	O
University	O
.	O

We	O
suggest	O
further	B
clinical	O-
trial	I
in	O
pregnant	O
mothers	O
who	O
are	O
at	O
risk	O
for	O
postnatal	O
depression	O
.	O

DNA	O
methylation	O
also	O
alters	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
to	O
regulate	O
gene	O
expression	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
two	O
study	O
groups	O
in	O
relation	O
to	O
the	O
baseline	O
depression	O
scores	O
(	O
0	O
.	O
74	O
).	O

Given	O
the	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
in	O
Belgium	O
and	O
probably	O
in	O
many	O
European	O
countries	O
,	O
a	O
vitamin	O
D	O
nutrition	O
policy	O
is	B
needed	I
at	O
the	O
country	O
and	O
European	O
level	O
.	O

They	O
are	O
listed	O
in	O
the	O
table	O
footnotes	O
.	O

These	O
models	O
demonstrate	O
that	O
with	O
a	O
10	O
%	O
increase	O
in	O
LINE	O
-	O
1	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
9	O
.	O
7	O
(	O
95	O
%	O
CI	O
:	O
2	O
.	O
9	O
,	O
16	O
.	O
6	O
),	O
and	O
with	O
a	O
10	O
%	O
increase	O
in	O
AluYb8	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
14	O
.	O
5	O
(	O
95	O
%	O
CI	O
:	O
4	O
.	O
9	O
,	O
24	O
.	O
0	O
)	O
(	O
Table	O
1	O
).	O

Thus	O
,	O
environmentally	O
induced	O
epigenetic	O
changes	O
may	O
not	O
always	O
be	O
mechanistically	O
involved	O
in	O
adverse	O
effects	O
;	O
instead	O
,	O
they	O
may	O
act	O
as	O
markers	O
of	O
past	O
exposures	O
(	O
Bakulski	O
&	O
Fallin2014	O
),	O
or	O
represent	O
adaptations	O
involved	O
in	O
maintaining	O
cellular	O
homeostasis	O
.	O

Feeding	O
the	O
HV	O
pup	O
diet	O
restored	O
POMC	O
and	O
BDNF	O
expression	O
to	O
control	O
levels	O
in	O
mature	O
offspring	O
.	O

However	O
,	O
they	O
were	O
different	O
regarding	O
to	O
using	O
other	O
supplements	O
outside	O
the	O
study	O
’	O
s	O
protocol	O
and	O
planned	O
pregnancy	O
(	O
Table	O
1	O
).	O

There	O
was	O
also	O
interclass	O
variation	O
in	O
the	O
frequency	O
of	O
CpGs	O
association	O
with	O
PcG	O
target	O
genes	O
,	O
with	O
classes	O
7	O
and	O
9	O
in	O
particular	O
having	O
a	O
much	O
higher	O
proportion	O
than	O
the	O
others	O
(	O
Figure	O
2F	O
).	O

A	O
Review	O
of	O
Effectiveness	O
of	O
Preventive	O
Treatments	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
3	O
.	O
3	O
.	O
1	O
.	O

This	O
system	O
will	O
allow	O
the	O
field	O
supervisors	O
to	O
monitor	O
the	O
performance	O
of	O
individual	O
data	O
collectors	O
.	O

Unlike	O
the	O
previously	O
published	O
data	O
on	O
vitamin	O
D	O
in	O
the	O
Auckland	O
cohort	O
[	O
20	O
],	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
measured	O
using	O
the	O
IDS	O
-	O
iSYS	O
chemiluminescent	O
-	O
based	O
assay	O
(	O
Abacus	O
,	O
ALS	O
)	O
as	O
per	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

[	O
22	O
]	O
used	O
developmental	O
testing	O
carried	O
out	O
by	O
the	O
mother	O
and	O
thus	O
results	O
may	O
not	O
be	O
as	O
reliable	O
as	O
those	O
reported	O
by	O
other	O
studies	O
,	O
which	O
used	O
trained	O
professionals	O
.	O

The	O
cut	O
-	O
points	O
were	O
based	O
on	O
categorizations	O
used	O
in	O
prior	O
research	O
[	O
4	O
,	O
11	O
].	O

Information	O
includes	O
medication	O
use	O
(	O
including	O
vaccines	O
),	O
HIV	O
status	O
,	O
obstetric	O
history	O
,	O
hospital	O
admission	O
during	O
pregnancy	O
,	O
use	O
of	O
alcohol	O
,	O
and	O
exposure	O
to	O
passive	O
smoking	O
.	O

As	O
can	O
be	O
seen	O
in	O
Figure2b	O
,	O
the	O
frequency	O
distribution	O
of	O
women	O
with	O
post	O
-	O
50	O
gram	O
1	O
-	O
hour	O
glucose	O
concentration	O
≥	O
140	O
mg	O
/	O
dl	O
(	O
i	O
.	O
e	O
.,	O
the	O
threshold	O
for	O
screen	O
positive	O
for	O
glucose	O
intolerance	O
)	O
also	O
had	O
a	O
curvilinear	O
pattern	O
.	O

Half	O
took	O
60	O
mg	O
of	O
iron	O
as	O
ferrous	O
sulfate	O
with	O
200	O
μg	O
of	O
folic	O
acid	O
and	O
1	O
μg	O
of	O
vitamin	O
B12once	O
a	O
day	O
;	O
the	O
others	O
took	O
double	O
this	O
dose	O
once	O
a	O
week	O
.	O

Samples	O
were	O
GC	O
-	O
RMA	O
normalised	O
(	O
Log2	O
).	O

Furthermore	O
,	O
the	O
study	O
field	O
-	O
supervisors	O
mapped	O
the	O
region	O
independently	O
to	O
verify	O
the	O
accuracy	O
of	O
the	O
maps	O
of	O
the	O
Agha	O
Khan	O
Trust	O
for	O
Culture	O
,	O
and	O
during	O
recruitment	O
they	O
visited	O
every	O
house	O
in	O
the	O
mapped	O
region	O
to	O
identify	O
families	O
with	O
young	O
children	O
.	O

Zinc	O
concentrations	O
are	O
determined	O
in	O
serum	O
using	O
atomic	O
absorption	O
spectrometry	O
[	O
74	O
].	O

Infants	O
reported	O
to	O
have	O
never	O
been	O
introduced	O
to	O
formula	O
and	O
to	O
be	O
breastfed	O
were	O
considered	O
to	O
be	O
exclusively	O
breastfed	O
,	O
while	O
those	O
who	O
were	O
ever	O
breastfed	O
and	O
ever	O
formula	O
-	O
fed	O
were	O
considered	O
to	O
be	O
fed	O
with	O
a	O
combination	O
of	O
breast	O
milk	O
and	O
formula	O
regardless	O
of	O
whether	O
or	O
not	O
the	O
infant	O
was	O
still	O
breastfed	O
at	O
the	O
time	O
of	O
stool	O
collection	O
.	O

For	O
example	O
,	O
epigenetic	O
mechanisms	O
and	O
markers	O
identified	O
within	O
the	O
47	O
studies	O
highlighted	O
in	O
this	O
review	O
could	O
be	O
further	B
examined	I
and	O
potentially	O
validated	O
in	O
existing	O
regulatory	O
studies	O
.	O

Distinct	O
species	O
and	O
model	O
systems	O
metabolize	O
xenobiotics	O
differently	O
depending	O
on	O
their	O
specific	O
enzymatic	O
profiles	O
.	O

High	O
educational	O
level	O
(	O
high	O
school	O
and	O
university	O
)	O
(	O
X2	O
=	O
8	O
.	O
714	O
;	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
first	O
time	O
pregnancy	O
(	O
X2	O
=	O
4	O
.	O
217	O
;	O
p	O
=	O
0	O
.	O
04	O
)	O
were	O
significantly	O
associated	O
with	O
poor	O
satisfaction	O
.	O

More	B
research	B
in	I
this	I
area	I
is	O
required	O
to	O
draw	O
sound	O
conclusions	O
.	O

These	O
studies	O
were	O
largely	O
retrospective	O
,	O
unrandomized	O
,	O
or	O
lacked	O
power	O
to	O
detect	O
differences	O
in	O
serious	O
adverse	O
perinatal	O
outcomes	O
and	O
will	O
not	O
be	O
listed	O
here	O
.	O

There	O
are	O
also	O
several	O
evidences	O
regarding	O
the	O
association	O
between	O
the	O
impaired	O
growth	O
indices	O
at	O
birth	O
and	O
increased	O
risk	O
of	O
developing	O
some	O
chronic	O
disorders	O
such	O
as	O
obesity	O
,	O
diabetes	O
[	O
5	O
],	O
cardiovascular	O
diseases	O
[	O
5	O
],	O
endothelial	O
dysfunction	O
[	O
6	O
],	O
nonalcoholic	O
fatty	O
liver	O
disease	O
[	O
7	O
],	O
and	O
chronic	O
kidney	O
disease	O
[	O
8	O
].	O

The	O
same	O
study	O
stressed	O
that	O
the	O
level	O
of	O
knowledge	O
about	O
food	O
sources	O
and	O
the	O
role	O
of	O
folic	O
acid	O
during	O
pregnancy	O
was	O
influenced	O
by	O
socio	O
-	O
demographic	O
factors	O
,	O
especially	O
the	O
level	O
of	O
education	O
[	O
38	O
].	O

Maternal	O
intake	O
of	O
sugar	O
during	O
pregnancy	O
and	O
childhood	O
respiratory	O
and	O
atopic	O
outcomes	O
Abstract	O
The	O
possible	O
role	O
of	O
maternal	O
consumption	O
of	O
free	O
sugar	O
during	O
pregnancy	O
in	O
the	O
inception	O
of	O
respiratory	O
and	O
atopic	O
diseases	O
has	O
not	O
been	O
studied	O
.	O

No	O
differences	O
in	O
large	O
for	O
gestational	O
age	O
,	O
macrosomia	O
,	O
neonatal	O
hypoglycemia	O
,	O
admission	O
to	O
neonatal	O
intensive	O
care	O
,	O
or	O
fetal	O
anomalies	O
were	O
observed	O
.	O

Protein	O
Expression	O
in	O
the	O
Nucleus	O
Accumbens	O
of	O
Rats	O
Exposed	O
to	O
Developmental	O
Vitamin	O
D	O
Deficiency	O
Abstract	O
Introduction	O
Developmental	O
vitamin	O
D	O
(	O
DVD	O
)	O
deficiency	O
is	O
a	O
candidate	O
risk	O
factor	O
for	O
schizophrenia	O
.	O

Anderson	O
Cancer	O
Center	O
are	O
currently	O
conducting	O
clinical	O
trials	O
in	O
Shanghai	O
on	O
a	O
cancer	O
therapy	O
that	O
uses	O
the	O
venom	O
of	O
the	O
Asiatic	O
toad	O
(	O
Bufo	O
gargarizans	O
).	O

Weak	O
Infrastructure	O
and	O
Political	O
Commitment	O
The	O
efforts	O
of	O
World	O
Food	O
Programme	O
(	O
WFP	O
)	O
in	O
overcoming	O
micronutrient	O
deficiencies	O
in	O
nutritionally	O
-	O
vulnerable	O
groups	O
and	O
low	O
-	O
income	O
food	O
-	O
deficit	O
countries	O
continue	O
to	O
be	O
thwarted	O
by	O
challenges	O
such	O
as	O
technical	O
and	O
managerial	O
capacity	O
constraints	O
,	O
the	O
need	O
for	O
systematic	O
compliance	O
with	O
procurement	O
specifications	O
and	O
quality	O
control	O
,	O
clearer	O
policies	O
on	O
micronutrient	O
content	O
labeling	O
,	O
and	O
the	O
need	O
for	O
cash	O
resources	O
to	O
support	O
many	O
aspects	O
associated	O
with	O
local	O
processing	O
and	O
fortification	O
activities	O
[	O
57	O
].	O

As	O
a	O
part	O
of	O
the	O
capacity	O
building	O
efforts	O
,	O
the	O
Ministry	O
of	O
Women	O
&	O
Child	O
Development	O
has	O
recommended	B
policy	O
related	O
and	O
institutional	O
transformations	O
.	O

Trial	O
registration	O
Iranian	O
Registry	O
of	O
Clinical	O
Trials	O
IRCT2015020310327N11	O
.	O

Therefore	O
,	O
this	O
explorative	O
project	O
will	O
contribute	O
to	O
identifying	O
factors	O
that	O
may	O
be	O
targeted	B
in	I
future	I
pre	O
-	O
and	O
/	O
or	O
post	O
-	O
conception	O
maternal	O
interventions	O
for	O
optimal	O
offspring	O
development	O
and	O
possibly	O
reduction	O
in	O
adult	O
NCD	O
risk	O
.	O

Results	O
HV	O
or	O
HFol	O
pup	O
diets	O
increased	O
brain	O
and	O
plasma	O
folate	O
concentrations	O
and	O
prevented	O
the	O
increase	O
in	O
food	O
intake	O
(	O
5	O
%,	O
P	O
=	O
0	O
.	O
03	O
),	O
body	O
weight	O
(	O
8	O
%,	O
P	O
=	O
0	O
.	O
0006	O
)	O
and	O
glucose	O
response	O
to	O
a	O
glucose	O
load	O
(	O
36	O
%,	O
P	O
=	O
0	O
.	O
02	O
)	O
found	O
in	O
those	O
fed	O
the	O
RV	O
diet	O
.	O

Adverse	O
Reactions	O
to	O
Food	O
No	O
studies	O
have	O
focused	O
explicitly	O
on	O
the	O
prevalence	O
of	O
food	O
allergy	O
in	O
pregnant	O
women	O
primarily	O
because	O
often	O
the	O
immune	O
response	O
in	O
the	O
offspring	O
is	O
the	O
main	O
focus	O
of	O
research	O
.	O

Breastfeeding	O
,	O
child	O
fish	O
consumption	O
,	O
maternal	O
dental	O
&	O
lifestyle	O
questionnaires	O
.	O
Neurodevelopmental	O
testing	O
of	O
child	O
completed	O
by	O
mother	O
using	O
ALSPAC	O
adaption	O
of	O
the	O
MacArthur	O
Communicative	O
Development	O
Inventory	O
(	O
MCDI	O
)	O
at	O
15	O
months	O
and	O
Denver	O
Developmental	O
Screening	O
Test	O
(	O
DDST	O
)	O
at	O
18	O
months	O
of	O
age	O
.	O
Fish	O
and	O
seafood	O
intake	O
measured	O
via	O
a	O
validated	O
FFQ	O
(	O
calibrated	O
for	O
LC	O
n	O
-	O
3PUFAs	O
in	O
blood	O
)	O
at	O
28	O
weeks	O
gestation	O
.	O
Infant	O
cognition	O
measured	O
usingVisual	O
Recognition	O
Memory	O
(	O
VRM	O
)	O
paradigm	O
at	O
6	O
months	O
of	O
age	O
.	O
Seafood	O
consumption	O
assessed	O
at	O
32	O
weeks	O
gestation	O
via	O
FFQ	O
.	O
Postal	O
questionnaires	O
on	O
diet	O
,	O
education	O
,	O
social	O
,	O
behavioural	O
and	O
developmental	O
outcomes	O
at	O
child	O
age	O
:	O
6	O
,	O
18	O
,	O
30	O
,	O
42	O
,	O
and	O
81	O
months	O
.	O
Wechsler	O
Intelligence	O
Scale	O
for	O
Children	O
III	O
used	O
to	O
assess	O
Intelligence	O
Quotient	O
(	O
IQ	O
)	O
at	O
8	O
years	O
and	O
Strengths	O
and	O
Difficulties	O
Questionnaire	O
(	O
SDQ	O
)	O
conducted	O
.	O

These	O
include	O
not	O
only	O
the	O
in	O
vitro	O
endocrine	O
TGs	O
and	O
in	O
vivo	O
reproductive	O
and	O
developmental	O
TGs	O
(	O
Greally	O
&	O
Jacobs2013	O
)	O
but	O
also	O
a	O
newly	O
revised	O
genotoxicity	O
TG	O
(	O
TG	O
483	O
)	O
where	O
spermatogonal	O
samples	O
could	O
be	O
further	B
utilized	O
for	O
RNA	O
analyzes	O
(	O
Linschooten	O
et	O
al	O
.	O
2009	O
;	O
Marczylo	O
et	O
al	O
.	O
2012	O
;	O
Metzler	O
-	O
Guillemain	O
et	O
al	O
.	O
2015	O
).	O

Red	O
and	O
processed	O
meat	O
intake	O
is	O
considered	O
less	O
healthful	O
,	O
and	O
consumption	O
below	O
the	O
median	O
confers	O
1	O
point	O
to	O
the	O
aMED	O
score	O
.	O

Additional	O
epigenetic	O
mechanisms	O
are	O
likely	O
to	O
be	O
elucidated	O
as	O
research	B
continues	I
.	O

Although	O
earlier	O
studies	O
have	O
mostly	O
examined	O
the	O
effects	O
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
,	O
there	O
are	O
few	O
studies	O
regarding	O
the	O
association	O
of	O
dietary	O
patterns	O
and	O
mentioned	O
measurements	O
.	O

Hence	O
,	O
there	O
is	O
continuing	O
interest	O
in	O
determining	O
how	O
vitamin	O
D	O
influences	O
pregnancy	O
health	O
.	O

Thirteen	O
of	O
14	O
cases	O
had	O
no	O
documented	O
recurrence	O
.	O

Our	O
results	O
suggest	O
that	O
habitual	O
short	O
/	O
long	O
sleep	O
duration	O
and	O
snoring	O
precede	O
the	O
clinical	O
diagnosis	O
of	O
GDM	O
.	O

Bell	O
-	O
Jefferson	O
and	O
her	O
brother	O
Peterson	O
Bell	O
played	O
in	O
and	O
around	O
the	O
mines	O
,	O
splashing	O
and	O
swimming	O
in	O
pools	O
of	O
radioactive	O
water	O
that	O
had	O
been	O
pumped	O
out	O
of	O
the	O
mines	O
and	O
then	O
collected	O
on	O
their	O
property	O
.	O

In	O
animal	O
models	O
,	O
prenatal	O
exposures	O
to	O
overnutrition	O
,	O
high	O
-	O
fat	O
and	O
high	O
-	O
protein	O
diets	O
,	O
“	O
junk	O
”	O
food	O
,	O
and	O
stress	O
have	O
been	O
linked	O
with	O
greater	O
adiposity	O
in	O
offspring	O
[	O
10	O
–	O
12	O
].	O

Circulating	O
Cathelicidin	O
Concentrations	O
in	O
a	O
Cohort	O
of	O
Healthy	O
Children	O
:	O
Influence	O
of	O
Age	O
,	O
Body	O
Composition	O
,	O
Gender	O
and	O
Vitamin	O
D	O
Status	O
Abstract	O
Cathelicidin	O
is	O
an	O
antimicrobial	O
peptide	O
whose	O
circulating	O
levels	O
are	O
related	O
to	O
vitamin	O
D	O
status	O
in	O
adults	O
.	O

Physiology	O
of	O
pregnancy	O
Thyroid	O
hormones	O
and	O
foetal	O
development	O
The	O
first	O
endocrine	O
structure	O
to	O
appear	O
during	O
embryonic	O
development	O
is	O
the	O
thyroid	O
gland	O
.	O

Both	O
,	O
the	O
EpiTect	O
Methyl	O
II	O
Signature	O
and	O
EpiTect	O
Methyl	O
II	O
Complete	O
PCR	O
Arrays	O
(	O
Qiagen	O
)	O
will	O
be	O
considered	O
.	O

(	O
2012	O
)¶/†	O
Leu	O
et	O
al	O
.	O

found	O
that	O
5000	O
IU	O
vitamin	O
D	O
per	O
day	O
for	O
6	O
weeks	O
had	O
no	O
effect	O
on	O
men	O
and	O
women	O
’	O
s	O
cognitive	O
and	O
emotional	O
function	O
[	O
69	O
].	O

We	O
asked	O
women	O
if	O
they	O
discussed	O
the	O
use	O
of	O
herbs	O
with	O
their	O
prenatal	O
care	O
provider	O
,	O
and	O
how	O
satisfied	O
they	O
were	O
with	O
these	O
discussions	O
;	O
we	O
asked	O
the	O
same	O
questions	O
about	O
prenatal	O
vitamin	O
use	O
for	O
comparison	O
.	O

The	O
expression	O
of	O
adipogenic	O
factors	O
(	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
beta	O
,	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
alpha	O
,	O
and	O
PPARG	O
)	O
in	O
the	O
subcutaneous	O
fat	O
and	O
IMF	O
was	O
higher	O
in	O
the	O
high	O
-	O
concentrate	O
group	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
,	O
indicating	O
that	O
the	O
dietary	O
roughage	O
/	O
concentrate	O
ratio	O
affects	O
adipogenic	O
gene	O
expression	O
in	O
fat	O
tissues	O
.	O

Vitamin	O
C	O
or	O
L	O
-	O
ascorbic	O
acid	O
has	O
several	O
roles	O
including	O
in	O
oxidation	O
–	O
reduction	O
reactions	O
and	O
collagen	O
synthesis	O
[	O
147	O
].	O

Plots	O
include	O
only	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
n	O
=	O
48	O
).	O

They	O
also	O
demonstrated	O
that	O
intake	O
of	O
prenatal	O
vitamins	O
at	O
the	O
vitamin	O
D	O
dose	O
of	O
400	O
IU	O
/	O
day	O
was	O
sufficient	O
to	O
prevent	O
vitamin	O
D	O
deficiency	O
but	O
was	O
not	O
high	O
enough	O
to	O
prevent	O
vitamin	O
D	O
insufficiency	O
.	O

The	O
management	O
of	O
anaphylaxis	O
during	O
pregnancy	O
is	O
the	O
same	O
as	O
for	O
nonpregnant	O
patients	O
.	O

We	O
have	O
investigated	O
whether	O
a	O
high	O
intake	O
of	O
free	O
sugar	O
in	O
pregnancy	O
is	O
associated	O
with	O
adverse	O
respiratory	O
and	O
atopic	O
outcomes	O
in	O
the	O
offspring	O
in	O
a	O
large	O
population	O
-	O
based	O
UK	O
birth	O
cohort	O
.	O

Compared	O
with	O
women	O
who	O
did	O
not	O
snore	O
during	O
pregnancy	O
,	O
the	O
adjusted	O
mean	O
1	O
-	O
hour	O
glucose	O
concentrations	O
were	O
noted	O
to	O
be	O
6	O
.	O
4	O
mg	O
/	O
dl	O
higher	O
among	O
those	O
women	O
who	O
snored	O
during	O
pregnancy	O
(	O
β	O
=	O
6	O
.	O
4	O
mg	O
/	O
dl	O
,	O
95	O
%	O
CI	O
0	O
.	O
32	O
-	O
12	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
04	O
).	O

During	O
acute	O
cold	O
exposure	O
,	O
BAT	O
was	O
shown	O
as	O
a	O
significant	O
independent	O
determinant	O
of	O
plasma	O
glucose	O
and	O
HbA1c	O
levels	O
(	O
Matsushita	O
et	O
al	O
.,	O
2014	O
).	O

Amplifications	O
were	O
done	O
in	O
triplicate	O
with	O
one	O
negative	O
control	O
for	O
internal	O
quality	O
control	O
at	O
the	O
MBL	O
.	O

High	O
dose	O
(>	O
2000	O
IU	O
)	O
vitamin	O
D	O
supplementation	O
is	O
associated	O
with	O
decreasing	O
risk	O
of	O
pregnancy	O
complications	O
[	O
23	O
–	O
25	O
].	O

Household	O
pets	O
were	O
assessed	O
during	O
pregnancy	O
and	O
serum	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
)	O
in	O
cord	O
blood	O
was	O
used	O
as	O
the	O
measure	O
of	O
vitamin	O
D	O
and	O
a	O
marker	O
of	O
maternal	O
level	O
.	O

(	O
2015	O
)*/†	O
Takeda	O
et	O
al	O
.	O

Current	O
understanding	O
suggests	O
that	O
hypoxia	O
is	O
one	O
of	O
the	O
complications	O
of	O
prolonged	O
labor	O
,	O
along	O
with	O
infection	O
,	O
or	O
head	O
trauma	O
from	O
extended	O
pressure	O
.	O

We	O
explore	O
women	O
’	O
s	O
and	O
family	O
members	O
’	O
perceptions	O
of	O
:	O
cultural	O
norms	O
during	O
pregnancy	O
;	O
birth	O
weight	O
;	O
IFA	O
supplementation	O
;	O
and	O
experience	O
using	O
IFA	O
supplements	O
during	O
pregnancy	O
.	O

Fear	O
of	O
labor	O
pain	O
is	O
another	O
concern	O
of	O
the	O
modern	O
-	O
day	O
mothers	O
[	O
78	O
].	O

For	O
an	O
excellent	O
discussion	O
of	O
the	O
obstetric	O
management	O
of	O
GDM	O
,	O
I	O
will	O
refer	O
the	O
reader	O
to	O
the	O
review	O
by	O
Conway	O
.	O
24	O
Diabetes	O
education	O
,	O
self	O
-	O
monitoring	O
of	O
blood	O
glucose	O
,	O
dietary	O
therapy	O
,	O
and	O
exercise	O
Self	O
-	O
care	O
is	O
an	O
important	O
component	O
of	O
the	O
management	O
of	O
GDM	O
.	O

Yet	O
,	O
specific	O
DNA	O
demethylase	O
enzyme	O
(	O
s	O
)	O
in	O
mammals	O
remained	O
elusive	O
until	O
the	O
discovery	O
of	O
the	O
10	O
–	O
11	O
translocation	O
(	O
TET	O
)	O
enzyme	O
family	O
.	O

Additional	O
recent	O
studies	O
about	O
pregnancy	O
diets	O
reveal	O
that	O
components	O
other	O
than	O
specific	O
allergens	O
,	O
such	O
as	O
fat	O
,	O
may	O
influence	O
atopy	O
outcomes	O
[	O
103	O
,	O
104	O
].	O

For	O
any	O
patient	O
,	O
both	O
with	O
first	O
diagnosis	O
or	O
recurrent	O
disease	O
,	O
post	O
-	O
operative	O
therapy	O
for	O
DTC	O
is	O
based	O
on	O
the	O
administration	O
of	O
supraphysiologic	O
"	O
suppressive	O
"	O
oral	O
doses	O
of	O
levothyroxine	O
.	O

This	O
study	O
is	O
registered	O
withClinicalTrials	O
.	O
gov	O
,	O
numberNCT00548379	O
.	O

We	O
computed	O
6	O
-	O
month	O
WFA	O
and	O
sex	O
-	O
specific	O
z	O
scores	O
with	O
2000	O
CDC	O
reference	O
data	O
[	O
22	O
]	O
and	O
defined	O
risk	O
of	O
obesity	O
as	O
WFA	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
.	O

The	O
association	O
between	O
“	O
standardised	O
”	O
25	O
(	O
OH	O
)	O
D	O
with	O
pregnancy	O
complications	O
is	O
presented	O
in	O
Table	O
2	O
.	O

These	O
included	O
maternal	O
age	O
at	O
delivery	O
,	O
sex	O
of	O
child	O
,	O
multiple	O
pregnancy	O
,	O
season	O
of	O
birth	O
,	O
maternal	O
history	O
of	O
atopic	O
diseases	O
(	O
hay	O
fever	O
,	O
asthma	O
,	O
eczema	O
,	O
allergies	O
,	O
or	O
attacks	O
of	O
wheezing	O
with	O
whistling	O
on	O
the	O
chest	O
or	O
attacks	O
of	O
breathlessness	O
in	O
the	O
past	O
2	O
years	O
),	O
parity	O
,	O
highest	O
educational	O
qualification	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
breastfeeding	O
duration	O
and	O
maternal	O
factors	O
during	O
pregnancy	O
(	O
smoking	O
status	O
,	O
anxiety	O
score	O
(	O
Crown	O
–	O
Crisp	O
Experiential	O
Index	O
),	O
paracetamol	O
use	O
,	O
antibiotic	O
use	O
,	O
infections	O
(	O
urinary	O
infection	O
,	O
influenza	O
,	O
rubella	O
,	O
thrush	O
,	O
genital	O
herpes	O
,	O
other	O
),	O
supplement	O
use	O
and	O
total	O
energy	O
intake	O
(	O
kJ	O
·	O
day	O
−	O
1	O
)).	O

Interpretation	O
of	O
the	O
findings	O
with	O
respect	O
to	O
mechanistic	O
connections	O
between	O
environmental	O
factors	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
effects	O
in	O
the	O
target	O
organ	O
/	O
tissue	O
can	O
therefore	O
be	O
challenging	O
.	O

The	O
results	O
from	O
infant	O
gut	O
microbiome	O
cluster	O
analyses	O
are	O
consistent	O
with	O
this	O
observation	O
.	O

We	O
found	O
the	O
lowest	O
odds	O
of	O
SGA	O
among	O
women	O
with	O
the	O
highest	O
T3	O
25OHD	O
concentration	O
,	O
≥	O
100	O
nmol	O
/	O
L	O
.	O

The	O
median	O
BMI	O
of	O
the	O
cohort	O
was	O
31	O
.	O
0	O
kg	O
/	O
m2	O
(	O
Inter	O
Quartile	O
Range	O
(	O
IQR	O
)	O
27	O
.	O
8	O
–	O
35	O
.	O
6	O
kg	O
/	O
m2	O
),	O
with	O
42	O
.	O
1	O
%	O
of	O
women	O
overweight	O
,	O
and	O
57	O
.	O
9	O
%	O
obese	O
.	O

Thus	O
a	O
study	O
with	O
80	O
%	O
power	O
and	O
95	O
%	O
significance	O
needed	O
22	O
079	O
child	O
-	O
months	O
per	O
group	O
(	O
total	O
of	O
2454	O
children	O
for	O
18	O
months	O
follow	O
-	O
up	O
).	O

The	O
feeding	O
strategy	O
for	O
highly	O
marbled	O
Korean	O
cattle	O
beef	O
has	O
been	O
also	O
described	O
by	O
Jo	O
et	O
al	O
[	O
96	O
].	O

This	O
trial	O
of	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
supplementation	O
along	O
with	O
antibiotic	O
treatment	O
of	O
children	O
younger	O
than	O
3	O
years	O
with	O
clinically	O
diagnosed	O
pneumonia	O
in	O
Kabul	O
showed	O
no	O
difference	O
in	O
the	O
time	O
to	O
recovery	O
between	O
the	O
groups	O
.	O

Investigations	O
revealed	O
normal	O
hemoglobin	O
,	O
total	O
and	O
differential	O
counts	O
and	O
normal	O
c	O
-	O
reactive	O
protein	O
.	O

These	O
probe	O
-	O
sets	O
represent	O
5	O
,	O
887	O
genes	O
at	O
stage	O
94	O
dpc	O
(	O
1	O
dpn	O
:	O
6	O
,	O
965	O
;	O
28	O
dpn	O
:	O
6	O
,	O
387	O
;	O
188	O
dpn	O
:	O
6	O
,	O
958	O
),	O
according	O
to	O
the	O
recent	O
annotation	O
[	O
18	O
].	O

The	O
aim	O
of	O
this	O
review	O
was	O
to	O
critically	O
appraise	O
literature	O
investigating	O
fish	O
intake	O
in	O
pregnant	O
women	O
to	O
assess	O
the	O
hypothesis	O
that	O
fish	O
consumption	O
during	O
pregnancy	O
positively	O
influences	O
foetal	O
neurodevelopment	O
.	O

Additionally	O
,	O
LINE1	O
,	O
AluYb8	O
,	O
and	O
specific	O
array	O
-	O
based	O
methylation	O
loci	O
often	O
interrogate	O
different	O
genetic	O
regions	O
;	O
therefore	O
,	O
their	O
methylation	O
may	O
have	O
a	O
differential	O
genomic	O
impact	O
.	O

Exposure	O
to	O
such	O
an	O
intra	O
-	O
uterine	O
environment	O
potentially	O
creates	O
a	O
vicious	O
cycle	O
in	O
which	O
the	O
propensity	O
to	O
obesity	O
is	O
perpetuated	O
,	O
with	O
major	O
adverse	O
public	O
health	O
implications	O
[	O
11	O
,	O
12	O
],	O
and	O
implications	O
for	O
the	O
health	O
of	O
successive	O
generations	O
[	O
13	O
].	O

Patients	O
whose	O
asthma	O
is	O
not	O
controlled	O
with	O
maximal	O
doses	O
of	O
bronchodilators	O
and	O
anti	O
-	O
inflammatory	O
agents	O
may	O
need	O
systemic	O
corticosteroids	O
.	O

However	O
,	O
it	O
is	O
unclear	O
at	O
this	O
time	O
whether	O
or	O
not	O
supplementation	O
of	O
vitamins	O
such	O
as	O
folate	O
can	O
reduce	O
congenital	O
anomalies	O
in	O
men	O
with	O
an	O
otherwise	O
well	O
-	O
balanced	O
diet	O
.	O

Results	O
3	O
.	O
1	O
.	O

Another	O
study	O
was	O
organized	O
to	O
determine	O
ASD	O
in	O
children	O
born	O
preterm	O
and	O
the	O
role	O
of	O
exposure	O
to	O
perinatal	O
inflammation	O
.	O

Nucleotide	O
polymorphism	O
of	O
the	O
β	O
2	O
adrenergic	O
receptor	O
gene	O
has	O
also	O
been	O
implicated	O
as	O
risk	O
factors	O
for	O
autism	O
,	O
namely	O
,	O
Gly	O
16	O
and	O
Glu	O
27	O
[	O
24	O
,	O
25	O
].	O

Urticaria	O
and	O
Angioedema	O
The	O
pattern	O
and	O
causes	O
of	O
urticaria	O
and	O
angioedema	O
in	O
pregnancy	O
are	O
similar	O
to	O
those	O
in	O
nonpregnant	O
patients	O
.	O

The	O
serum	O
level	O
of	O
25	O
-	O
OH	O
Vitamin	O
D2	O
in	O
the	O
intervention	O
group	O
was	O
11	O
.	O
61	O
±	O
6	O
.	O
71	O
(	O
6	O
.	O
06	O
–	O
24	O
.	O
71	O
)	O
nmol	O
/	O
L	O
,	O
however	O
,	O
the	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
level	O
in	O
the	O
fourteen	O
cases	O
in	O
the	O
control	O
group	O
was	O
too	O
low	O
to	O
be	O
detected	O
with	O
the	O
current	O
technology	O
(	O
Table	O
2	O
).	O

Allergic	O
rhinitis	O
is	O
often	O
preexisting	O
but	O
may	O
occur	O
or	O
be	O
recognized	O
for	O
the	O
first	O
time	O
during	O
pregnancy	O
.	O

The	O
active	O
metabolite	O
of	O
vitamin	O
D	O
,	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
]	O
increases	O
intestinal	O
calcium	O
absorption	O
and	O
decreases	O
renal	O
calcium	O
excretion	O
,	O
thus	O
increasing	O
the	O
pool	O
of	O
calcium	O
available	O
both	O
for	O
mother	O
and	O
foetus	O
.	O

While	O
this	O
approach	O
is	O
being	O
pursued	O
,	O
we	O
recommend	B
that	O
appropriate	O
measures	O
be	O
taken	O
to	O
strengthen	O
the	O
existing	O
health	O
systems	O
in	O
dealing	O
with	O
gastro	O
-	O
intestinal	O
and	O
life	O
-	O
threatening	O
side	O
effects	O
of	O
iron	O
supplements	O
.	O

For	O
all	O
genes	O
exemplarily	O
analysed	O
,	O
qRT	O
-	O
PCR	O
confirmed	O
the	O
direction	O
of	O
differential	O
regulation	O
as	O
obtained	O
by	O
microarray	O
analysis	O
.	O

The	O
most	O
abundant	O
taxonomic	O
group	O
was	O
Enterobacteriaceae	O
comprising	O
20	O
.	O
0	O
%	O
of	O
the	O
6	O
-	O
week	O
infant	O
stool	O
microbiome	O
,	O
followed	O
by	O
Bifidobacterium	O
(	O
18	O
.	O
4	O
%),	O
Bacteroides	O
(	O
10	O
.	O
4	O
%),	O
and	O
Streptococcus	O
(	O
8	O
.	O
10	O
%)	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S1	O
).	O

Harper	O
and	O
Pethick	O
[	O
23	O
]	O
recommended	B
that	O
producers	O
focus	O
on	O
individuals	O
with	O
high	O
genetic	O
capacity	O
to	O
create	O
more	O
preadipocytes	O
within	O
animal	O
muscle	O
.	O

Perinatal	O
risk	O
factors	O
that	O
have	O
a	O
suggested	O
association	O
include	O
β	O
2	O
adrenergic	O
receptor	O
agonists	O
,	O
labor	O
induction	O
and	O
augmentation	O
,	O
maternal	O
infection	O
and	O
disease	O
(	O
i	O
.	O
e	O
.,	O
antiphospholipid	O
syndrome	O
),	O
antiepileptic	O
drugs	O
,	O
cocaine	O
use	O
,	O
and	O
oral	O
supplements	O
.	O

Ethics	O
approval	O
was	O
obtained	O
from	O
the	O
ALSPAC	O
Ethics	O
and	O
Law	O
Committee	O
(	O
IRB	O
00003312	O
)	O
and	O
the	O
Local	O
National	O
Health	O
Service	O
Research	O
Ethics	O
Committees	O
.	O

In	O
our	O
study	O
,	O
after	O
adjusting	O
for	O
the	O
number	O
of	O
prenatal	O
consultations	O
,	O
the	O
only	O
socio	O
-	O
demographic	O
factors	O
that	O
persisted	O
on	O
being	O
associated	O
with	O
the	O
use	O
of	O
multivitamins	O
during	O
pregnancy	O
were	O
:	O
area	O
of	O
residence	O
;	O
level	O
of	O
education	O
;	O
parity	O
and	O
receipt	O
of	O
advice	O
about	O
diet	O
and	O
breastfeeding	O
.	O

Live	O
-	O
born	O
infants	O
at	O
6	O
-	O
months	O
of	O
age	O
,	O
and	O
whose	O
mother	O
provided	O
consent	O
to	O
ongoing	O
follow	O
-	O
up	O
were	O
eligible	O
.	O

The	O
validity	O
of	O
the	O
fat	O
estimates	O
from	O
the	O
FFQ	O
assessed	O
using	O
Pearson	O
correlation	O
coefficients	O
between	O
FFQ	O
data	O
and	O
estimates	O
derived	O
from	O
weighed	O
food	O
records	O
varied	O
between	O
r	O
=	O
0	O
.	O
4	O
and	O
r	O
=	O
0	O
.	O
5	O
.	O

DNMT1	O
,	O
the	O
maintenance	O
DNMT	O
,	O
preferentially	O
methylates	O
hemimethylated	O
DNA	O
and	O
thus	O
maintains	O
DNA	O
methylation	O
following	O
DNA	O
replication	O
.	O

Our	O
recent	O
study	O
indicated	O
that	O
a	O
lower	O
ambient	O
temperature	O
decreased	O
growth	O
and	O
feed	O
efficiency	O
in	O
Korean	O
cattle	O
steers	O
[	O
78	O
].	O

Our	O
inclusion	O
criteria	O
were	O
infants	O
aged	O
1	O
–	O
11	O
months	O
and	O
living	O
in	O
our	O
study	O
region	O
.	O

In	O
this	O
pilot	O
study	O
,	O
we	O
assessed	O
associations	O
of	O
maternal	O
self	O
-	O
reported	O
sleep	O
duration	O
and	O
snoring	O
during	O
early	O
pregnancy	O
with	O
glucose	O
intolerance	O
and	O
a	O
diagnosis	O
of	O
GDM	O
later	O
in	O
pregnancy	O
.	O

Importantly	O
,	O
as	O
Alvarez	O
–	O
Rodriguez	O
and	O
colleagues	O
have	O
found	O
a	O
negative	O
correlation	O
between	O
age	O
and	O
immune	O
function	O
in	O
healthy	O
adult	O
subjects	O
,	O
especially	O
those	O
over	O
the	O
age	O
of	O
60	O
[	O
15	O
],	O
perhaps	O
innate	O
immune	O
function	O
,	O
in	O
particular	O
cytokine	O
function	O
,	O
increases	O
with	O
age	O
for	O
a	O
period	O
of	O
time	O
,	O
reaches	O
a	O
threshold	O
and	O
then	O
decreases	O
later	O
in	O
life	O
.	O

In	O
contrast	O
,	O
CC	O
females	O
exhibited	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Cpt1b	O
and	O
Cox4i1	O
(	O
Figures5C	O
,	O
D	O
).	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
using	O
the	O
PITA	O
algorithm	O
.	O

Therefore	O
,	O
strategies	B
that	O
up	O
-	O
regulate	O
both	O
hyperplasia	O
and	O
hypertrophy	O
of	O
fat	O
cells	O
are	O
effective	O
ways	O
to	O
improve	O
IMF	O
deposition	O
.	O

An	O
association	O
between	O
thyroid	O
cancer	O
and	O
parity	O
or	O
full	O
-	O
term	O
pregnancy	O
has	O
been	O
assessed	O
in	O
many	O
studies	O
without	O
significant	O
or	O
conclusive	O
results6	O
.	O

Besides	O
sunlight	O
exposure	O
,	O
Vitamin	O
D	O
supplementation	O
is	O
also	O
an	O
important	O
factor	O
that	O
affects	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
among	O
women	O
with	O
GDM	O
.	O

While	O
the	O
GraviD	O
study	O
indicates	O
an	O
association	O
between	O
T3	O
25OHD	O
and	O
consequences	O
of	O
placental	O
insufficiency	O
,	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
might	O
be	O
a	O
stronger	O
predictor	O
of	O
placental	O
dysfunction	O
,	O
as	O
it	O
is	O
associated	O
with	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

However	O
,	O
the	O
potential	O
side	O
effects	O
of	O
any	O
drug	O
must	O
be	O
balanced	O
against	O
the	O
risks	O
of	O
the	O
mother	O
or	O
the	O
infant	O
having	O
inadequately	O
treated	O
disease	O
.	O

Critics	O
of	O
these	O
genetic	O
predisposition	O
argued	O
that	O
since	O
many	O
genes	O
are	O
involved	O
in	O
the	O
etiology	O
of	O
autism	O
,	O
the	O
role	O
of	O
any	O
single	O
gene	O
polymorphism	O
in	O
causing	O
autism	O
is	O
small	O
.	O

However	O
,	O
a	O
large	O
randomized	O
controlled	O
trial	O
comparing	O
aspart	O
with	O
regular	O
human	O
insulin	O
in	O
322	O
pregnant	O
women	O
with	O
type	O
1	O
diabetes	O
has	O
been	O
performed	O
.	O
44Comparable	O
birth	O
outcomes	O
were	O
found	O
between	O
the	O
two	O
arms	O
,	O
suggesting	O
that	O
aspart	O
is	O
as	O
safe	O
and	O
effective	O
as	O
human	O
insulin	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
effect	O
of	O
vitamin	O
D	O
on	O
depression	O
in	O
non	O
-	O
pregnant	O
people	O
are	O
not	O
entirely	O
clear	O
.	O

It	O
is	O
still	O
unknown	O
whether	O
both	O
,	O
the	O
endocannabinoid	O
(	O
eCB	O
)	O
machinery	O
and	O
the	O
lipid	O
metabolism	O
are	O
implicated	O
in	O
long	O
-	O
term	O
adaptive	O
responses	O
to	O
fetal	O
reprogramming	O
caused	O
by	O
maternal	O
undernutrition	O
.	O

Vitamin	O
D	O
is	O
likely	O
safe	O
during	O
pregnancy	O
and	O
breast	O
feeding	O
when	O
taken	O
by	O
mouth	O
in	O
recommended	B
amounts	O
,	O
that	O
is	O
10	O
mcg	O
(	O
400	O
USP	O
units	O
)	O
of	O
vitamin	O
D	O
daily	O
in	O
normal	O
pregnancy	O
.	O

Many	O
questions	O
remain	O
and	O
future	B
research	I
will	O
benefit	O
from	O
focused	O
studies	O
aimed	O
at	O
specific	O
exposures	O
and	O
subpopulations	O
,	O
allowing	O
for	O
more	O
detailed	O
analyses	O
by	O
histologic	O
subtypes	O
.	O

Eligible	O
criteria	O
included	O
singleton	O
pregnant	O
women	O
during	O
the	O
first	O
trimester	O
without	O
any	O
medical	O
condition	O
,	O
use	O
of	O
medications	O
,	O
and	O
without	O
following	O
a	O
specific	O
diet	O
.	O

Whilst	O
there	O
are	O
studies	O
demonstrating	O
short	O
-	O
term	O
safety	O
of	O
glyburide	O
and	O
metformin	O
during	O
pregnancy	O
,	O
I	O
suggest	O
that	O
they	O
be	O
reserved	O
for	O
situations	O
where	O
implementation	O
of	O
insulin	O
therapy	O
is	O
impractical	O
or	O
not	O
possible	O
.	O

Results	O
from	O
screening	O
and	O
diagnostic	O
testing	O
for	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
were	O
abstracted	O
from	O
medical	O
records	O
.	O

Interaction	O
between	O
time	O
and	O
diet	O
,	O
time	O
and	O
sex	O
,	O
and	O
time	O
,	O
diet	O
,	O
and	O
sex	O
were	O
also	O
significant	O
[	O
F	O
(	O
16	O
,	O
58	O
)=	O
1	O
.	O
83	O
,	O
P	O
<	O
0	O
.	O
05	O
;	O
F	O
(	O
16	O
,	O
58	O
)=	O
72	O
.	O
72	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
F	O
(	O
16	O
,	O
58	O
)=	O
2	O
.	O
72	O
,	O
P	O
<	O
0	O
.	O
01	O
,	O
respectively	O
].	O

Characterizing	O
normal	O
variation	O
within	O
the	O
epigenome	O
between	O
non	O
-	O
disease	O
states	O
would	O
provide	B
valuable	I
data	I
to	B
begin	I
establishing	I
limits	O
of	O
epignetic	O
change	O
above	O
which	O
cellular	O
homeostasis	O
fails	O
and	O
epigenetic	O
toxicity	O
is	O
induced	O
.	O

Fructose	O
also	O
causes	O
generation	O
of	O
uric	O
acid	O
[	O
38	O
],	O
and	O
experimental	O
evidence	O
in	O
mice	O
suggests	O
that	O
uric	O
acid	O
may	O
be	O
an	O
essential	O
initiator	O
and	O
amplifier	O
of	O
T	O
-	O
helper	O
cell	O
type	O
2	O
(	O
Th2	O
)	O
immunity	O
and	O
allergic	O
inflammation	O
,	O
through	O
activation	O
of	O
inflammatory	O
dendritic	O
cells	O
[	O
39	O
].	O

More	O
than	O
50	O
%	O
of	O
the	O
women	O
included	O
had	O
a	O
lower	O
education	O
level	O
,	O
which	O
means	O
only	O
completion	O
of	O
secondary	O
school	O
or	O
even	O
lower	O
education	O
.	O

However	O
,	O
some	O
studies	O
have	O
revealed	O
that	O
mild	O
temperature	O
stress	O
can	O
increase	O
body	O
fat	O
deposition	O
and	O
marbling	O
for	O
insulation	O
and	O
other	O
purposes	O
[	O
74	O
,	O
82	O
],	O
as	O
described	O
above	O
.	O

Associations	O
have	O
also	O
been	O
shown	O
between	O
vitamin	O
D	O
insufficiency	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
and	O
increased	O
risk	O
of	O
infant	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
and	O
low	O
birth	O
weight	O
(	O
LBW	O
)	O
[	O
4	O
].	O

Hence	O
efforts	O
should	B
be	I
geared	O
towards	O
improving	O
on	O
health	O
centre	O
variables	O
(	O
cleanliness	O
,	O
comfort	O
in	O
sitting	O
area	O
and	O
quality	O
of	O
care	O
amongst	O
others	O
)	O
to	O
improve	O
on	O
their	O
utilization	O
by	O
the	O
women	O
who	O
live	O
nearby	O
especially	O
for	O
those	O
health	O
centres	O
which	O
are	O
relatively	O
new	O
and	O
by	O
so	O
doing	O
increasing	O
their	O
attendance	O
rate	O
.	O

At	O
T1	O
and	O
T3	O
,	O
participants	O
answered	O
questionnaires	O
regarding	O
lifestyle	O
factors	O
and	O
background	O
data	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
atopy	O
without	O
asthma	O
,	O
nonatopic	O
and	O
atopic	O
asthma	O
#	O
in	O
the	O
offspringMaternal	O
free	O
sugar	O
intake	O
during	O
pregnancyp	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAtopy	O
without	O
asthma	O
n	O
=	O
794	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
78	O
(	O
0	O
.	O
61	O
–	O
1	O
.	O
01	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
34	O
)	O
0	O
.	O
96	O
(	O
0	O
.	O
73	O
–	O
1	O
.	O
25	O
)	O
1	O
.	O
09	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
50	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
12	O
)	O
0	O
.	O
30	O
Adjusted	O
OR	O
+(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
77	O
(	O
0	O
.	O
60	O
–	O
0	O
.	O
99	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
34	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
72	O
–	O
1	O
.	O
25	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
85	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
19	O
Nonatopic	O
asthma	O
n	O
=	O
301	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
82	O
(	O
0	O
.	O
57	O
–	O
1	O
.	O
16	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
46	O
–	O
0	O
.	O
99	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
52	O
–	O
1	O
.	O
16	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
52	O
–	O
1	O
.	O
34	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
85	O
–	O
1	O
.	O
06	O
)	O
0	O
.	O
34	O
Adjusted	O
OR	O
+(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
87	O
(	O
0	O
.	O
61	O
–	O
1	O
.	O
25	O
)	O
0	O
.	O
73	O
(	O
0	O
.	O
49	O
–	O
1	O
.	O
08	O
)	O
0	O
.	O
78	O
(	O
0	O
.	O
52	O
–	O
1	O
.	O
18	O
)	O
0	O
.	O
71	O
(	O
0	O
.	O
43	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
92	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
03	O
)	O
0	O
.	O
14	O
Atopic	O
asthma	O
n	O
=	O
337	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
66	O
(	O
1	O
.	O
14	O
–	O
2	O
.	O
41	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
78	O
–	O
1	O
.	O
77	O
)	O
2	O
.	O
09	O
(	O
1	O
.	O
39	O
–	O
3	O
.	O
14	O
)	O
1	O
.	O
79	O
(	O
1	O
.	O
11	O
–	O
2	O
.	O
90	O
)	O
1	O
.	O
14	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
27	O
)	O
0	O
.	O
01	O
Adjusted	O
OR	O
+(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
75	O
(	O
1	O
.	O
20	O
–	O
2	O
.	O
56	O
)	O
1	O
.	O
27	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
93	O
)	O
2	O
.	O
18	O
(	O
1	O
.	O
45	O
–	O
3	O
.	O
30	O
)	O
2	O
.	O
01	O
(	O
1	O
.	O
23	O
–	O
3	O
.	O
29	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
05	O
–	O
1	O
.	O
30	O
)	O
0	O
.	O
004	O
#:	O
no	O
atopy	O
or	O
asthma	O
was	O
considered	O
as	O
baseline	O
category	O
(	O
n	O
=	O
3796	O
);¶:	O
controlling	O
for	O
energy	O
intake	O
;+:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

Evaluations	O
of	O
these	O
programs	O
using	O
maternal	O
anaemia	O
as	O
the	O
outcome	O
report	O
little	O
or	O
no	O
impact	O
because	O
of	O
the	O
multiple	O
causes	O
of	O
maternal	O
anaemia	O
,	O
low	O
compliance	O
,	O
and	O
inadequate	O
distribution	O
programs	O
.	O

It	O
is	O
a	O
well	O
-	O
known	O
hormone	O
increasing	O
BAT	O
activity	O
and	O
inducing	O
“	O
browning	O
”	O
of	O
WAT	O
via	O
activation	O
of	O
the	O
sympathetic	O
nervous	O
system	O
and	O
resulting	O
increased	O
β3	O
adrenoceptor	O
signaling	O
(	O
Haynes	O
et	O
al	O
.,	O
1997	O
;	O
Commins	O
et	O
al	O
.,	O
2000	O
).	O

Tyagi	O
et	O
al	O
.	O

The	O
corresponding	O
RR	O
for	O
lean	O
women	O
(<	O
25	O
kg	O
/	O
m2	O
)	O
was	O
3	O
.	O
23	O
(	O
95	O
%	O
CI	O
0	O
.	O
34	O
-	O
30	O
.	O
41	O
)	O
and	O
9	O
.	O
83	O
(	O
95	O
%	O
CI	O
1	O
.	O
12	O
-	O
86	O
.	O
32	O
)	O
for	O
overweight	O
women	O
(≥	O
25	O
kg	O
/	O
m2	O
).	O

Vitamin	O
A	O
Restricting	O
vitamin	O
A	O
intake	O
increases	O
IMF	O
deposition	O
.	O

From	O
the	O
responses	O
to	O
the	O
questions	O
on	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
,	O
a	O
variable	O
was	O
created	O
by	O
categorizing	O
women	O
into	O
three	O
groups	O
(	O
Additional	O
file1	O
).	O

PubMed	O
Central	O
:	O

Fish	O
Intake	O
during	O
Pregnancy	O
and	O
Foetal	O
Neurodevelopment	O
—	O
A	O
Systematic	O
Review	O
of	O
the	O
Evidence	O
Abstract	O
Fish	O
is	O
a	O
source	O
of	O
several	O
nutrients	O
that	O
are	O
important	O
for	O
healthy	O
foetal	O
development	O
.	O

Calcium	O
binding	O
proteins	O
are	O
central	O
to	O
a	O
wide	O
range	O
of	O
cellular	O
functions	O
,	O
of	O
which	O
calcium	O
sequestration	O
and	O
buffering	O
are	O
particularly	O
important	O
for	O
neurons	O
.	O

Briefly	O
,	O
DVD	O
-	O
deficient	O
neonates	O
had	O
larger	O
lateral	O
ventricles	O
,	O
increased	O
cellular	O
proliferation	O
and	O
reduced	O
apoptosis	O
,	O
altered	O
neurogenesis	O
,	O
reduced	O
density	O
of	O
neurotrophin	O
receptor	O
(	O
p75NTR	O
),	O
and	O
reduced	O
levels	O
of	O
nerve	O
growth	O
factor	O
(	O
NGF	O
)	O
and	O
glial	O
cell	O
line	O
-	O
derived	O
growth	O
factor	O
(	O
GDNF	O
)	O
compared	O
to	O
controls	O
[	O
5	O
]–[	O
7	O
].	O

A	O
seasonal	O
infectious	O
etiology	O
for	O
disease	O
is	O
complicated	O
by	O
many	O
factors	O
[	O
126	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Background	O
characteristics	O
of	O
the	O
participantsBackground	O
characteristics	O
Age	O
,	O
years	O
(	O
mean	O
±	O
SD	O
)	O
27	O
.	O
5	O
±	O
5	O
.	O
59Urban	O
environment	O
,	O
N	O
(%)	O
218	O
(	O
54	O
.	O
3	O
)	O
Formal	O
education	O
,	O
number	O
of	O
years	O
≤	O
8	O
(%)	O
25	O
.	O
5	O
9	O
-	O
12	O
(%)	O
40	O
.	O
5	O
>	O
12	O
(%)	O
34Married	O
,	O
N	O
(%)	O
323	O
(	O
80	O
.	O
8	O
)	O
Number	O
of	O
births	O
,	O
N	O
(%)	O
Primiparous198	O
(	O
49	O
.	O
5	O
)	O
Secundiparous129	O
(	O
32	O
.	O
3	O
)	O
Multiparous73	O
(	O
18	O
.	O
2	O
)	O
Wanted	O
pregnancy	O
,	O
N	O
(%)	O
360	O
(	O
90	O
)	O
Gestational	O
age	O
at	O
first	O
prenatal	O
visit	O
,	O
mean	O
±	O
SD2	O
.	O
59	O
±	O
1	O
.	O
23First	O
prenatal	O
visit	O
at	O
≤	O
4	O
months	O
of	O
pregnancy	O
,	O
N	O
(%)	O
364	O
(	O
91	O
)	O
Number	O
of	O
prenatal	O
visits	O
at	O
general	O
practitioner	O
,	O
mean	O
±	O
SD4	O
.	O
82	O
±	O
2	O
.	O
54Number	O
of	O
prenatal	O
visits	O
at	O
obstetrician	O
,	O
mean	O
±	O
SD4	O
.	O
76	O
±	O
3	O
.	O
07Total	O
number	O
of	O
prenatal	O
visits	O
,	O
mean	O
±	O
SD9	O
.	O
58	O
±	O
4	O
.	O
88Nutritional	O
knowledge	O
score	O
,	O
mean	O
±	O
SD11	O
±	O
4	O
.	O
8Advice	O
on	O
diet	O
,	O
YES	O
(	O
N	O
,%)	O
168	O
(	O
42	O
)	O
Advice	O
on	O
breastfeeding	O
,	O
YES	O
(	O
N	O
,%)	O
334	O
(	O
83	O
.	O
5	O
)	O
Use	O
of	O
folic	O
acid	O
(	O
N	O
,%)	O
192	O
(	O
48	O
)	O
Use	O
of	O
iron	O
(	O
N	O
,%)	O
181	O
(	O
45	O
.	O
3	O
)	O
Use	O
of	O
multivitamins	O
(	O
N	O
,%)	O
272	O
(	O
68	O
)	O
Statistical	O
analysis	O
Associations	O
between	O
socio	O
-	O
demographic	O
factors	O
,	O
prenatal	O
care	O
,	O
the	O
level	O
of	O
nutritional	O
knowledge	O
and	O
the	O
intake	O
of	O
nutritional	O
supplements	O
were	O
evaluated	O
using	O
the	O
Chi	O
-	O
square	O
test	O
(	O
χ2	O
)	O
and	O
binomial	O
logistical	O
regression	O
[	O
24	O
].	O

To	O
date	O
,	O
a	O
convincing	O
explanation	O
for	O
the	O
occurrence	O
of	O
adult	O
gliomas	O
decades	O
after	O
a	O
seasonal	O
exposure	O
at	O
birth	O
remains	O
elusive	O
.	O

Thus	O
doses	O
of	O
D	O
vitamin	O
and	O
calcium	O
supplementation	O
,	O
which	O
may	O
differ	O
from	O
those	O
recommended	B
in	O
normal	O
pregnancy	O
,	O
need	O
to	O
be	O
carefully	O
tailored	O
in	O
thyroidectomised	O
patients	O
.	O

Cut	O
-	O
off	O
points	O
with	O
values	O
more	O
than	O
9	O
,	O
12	O
,	O
13	O
,	O
and	O
14	O
were	O
used	O
in	O
different	O
studies	O
to	O
determine	O
perinatal	O
depression	O
[	O
37	O
,	O
43	O
,	O
44	O
].	O

Several	O
studies	O
have	O
reported	O
higher	O
IMF	O
content	O
in	O
high	O
concentrate	O
diets	O
compared	O
with	O
low	O
concentrate	O
diets	O
(	O
reviewed	O
in	O
Wood	O
et	O
al	O
[	O
116	O
]).	O

Being	O
right	O
-	O
handed	O
has	O
been	O
associated	O
with	O
a	O
greater	O
risk	O
for	O
glioma	O
than	O
being	O
left	O
-	O
handed	O
or	O
ambidextrous	O
[	O
178	O
].	O

In	O
the	O
USA	O
excessive	O
GWG	O
remains	O
of	O
predominant	O
concern	O
,	O
as	O
60	O
%	O
of	O
obese	O
women	O
gain	O
more	O
than	O
recommended	O
.	O

The	O
effect	O
of	O
maternal	O
dairy	O
intake	O
on	O
infant	O
gut	O
microbiota	O
was	O
primarily	O
observed	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
.	O

Other	O
studies	O
reported	O
36	O
–	O
54	O
%	O
iron	O
supplementation	O
[	O
51	O
,	O
55	O
].	O

Thus	O
it	O
is	O
possible	O
that	O
longer	O
follow	O
up	O
may	O
be	O
needed	B
to	O
determine	O
significant	O
associations	O
.	O

For	O
continuous	O
outcomes	O
,	O
differences	O
in	O
means	O
with	O
95	O
%	O
CI	O
were	O
estimated	O
using	O
linear	O
regression	O
.	O

In	O
this	O
context	O
,	O
it	O
is	O
plausible	O
in	O
our	O
experimental	O
model	O
that	O
RC	O
offspring	O
did	O
not	O
showed	O
underweight	O
and	O
,	O
therefore	O
,	O
hyperphagia	O
in	O
any	O
stage	O
.	O

They	O
include	O
hormones	O
,	O
such	O
as	O
insulin	O
,	O
leptin	O
and	O
glucocorticoids	O
,	O
proinflammatory	O
cytokines	O
,	O
as	O
well	O
as	O
complex	O
epigenetic	O
modifications	O
(	O
Tamashiro	O
and	O
Moran	O
,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2013	O
).	O

[	O
2	O
]	O
hypothesize	O
that	O
the	O
increased	O
prevalence	O
of	O
autism	O
may	O
be	O
in	O
part	O
due	O
to	O
higher	O
success	O
in	O
obstetric	O
and	O
neonatal	O
care	O
,	O
which	O
resulted	O
in	O
an	O
increased	O
survival	O
rates	O
of	O
hypoxic	O
neonates	O
with	O
brain	O
damage	O
.	O

Recent	O
nationwide	O
shortages	O
of	O
low	O
-	O
calcium	O
formula	O
(	O
LCF	O
)	O
suggest	O
this	O
problem	O
may	O
be	O
widespread	O
.	O

The	O
primary	O
objective	O
of	O
a	O
quantitative	O
meta	O
-	O
analysis	O
is	O
to	O
combine	O
the	O
results	O
of	O
previous	O
studies	O
examining	O
a	O
specific	O
research	O
question	O
to	O
arrive	O
at	O
a	O
summary	O
conclusion	O
about	O
a	O
body	O
of	O
research	O
.	O

Screening	O
for	O
diabetes	O
,	O
at	O
regular	O
intervals	O
,	O
is	O
recommended	B
by	O
a	O
number	O
of	O
diabetes	O
societies	O
.	O
4	O
,	O
85This	O
is	O
important	O
for	O
the	O
early	O
diagnosis	O
of	O
diabetes	O
,	O
to	O
facilitate	O
the	O
prevention	O
of	O
complications	O
.	O

The	O
researchers	O
proposed	O
three	O
possible	O
explanations	O
for	O
their	O
findings	O
:	O
the	O
birds	O
could	O
have	O
been	O
exposed	O
to	O
the	O
bacteria	O
through	O
contact	O
with	O
other	O
species	O
of	O
birds	O
migrating	O
from	O
other	O
regions	O
,	O
or	O
resistance	O
could	O
have	O
developed	O
either	O
through	O
spontaneous	O
mutations	O
or	O
through	O
horizontal	O
gene	O
transfer	O
from	O
other	O
microbes	O
.	O

Discussion	O
In	O
this	O
population	O
-	O
based	O
birth	O
cohort	O
study	O
,	O
we	O
found	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
,	O
independently	O
of	O
sugar	O
intake	O
in	O
early	O
childhood	O
.	O

After	O
multivariate	O
adjustment	O
,	O
the	O
intake	O
of	O
omega	O
-	O
6	O
fatty	O
acids	O
was	O
significantly	O
associated	O
with	O
a	O
decreased	O
relative	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
metabolic	O
enzymes	O
regulating	O
de	O
novo	O
lipogenesis	O
(	O
Acaca	O
,	O
Fasn	O
,	O
Scd1	O
)	O
and	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1a	O
,	O
Cpt1b	O
,	O
Acox1	O
),	O
and	O
key	O
regulators	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
(	O
Chrebp	O
,	O
Srebp1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
Hmgcr	O
)	O
and	O
mitochondrial	O
respiration	O
(	O
Ucp1	O
,	O
Cox4i1	O
)	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure5	O
).	O

There	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
any	O
of	O
the	O
baseline	O
characteristics	O
between	O
the	O
groups	O
(	O
table	O
1	O
),	O
including	O
reported	O
sun	O
exposure	O
.	O

The	O
epidemiologic	O
association	O
of	O
obesity	O
,	O
particularly	O
of	O
the	O
visceral	O
type	O
,	O
with	O
type	O
2	O
diabetes	O
has	O
been	O
recognized	O
for	O
decades	O
.	O

Interestingly	O
,	O
mice	O
carrying	O
additional	O
copies	O
of	O
Pten	O
(	O
Ptentgmice	O
)	O
are	O
not	O
only	O
protected	O
from	O
cancer	O
and	O
exhibit	O
extended	O
longevity	O
,	O
but	O
,	O
according	O
to	O
the	O
authors	O
,	O
they	O
also	O
present	O
enhanced	O
energy	O
expenditure	O
that	O
participates	O
in	O
counteracting	O
the	O
development	O
of	O
obesity	O
.	O

For	O
all	O
regression	O
analyses	O
,	O
two	O
stages	O
of	O
adjustment	O
were	O
used	O
.	O

Oken	O
et	O
al	O
.	O

The	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
deficiency	O
rate	O
of	O
Summer	O
is	O
zero	O
in	O
both	O
groups	O
,	O
but	O
is	O
high	O
of	O
other	O
three	O
seasons	O
(	O
Fig	O
.	O

The	O
results	O
showed	O
that	O
in	O
both	O
subgroups	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
statistically	O
significant	O
higher	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
at	O
childbirth	O
and	O
lower	O
depression	O
score	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
than	O
the	O
control	O
group	O
(	O
Table	O
4	O
).	O

Glucose	O
response	O
to	O
glucose	O
gavage	O
(	O
0	O
.	O
375	O
g	O
glucose	O
mL	O
−	O
1	O
,	O
5	O
g	O
of	O
glucose	O
per	O
kg	O
body	O
weight	O
)	O
was	O
measured	O
at	O
18	O
weeks	O
post	O
-	O
weaning	O
.	O

Pre	O
-	O
cast	O
immobilised	O
pH	O
gradient	O
strips	O
(	O
IPG	O
,	O
11	O
cm	O
,	O
pH	O
3	O
–	O
10	O
,	O
Proteome	O
Systems	O
,	O
North	O
Ryde	O
,	O
Australia	O
)	O
were	O
passively	O
rehydrated	O
in	O
200	O
µg	O
sample	O
protein	O
extract	O
for	O
6	O
hr	O
at	O
room	O
temperature	O
.	O

Additionally	O
,	O
RC	O
males	O
exhibited	O
an	O
increase	O
in	O
body	O
weight	O
than	O
RC	O
females	O
in	O
several	O
days	O
of	O
the	O
lactation	O
period	O
(	O
PND	O
1	O
and	O
PND	O
2	O
–	O
5	O
,	O
16	O
,	O
17	O
,	O
and	O
2	O
).	O

The	O
drop	O
-	O
outs	O
had	O
a	O
slightly	O
higher	O
BMI	O
,	O
lower	O
education	O
and	O
were	O
more	O
often	O
smokers	O
and	O
born	O
outside	O
of	O
the	O
Nordic	O
countries	O
.	O

Food	O
consumption	O
frequency	O
of	O
food	O
rich	O
in	O
Vitamin	O
D	O
Participants	O
filled	O
dietary	O
records	O
for	O
7	O
–	O
232	O
days	O
,	O
with	O
an	O
average	O
of	O
31	O
.	O
7	O
days	O
.	O

A	O
comprehensive	O
systematic	O
review	O
by	O
Thangaratinam	O
and	O
colleagues	O
[	O
14	O
]	O
has	O
identified	O
numerous	O
studies	O
assessing	O
dietary	O
and	O
lifestyle	O
interventions	O
in	O
pregnancy	O
,	O
albeit	O
mostly	O
small	O
in	O
scope	O
.	O

This	O
observation	O
is	O
similar	O
to	O
studies	O
carried	O
out	O
in	O
Kenya	O
[	O
13	O
]	O
and	O
South	O
Africa	O
[	O
14	O
]	O
where	O
women	O
started	O
clinic	O
late	O
because	O
of	O
perceived	O
lack	O
of	O
benefit	O
,	O
limited	O
facility	O
access	O
,	O
uncertainty	O
about	O
pregnancy	O
and	O
“	O
laziness	O
”	O
to	O
go	O
for	O
many	O
visits	O
.	O

It	O
is	O
quite	O
possible	O
that	O
the	O
adverse	O
findings	O
in	O
this	O
study	O
are	O
due	O
to	O
more	O
women	O
in	O
the	O
metformin	O
group	O
having	O
a	O
greater	O
severity	O
of	O
hyperglycemia	O
early	O
in	O
the	O
pregnancy	O
.	O

In	O
adipose	O
tissue	O
,	O
it	O
appears	O
that	O
PPARγ	O
transcriptionally	O
controls	O
FGF21	O
,	O
which	O
then	O
acts	O
as	O
an	O
autocrine	O
or	O
paracrine	O
way	O
to	O
increase	O
PPARγ	O
transcriptional	O
activity	O
in	O
a	O
feed	O
-	O
forward	O
loop	O
system	O
(	O
Wang	O
et	O
al	O
.,	O
2008	O
;	O
Dutchak	O
et	O
al	O
.,	O
2012	O
).	O

Studies	O
examining	O
the	O
impact	O
of	O
environmental	O
exposures	O
on	O
DNA	O
methylation	O
have	O
often	O
focused	O
on	O
the	O
global	O
extent	O
of	O
5	O
-	O
methylcytosine	O
,	O
using	O
various	O
approaches	O
(	O
Einstein	O
et	O
al	O
.	O

Higher	O
percentage	O
of	O
calories	O
from	O
protein	O
early	O
in	O
pregnancy	O
(	O
OR	O
=	O
0	O
.	O
38	O
(	O
0	O
.	O
19	O
,	O
0	O
.	O
78	O
);	O
P	O
=	O
0	O
.	O
04	O
)	O
was	O
also	O
a	O
significant	O
predictor	O
of	O
reduced	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
at	O
6	O
months	O
.	O

Trial	O
Registration	O
:	O
Australian	O
and	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ACTRN12607000161426	O
).	O

When	O
appropriate	O
,	O
data	O
from	O
body	O
weight	O
,	O
caloric	O
intake	O
and	O
compulsive	O
feeding	O
test	O
over	O
time	O
were	O
analyzed	O
by	O
Student	O
'	O
s	O
t	O
-	O
test	O
or	O
three	O
-	O
way	O
repeated	O
measures	O
analysis	O
of	O
variance	O
(	O
ANOVA	O
)	O
with	O
time	O
,	O
diet	O
and	O
sex	O
as	O
factors	O
.	O

These	O
works	O
of	O
literature	O
were	O
obtained	O
from	O
the	O
commonly	O
used	O
medical	O
databases	O
such	O
as	O
PubMed	O
(	O
Medline	O
),	O
AJOL	O
,	O
and	O
Google	O
Scholar	O
;	O
in	O
addition	O
,	O
Cochrane	O
Library	O
was	O
used	O
as	O
source	O
for	O
systematic	O
reviews	O
on	O
the	O
subject	O
matter	O
.	O

IUFD	O
was	O
defined	O
as	O
pregnancy	O
loss	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

Data	O
will	O
also	O
be	O
analysed	O
retrospectively	O
in	O
matched	O
-	O
control	O
sub	O
-	O
studies	O
by	O
determining	O
associations	O
between	O
observed	O
outcomes	O
and	O
variables	O
collected	O
at	O
previous	O
time	O
points	O
.	O

However	O
,	O
its	O
use	O
should	B
be	I
limited	O
to	O
a	O
selected	O
group	O
of	O
patients	O
who	O
are	O
unable	O
to	O
tolerate	O
oral	O
iron	O
and	O
in	O
whom	O
oral	O
iron	O
therapy	O
fails	O
due	O
to	O
noncompliance	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
of	O
associations	O
of	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
with	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
versus	O
paternal	O
intake	O
after	O
pregnancyFree	O
sugar	O
intakep	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAtopy	O
n	O
=	O
3063	O
Maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
04	O
(	O
0	O
.	O
78	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
55	O
)	O
1	O
.	O
33	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
82	O
)	O
1	O
.	O
64	O
(	O
1	O
.	O
14	O
–	O
2	O
.	O
37	O
)	O
1	O
.	O
13	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
23	O
)	O
0	O
.	O
004	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
02	O
(	O
0	O
.	O
77	O
–	O
1	O
.	O
36	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
53	O
)	O
1	O
.	O
31	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
79	O
)	O
1	O
.	O
61	O
(	O
1	O
.	O
11	O
–	O
2	O
.	O
33	O
)	O
1	O
.	O
13	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
22	O
)	O
0	O
.	O
005	O
Paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
12	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
50	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
73	O
)	O
1	O
.	O
36	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
86	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
81	O
–	O
1	O
.	O
68	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
22	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
10	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
30	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
78	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
76	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
34	O
Atopic	O
asthma	O
n	O
=	O
2830	O
Maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
002	O
.	O
11	O
(	O
1	O
.	O
26	O
–	O
3	O
.	O
52	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
66	O
–	O
2	O
.	O
11	O
)	O
2	O
.	O
82	O
(	O
1	O
.	O
60	O
–	O
4	O
.	O
96	O
)	O
2	O
.	O
01	O
(	O
1	O
.	O
01	O
–	O
4	O
.	O
00	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
02	O
–	O
1	O
.	O
36	O
)	O
0	O
.	O
03	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
002	O
.	O
13	O
(	O
1	O
.	O
27	O
–	O
3	O
.	O
57	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
65	O
–	O
2	O
.	O
11	O
)	O
2	O
.	O
80	O
(	O
1	O
.	O
58	O
–	O
4	O
.	O
94	O
)	O
1	O
.	O
96	O
(	O
0	O
.	O
98	O
–	O
3	O
.	O
93	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
01	O
–	O
1	O
.	O
35	O
)	O
0	O
.	O
04	O
Paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
99	O
(	O
0	O
.	O
60	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
26	O
(	O
0	O
.	O
75	O
–	O
2	O
.	O
11	O
)	O
1	O
.	O
47	O
(	O
0	O
.	O
87	O
–	O
2	O
.	O
48	O
)	O
0	O
.	O
92	O
(	O
0	O
.	O
48	O
–	O
1	O
.	O
77	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
90	O
–	O
1	O
.	O
21	O
)	O
0	O
.	O
55	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
96	O
(	O
0	O
.	O
59	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
73	O
–	O
2	O
.	O
06	O
)	O
1	O
.	O
39	O
(	O
0	O
.	O
82	O
–	O
2	O
.	O
35	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
45	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
03	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
19	O
)	O
0	O
.	O
72	O
#:	O
controlling	O
only	O
for	O
previously	O
mentioned	O
potential	O
confounders	O
;¶:	O
mutually	O
adjusting	O
for	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
,	O
in	O
addition	O
to	O
previously	O
mentioned	O
potential	O
confounders	O
When	O
we	O
analysed	O
the	O
association	O
between	O
maternal	O
free	O
sugar	O
intake	O
and	O
the	O
number	O
of	O
positive	O
reactions	O
to	O
cat	O
,	O
grass	O
and	O
dust	O
mite	O
allergens	O
,	O
we	O
observed	O
a	O
stronger	O
association	O
for	O
children	O
with	O
two	O
or	O
more	O
positive	O
reactions	O
(	O
table	O
5	O
).	O

In	O
our	O
patient	O
,	O
the	O
lesion	O
did	O
not	O
recur	O
after	O
the	O
second	O
surgical	O
removal	O
after	O
6	O
months	O
of	O
observation	O
.	O

Samples	O
with	O
concentrations	O
above	O
the	O
standard	O
curve	O
upper	O
limit	O
were	O
diluted	O
further	O
due	O
to	O
their	O
higher	O
cathelicidin	O
concentration	O
.	O

The	O
distinguishing	O
feature	O
of	O
AAOC	O
is	O
that	O
the	O
capillary	O
formation	O
is	O
not	O
lobular	O
as	O
seen	O
in	O
PG	O
but	O
rather	O
a	O
diffuse	O
pattern	O
.	O

2	O
-	O
D	O
gel	O
electrophoresis	O
-	O
based	O
proteomics	O
and	O
mass	O
spectroscopy	O
were	O
used	O
to	O
investigate	O
differential	O
protein	O
expression	O
.	O

The	O
PRISMA	O
statement	O
process	O
was	O
followed	O
[	O
17	O
]	O
as	O
shown	O
inFigure	O
1	O
.	O

All	O
data	O
are	O
expressed	O
as	O
means	O
±	O
standard	O
error	O
of	O
means	O
(	O
SEM	O
).	O

Our	O
results	O
lie	O
within	O
these	O
ranges	O
,	O
but	O
it	O
is	O
difficult	O
to	O
make	O
a	O
comparison	O
,	O
as	O
the	O
variations	O
are	O
very	O
wide	O
and	O
we	O
recorded	O
the	O
use	O
of	O
folic	O
acid	O
throughout	O
pregnancy	O
without	O
focusing	O
on	O
the	O
first	O
trimester	O
.	O

However	O
,	O
there	O
were	O
no	O
petechial	O
lesions	O
,	O
lower	O
limb	O
edema	O
,	O
or	O
focal	O
neurological	O
deficit	O
.	O

Based	O
on	O
the	O
behavioural	O
findings	O
in	O
DVD	O
-	O
deficient	O
rats	O
,	O
there	B
is	I
a	I
case	I
to	O
explore	O
proteomic	O
dysregulation	O
in	O
rats	O
after	O
exposure	O
to	O
drugs	O
known	O
to	O
disrupt	O
dopaminergic	O
and	O
glutaminergic	O
pathways	O
.	O

The	O
most	O
common	O
allergens	O
worldwide	O
include	O
pollen	O
,	O
dust	O
mites	O
,	O
molds	O
,	O
animal	O
dander	O
,	O
cockroach	O
,	O
insect	O
venom	O
,	O
and	O
certain	O
foods	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
number	O
of	O
positive	O
skin	O
prick	O
tests	O
(	O
SPTs	O
)#	O
Free	O
sugar1	O
positive	O
SPT	O
¶≥	O
2	O
positive	O
SPTs	O
+	O
Adjusted	O
OR	O
§(	O
95	O
%	O
CI	O
)	O
p	O
-	O
trendAdjusted	O
OR	O
§(	O
95	O
%	O
CI	O
)	O
p	O
-	O
trendQuintile	O
1	O
1	O
.	O
001	O
.	O
00	O
Quintile	O
2	O
0	O
.	O
87	O
(	O
0	O
.	O
68	O
–	O
1	O
.	O
12	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
57	O
)	O
Quintile	O
3	O
1	O
.	O
07	O
(	O
0	O
.	O
83	O
–	O
1	O
.	O
37	O
)	O
1	O
.	O
14	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
56	O
)	O
Quintile	O
4	O
1	O
.	O
09	O
(	O
0	O
.	O
83	O
–	O
1	O
.	O
43	O
)	O
1	O
.	O
37	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
90	O
)	O
Quintile	O
5	O
1	O
.	O
19	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
73	O
(	O
1	O
.	O
18	O
–	O
2	O
.	O
52	O
)	O
Per	O
quintile	O
1	O
.	O
06	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
121	O
.	O
13	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
23	O
)	O
0	O
.	O
006	O
#:	O
no	O
positive	O
SPT	O
was	O
considered	O
as	O
baseline	O
category	O
(	O
n	O
=	O
4797	O
);¶:	O
n	O
=	O
783	O
;+:	O
n	O
=	O
531	O
;§:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

In	O
a	O
study	O
by	O
Mozafari	O
-	O
Khosravi	O
et	O
al	O
.,	O
300	O
,	O
000	O
and	O
150	O
,	O
000	O
IU	O
vitamin	O
D	O
were	O
administered	O
by	O
injection	O
to	O
the	O
two	O
groups	O
who	O
suffered	O
depression	O
and	O
the	O
third	O
group	O
did	O
not	O
receive	O
vitamin	O
D	O
.	O
High	O
doses	O
of	O
vitamin	O
D	O
were	O
effective	O
in	O
decreasing	O
depression	O
levels	O
after	O
3	O
months	O
[	O
30	O
].	O

However	O
,	O
women	O
attending	O
for	O
their	O
subsequent	O
pregnancies	O
and	O
those	O
at	O
their	O
third	O
or	O
more	O
visits	O
were	O
more	O
tolerant	O
of	O
the	O
services	O
provided	O
at	O
the	O
health	O
centres	O
.	O

There	O
are	O
also	O
data	O
from	O
a	O
total	O
of	O
48	O
women	O
with	O
GDM	O
.	O
46	O
,	O
47To	O
date	O
no	O
randomized	O
controlled	O
studies	O
have	O
been	O
published	O
.	O

Discussion	O
This	O
paper	O
aims	O
to	O
describe	O
the	O
study	O
protocol	O
of	O
a	O
community	O
based	O
randomised	O
controlled	O
trial	O
evaluating	O
the	O
impact	O
of	O
the	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
early	O
in	O
pregnancy	O
on	O
the	O
risk	O
of	O
neonatal	O
mortality	O
.	O

Interpretations	O
Quarterly	O
bolus	O
doses	O
of	O
oral	O
vitamin	O
D3supplementation	O
to	O
infants	O
are	O
not	O
an	O
effective	O
intervention	O
to	O
reduce	O
the	O
incidence	O
of	O
pneumonia	O
in	O
infants	O
in	O
this	O
setting	O
.	O

Such	O
overviews	O
are	O
,	O
however	O
,	O
rarely	O
included	O
in	O
the	O
relevant	O
literature	O
associated	O
with	O
extended	O
lifetime	O
studies	O
.	O

When	O
dealing	O
with	O
MTC	O
,	O
we	O
should	O
always	O
bear	O
in	O
mind	O
that	O
these	O
patients	O
may	O
be	O
the	O
index	O
-	O
case	O
for	O
one	O
of	O
the	O
familial	O
forms	O
of	O
the	O
disease	O
:	O
presymptomatic	O
screening	O
of	O
relatives	O
of	O
MTC	O
patients	O
enables	O
early	O
diagnosis	O
of	O
this	O
malignancy	O
.	O

Anaphylaxis	O
associated	O
with	O
folic	O
acid	O
:	O
domestic	O
case	O
review	O
Background	O
Synthetic	O
folic	O
acid	O
has	O
been	O
shown	O
to	O
cause	O
serious	O
,	O
potentially	O
life	O
-	O
threatening	O
IgE	O
mediated	O
anaphylaxis	O
[	O
1	O
-	O
3	O
].	O

Collectively	O
,	O
these	O
data	O
suggest	O
that	O
sleep	O
disturbances	O
may	O
augment	O
pro	O
-	O
inflammatory	O
responses	O
that	O
may	O
then	O
contribute	O
to	O
altered	O
glucose	O
metabolism	O
.	O

The	O
MS	O
generally	O
increases	O
with	O
slaughter	O
age	O
in	O
Korean	O
cattle	O
.	O

2	O
.	O
2	O
.	O
4	O
.	O

NcDNA	O
is	O
transcribed	O
into	O
ncRNAs	O
,	O
which	O
play	O
major	O
roles	O
in	O
regulating	O
gene	O
expression	O
.	O

This	O
stage	O
appeared	O
as	O
a	O
phase	O
of	O
recovery	O
of	O
the	O
activity	O
of	O
genes	O
.	O

Therefore	O
,	O
we	O
hypothesized	O
that	O
the	O
effects	O
of	O
HV	O
gestational	O
diets	O
on	O
obesogenic	O
phenotype	O
in	O
the	O
offspring	O
arise	O
as	O
a	O
consequence	O
of	O
altered	O
hypothalamic	O
control	O
of	O
feeding	O
behavior	O
and	O
these	O
effects	O
could	O
be	O
prevented	O
by	O
feeding	O
them	O
HV	O
or	O
HFol	O
diets	O
.	O

A	O
similar	O
pattern	O
was	O
demonstrated	O
in	O
children	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
.	O

Understanding	O
the	O
factors	O
affecting	O
IMF	O
deposition	O
and	O
the	O
mechanisms	O
responsible	O
for	O
its	O
deposition	O
is	O
important	O
when	O
manipulating	O
IMF	O
deposition	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Drugs	O
All	O
nonprescription	O
drugs	O
(	O
eg	O
,	O
antiacids	O
)	O
should	B
be	I
avoided	O
during	O
pregnancy	O
and	O
lactation	O
unless	O
recommended	O
by	O
a	O
physician	O
;	O
patients	O
should	B
avoid	O
intake	O
of	O
any	O
medication	O
including	O
over	O
-	O
the	O
-	O
counter	O
substances	O
without	O
consulting	O
their	O
physicians	O
.	O

Statistical	O
analyses	O
compared	O
cathelicidin	O
concentrations	O
with	O
concentrations	O
of	O
25	O
(	O
OH	O
)	O
D	O
at	O
various	O
time	O
points	O
(	O
maternal	O
levels	O
throughout	O
pregnancy	O
,	O
at	O
birth	O
,	O
and	O
child	O
’	O
s	O
current	O
level	O
);	O
and	O
with	O
race	O
/	O
ethnicity	O
,	O
age	O
,	O
gender	O
,	O
BMI	O
,	O
percent	O
fat	O
,	O
and	O
frequency	O
of	O
infections	O
using	O
Student	O
’	O
s	O
t	O
-	O
test	O
,	O
χ2	O
,	O
Wilcoxon	O
ranked	O
-	O
sum	O
analysis	O
,	O
and	O
multivariate	O
regression	O
.	O

Robinson	O
et	O
al	O
.	O

To	O
avoid	O
litter	O
effects	O
,	O
samples	O
from	O
6	O
to	O
15	O
liters	O
per	O
perinatal	O
group	O
were	O
used	O
in	O
all	O
determinations	O
.	O

Among	O
the	O
SGA	O
cases	O
defined	O
by	O
length	O
only	O
,	O
most	O
were	O
close	O
to	O
also	O
meeting	O
the	O
SGA	O
definition	O
for	O
birth	O
weight	O
.	O

Images	O
PubMed	O
Central	O
:	O

White	O
adipocytes	O
are	O
composed	O
of	O
a	O
large	O
single	O
,	O
spherical	O
lipid	O
vacuole	O
and	O
a	O
peripherally	O
located	O
nucleus	O
,	O
together	O
with	O
few	O
mitochondria	O
.	O

We	O
have	O
previously	O
shown	O
that	O
higher	O
vitamin	O
D	O
status	O
in	O
late	O
pregnancy	O
and	O
larger	O
increase	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
is	O
associated	O
with	O
lower	O
risk	O
of	O
preeclampsia	O
[	O
3	O
].	O

(	O
2011	O
)*/†	O
Peng	O
et	O
al	O
.	O

Maternal	O
Disease	O
In	O
addition	O
to	O
environmental	O
factors	O
,	O
infection	O
and	O
disease	O
may	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
autism	O
.	O

Evidence	O
from	O
more	O
contemporary	O
populations	O
is	O
that	O
the	O
likelihood	O
of	O
subsequent	O
diabetes	O
may	O
be	O
substantially	O
higher	O
.	O
22Women	O
who	O
have	O
had	O
GDM	O
account	O
for	O
a	O
significant	O
burden	O
of	O
the	O
population	O
prevalence	O
of	O
diabetes	O
.	O

To	O
get	O
access	O
to	O
the	O
workers	O
,	O
the	O
researchers	O
had	O
to	O
strike	O
a	O
Faustian	O
bargain	O
with	O
the	O
mining	O
companies	O
:	O
They	O
could	O
not	O
inform	O
the	O
miners	O
of	O
the	O
potential	O
health	O
hazards	O
of	O
their	O
work	O
.	O
2Seeing	O
it	O
as	O
the	O
only	O
way	O
to	O
convince	O
government	O
regulators	O
to	O
improve	O
safety	O
in	O
the	O
mines	O
,	O
the	O
researchers	O
accepted	O
.	O
16By	O
1965	O
,	O
the	O
investigators	O
reported	O
an	O
association	O
between	O
cumulative	O
exposure	O
to	O
uranium	O
and	O
lung	O
cancer	O
among	O
white	O
miners	O
and	O
had	O
definitively	O
identified	O
the	O
cause	O
as	O
radiation	O
exposure	O
.	O
17	O
In	O
1984	O
another	O
team	O
published	O
results	O
of	O
a	O
case	O
–	O
control	O
study	O
that	O
further	O
implicated	O
uranium	O
mining	O
as	O
a	O
cause	O
of	O
lung	O
cancer	O
in	O
Navajo	O
men	O
.	O

In	O
the	O
analyses	O
stratified	O
to	O
infants	O
born	O
vaginally	O
and	O
adjusted	O
for	O
other	O
potential	O
confounders	O
,	O
maternal	O
fruit	O
intake	O
was	O
associated	O
with	O
infant	O
gut	O
microbial	O
community	O
structure	O
(	O
PERMANOVA	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
effect	O
is	O
characterised	O
by	O
a	O
programming	O
of	O
the	O
genome	O
that	O
leads	O
to	O
different	O
responsiveness	O
and	O
adaptability	O
of	O
the	O
gene	O
expression	O
machinery	O
to	O
chronic	O
and	O
acute	O
environmental	O
stimuli	O
,	O
i	O
.	O
e	O
.	O

Although	O
the	O
importance	O
of	O
IFA	O
supplements	O
to	O
prevent	O
maternal	O
anaemia	O
and	O
mortality	O
is	O
widely	O
accepted	O
,	O
most	O
antenatal	O
IFA	O
supplements	O
distribution	O
programs	O
are	O
of	O
low	O
priority	O
.	O

After	O
delivery	O
,	O
thyroxine	O
dose	O
can	O
be	O
gradually	O
reduced	O
to	O
pre	O
-	O
pregnancy	O
levels	O
,	O
while	O
TSH	O
levels	O
should	O
be	O
constantly	O
monitored1015	O
.	O

(	O
2010	O
)¶/*/†	O
Lifestyle	O
factors	O
Alcohol	O
(	O
ethanol	O
)	O
Mouse	O
RatOral	O
(	O
water	O
)	O
(	O
10	O
g	O
/	O
kg	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
5	O
.	O
25	O
g	O
/	O
kg	O
/	O
d	O
or	O
56	O
%	O
(	O
v	O
/	O
v	O
)/	O
d	O
)	O
Injection	O
(	O
ip	O
)	O
(	O
2	O
.	O
9	O
g	O
/	O
kg	O
+	O
1	O
.	O
45	O
g	O
/	O
kg	O
2	O
h	O
later	O
In	O
utero	O
Neonatal	O
Adolescence	O
/	O
early	O
adulthood	O
In	O
utero	O
Neonatal	O
Childhood	O
Adolescence	O
Adulthood	O
F0	O
-	O
F1generationsNeurological	O
,	O
behavioral	O
,	O
cardiac	O
and	O
mesenchymal	O
stem	O
cell	O
abnormalitiesHistone	O
modification	O
miRNAsIgnacio	O
et	O
al	O
.	O

The	O
mean	O
maternal	O
serum	O
visfatin	O
level	O
during	O
pregnancy	O
significantly	O
increased	O
with	O
increasing	O
gestational	O
age	O
in	O
parallel	O
to	O
weight	O
gain	O
and	O
insulin	O
resistance	O
in	O
both	O
groups	O
separately	O
.	O

The	O
ascertainment	O
of	O
study	O
outcomes	O
was	O
robust	O
,	O
and	O
done	O
clinically	O
through	O
masked	O
experienced	O
and	O
retrained	O
paediatricians	O
with	O
Integrated	O
Management	O
of	O
Childhood	O
Illnesses	O
clinical	O
definitions	O
of	O
pneumonia	O
applied	O
in	O
other	O
trials18and	O
radiologically	O
through	O
the	O
interpretation	O
of	O
chest	O
radiographs	O
by	O
masked	O
,	O
experienced	O
,	O
and	O
external	O
readers	O
by	O
use	O
of	O
WHO	O
standards	O
.	O

Infant	O
skin	O
prick	O
tests	O
are	O
performed	O
at	O
phases	O
7	O
and	O
8	O
by	O
a	O
medical	O
doctor	O
according	O
to	O
the	O
procedure	O
described	O
in	O
the	O
Allergy	O
Society	O
of	O
South	O
Africa	O
’	O
s	O
position	O
statement	O
on	O
skin	O
prick	O
testing	O
[	O
49	O
].	O

They	O
reported	O
that	O
the	O
average	O
breed	O
type	O
list	O
included	O
purebred	O
or	O
crossbred	O
Angus	O
,	O
Brahman	O
,	O
Simmental	O
,	O
Charolais	O
,	O
Hereford	O
,	O
Jersey	O
,	O
Korean	O
Brown	O
cattle	O
,	O
Maine	O
Anjou	O
,	O
Pinzgauer	O
,	O
Sahiwal	O
,	O
Salers	O
,	O
and	O
South	O
Devon	O
with	O
estimates	O
MS	O
heritability	O
of	O
0	O
.	O
37	O
(	O
range	O
0	O
.	O
30	O
to	O
0	O
.	O
57	O
).	O

This	O
interpretation	O
also	O
agrees	O
with	O
the	O
down	O
-	O
regulation	O
of	O
the	O
endocannabinoid	O
metabolism	O
in	O
peripheral	O
tissues	O
.	O

There	O
was	O
an	O
overall	O
significant	O
relationship	O
between	O
AluYb8	O
methylation	O
extent	O
and	O
bioinformatically	O
derived	O
CpG	O
class	O
methylation	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
but	O
not	O
between	O
LINE	O
-	O
1	O
methylation	O
and	O
bioinformatically	O
derived	O
CpG	O
class	O
methylation	O
.	O

The	O
acceptance	O
capacity	O
of	O
methyl	O
groups	O
in	O
the	O
whole	O
genome	O
is	O
known	O
to	O
be	O
inversely	O
related	O
to	O
the	O
exogenous3H	O
-	O
methyl	O
incorporation	O
.	O

To	O
ensure	O
the	O
absence	O
of	O
a	O
DNA	O
contamination	O
within	O
the	O
isolated	O
RNA	O
a	O
PCR	O
amplification	O
with	O
the	O
porcine	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
)	O
gene	O
was	O
done	O
(	O
Forward	O
primer	O
:	O
aagcagggatgatgttctgg	O
;	O
Reverse	O
primer	O
:	O
atgcctcctgtaccaccaac	O
).	O

The	O
numbers	O
at	O
the	O
horizontal	O
arrows	O
indicate	O
the	O
quantity	O
of	O
probe	O
-	O
sets	O
significantly	O
regulated	O
between	O
the	O
adjacent	O
ontogenetic	O
stages	O
in	O
either	O
AP	O
or	O
LP	O
offspring	O
,	O
whereas	O
the	O
numbers	O
in	O
the	O
intersections	O
indicate	O
the	O
quantity	O
of	O
probe	O
-	O
sets	O
commonly	O
regulated	O
between	O
stages	O
in	O
AP	O
and	O
LP	O
offspring	O
.	O

The	O
odds	O
of	O
having	O
a	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
lower	O
than	O
20	O
ng	O
/	O
ml	O
(	O
vitamin	O
D	O
deficiency	O
)	O
versus	O
a	O
non	O
deficient	O
vitamin	O
D	O
status	O
were	O
estimated	O
through	O
multiple	O
logistic	O
regressions	O
while	O
entering	O
the	O
following	O
variables	O
as	O
predictors	O
in	O
the	O
model	O
:	O
season	O
,	O
age	O
,	O
trimester	O
of	O
pregnancy	O
,	O
region	O
,	O
BMI	O
,	O
smoking	O
behaviour	O
,	O
alcohol	O
consumption	O
,	O
use	O
of	O
vitamin	O
D	O
-	O
containing	O
food	O
supplements	O
,	O
fish	O
consumption	O
,	O
milk	O
and	O
dairy	O
product	O
consumption	O
,	O
education	O
level	O
,	O
ethnicity	O
,	O
parity	O
,	O
exposure	O
to	O
sunlight	O
during	O
weekdays	O
,	O
exposure	O
to	O
sunlight	O
during	O
weekend	O
days	O
,	O
use	O
of	O
sunscreen	O
lotion	O
,	O
use	O
of	O
solarium	O
,	O
shadow	O
or	O
sun	O
preference	O
and	O
sometimes	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
(	O
yes	O
/	O
no	O
question	O
).	O

Then	O
,	O
41	O
eligible	O
pregnant	O
women	O
in	O
their	O
first	O
trimester	O
were	O
selected	O
through	O
convenience	O
sampling	O
.	O

found	O
that	O
a	O
prolonged	O
labor	O
(	O
greater	O
than	O
18	O
–	O
24	O
hours	O
)	O
resulted	O
in	O
an	O
increased	O
risk	O
for	O
autism	O
[	O
18	O
].	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

The	O
CB1	O
receptor	O
inverse	O
agonist	O
AM251	O
was	O
able	O
to	O
decrease	O
the	O
motivation	O
to	O
obtain	O
highly	O
palatable	O
food	O
in	O
a	O
free	O
choice	O
test	O
(	O
Mathes	O
et	O
al	O
.,	O
2008	O
;	O
Droste	O
et	O
al	O
.,	O
2010	O
;	O
Deshmukh	O
and	O
Sharma	O
,	O
2012	O
).	O

The	O
most	O
discussed	O
health	O
topic	O
was	O
hygiene	O
and	O
nutrition	O
in	O
pregnancy	O
like	O
in	O
other	O
studies	O
[	O
4	O
,	O
22	O
].	O

PubMed	O
Central	O
:	O

White	O
children	O
had	O
a	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
35	O
.	O
1	O
ng	O
/	O
mL	O
(	O
87	O
.	O
8	O
nmol	O
/	O
L	O
)	O
at	O
the	O
follow	O
-	O
up	O
visit	O
,	O
which	O
was	O
also	O
found	O
to	O
be	O
significantly	O
higher	O
than	O
both	O
Black	O
and	O
Hispanic	O
children	O
with	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
of	O
22	O
.	O
5	O
ng	O
/	O
mL	O
(	O
56	O
.	O
3	O
nmol	O
/	O
L	O
)	O
and	O
25	O
.	O
4	O
ng	O
/	O
mL	O
(	O
63	O
.	O
5	O
nmol	O
/	O
L	O
),	O
respectively	O
(	O
p	O
≤	O
0	O
.	O
0001	O
and	O
≤	O
0	O
.	O
0001	O
,	O
respectively	O
).	O

Familial	O
cases	O
account	O
for	O
about	O
30	O
%	O
of	O
MTCs	O
.	O

Results	O
Figure	O
1shows	O
the	O
trial	O
profile	O
.	O

We	O
will	O
compare	O
the	O
causes	O
of	O
death	O
by	O
sex	O
of	O
newborn	O
,	O
the	O
time	O
-	O
period	O
of	O
death	O
,	O
and	O
treatment	O
arms	O
(	O
intervention	O
Vs	O
control	O
).	O

This	O
study	O
is	O
critical	O
because	O
it	O
will	O
determine	O
if	O
antenatal	O
IFA	O
supplements	O
commenced	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
,	O
rather	O
than	O
later	O
,	O
will	O
significantly	O
reduce	O
neonatal	O
deaths	O
in	O
the	O
first	O
month	O
of	O
life	O
,	O
and	O
if	O
this	O
approach	O
is	O
cost	O
-	O
effective	O
.	O

With	O
respect	O
to	O
the	O
nucleus	O
accumbens	O
,	O
calcium	O
-	O
binding	O
proteins	O
such	O
as	O
calbindin	O
are	O
often	O
used	O
to	O
demarcate	O
discrete	O
neuroanatomical	O
boundaries	O
,	O
inferring	O
that	O
these	O
proteins	O
confer	O
selective	O
functional	O
properties	O
to	O
these	O
cells	O
[	O
35	O
].	O

Thus	O
,	O
the	O
dietary	O
vitamin	O
C	O
requirement	O
for	O
beef	O
cattle	O
is	O
not	O
specified	O
in	O
the	O
NRC	O
[	O
146	O
].	O

Further	B
questions	I
arise	O
with	O
respect	O
to	O
the	O
previous	O
treatment	O
trial	O
in	O
the	O
same	O
region	O
of	O
Kabul	O
,	O
which	O
showed	O
that	O
a	O
single	O
high	O
-	O
dose	O
supplementation	O
with	O
100	O
000	O
IU	O
vitamin	O
D3given	O
orally	O
to	O
young	O
children	O
,	O
along	O
with	O
antibiotic	O
treatment	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
reduced	O
repeat	O
episodes	O
of	O
pneumonia	O
in	O
the	O
subsequent	O
3	O
months	O
.	O
3The	O
inconsistent	O
results	O
could	O
be	O
related	O
to	O
the	O
evidence	O
that	O
stimulation	O
of	O
Toll	O
-	O
like	O
receptors	O
on	O
macrophages	O
and	O
monocytes	O
by	O
bacterial	O
antigens	O
is	O
important	O
in	O
up	O
-	O
regulation	O
of	O
CYP27B1	O
and	O
the	O
vitamin	O
D	O
receptor	O
,	O
5which	O
are	O
crucial	O
in	O
production	O
of	O
cathelicidins	O
in	O
vitamin	O
-	O
D	O
-	O
depleted	O
individuals	O
.	O

Recent	O
work	O
has	O
demonstrated	O
that	O
placental	O
genetic	O
and	O
epigenetic	O
profiles	O
may	O
possibly	O
serve	O
as	O
markers	O
(	O
Filiberto	O
et	O
al	O
.	O

The	O
result	O
was	O
that	O
196	O
participants	O
will	O
be	O
required	O
.	O

Among	O
pregnant	O
women	O
,	O
IDA	O
has	O
been	O
associated	O
with	O
increased	O
risks	O
of	O
low	O
birth	O
weight	O
,	O
prematurity	O
,	O
and	O
maternal	O
morbidity	O
[	O
11	O
].	O

The	O
day	O
before	O
the	O
test	O
,	O
all	O
animals	O
were	O
food	O
-	O
deprived	O
for	O
20	O
h	O
.	O
Then	O
AM251	O
or	O
vehicle	O
was	O
intraperitoneally	O
administered	O
(	O
3	O
mg	O
/	O
mL	O
).	O

The	O
hypothalamus	O
is	O
able	O
to	O
cross	O
-	O
talk	O
to	O
other	O
metabolically	O
relevant	O
tissues	O
such	O
as	O
liver	O
and	O
adipose	O
tissue	O
through	O
sympathetic	O
circuits	O
and	O
circulating	O
signals	O
(	O
leptin	O
,	O
insulin	O
,	O
CCK	O
,	O
neurotrophins	O
,	O
IL	O
-	O
6	O
)	O
by	O
the	O
homeostatic	O
regulation	O
of	O
the	O
endocannabinoid	O
signaling	O
system	O
(	O
Das	O
,	O
2010	O
;	O
Maccarrone	O
et	O
al	O
.,	O
2014	O
;	O
Seoane	O
-	O
Collazo	O
et	O
al	O
.,	O
2015	O
).	O

2009	O
),	O
including	O
the	O
examination	O
of	O
repetitive	O
elements	O
as	O
surrogate	O
markers	O
of	O
global	O
methylation	O
(	O
Choi	O
et	O
al	O
.	O

Very	O
few	O
women	O
(	O
6	O
%)	O
enrolled	O
for	O
ANC	O
during	O
their	O
first	O
trimester	O
of	O
pregnancy	O
,	O
the	O
median	O
gestational	O
age	O
was	O
28	O
weeks	O
(	O
range	O
15	O
to	O
41	O
weeks	O
).	O

(	O
2010	O
)¶/†	O
Melkamu	O
et	O
al	O
.	O

Statistical	O
significance	O
was	O
set	O
at	O
p	O
<	O
0	O
.	O
05	O
(	O
two	O
-	O
sided	O
)	O
with	O
no	O
adjustment	O
for	O
multiple	O
comparisons	O
,	O
and	O
all	O
analyses	O
followed	O
a	O
pre	O
-	O
specified	O
plan	O
.	O

However	O
,	O
there	O
was	O
no	O
difference	O
in	O
sperm	O
tail	O
DNA	O
fragmentation	O
,	O
tail	O
length	O
,	O
or	O
motility	O
(	O
p	O
>	O
0	O
.	O
05	O
).	O

This	O
should	B
be	I
solved	O
in	O
the	O
future	B
by	O
the	O
identification	O
of	O
selective	O
human	O
β3	O
agonists	O
(	O
Mund	O
and	O
Frishman	O
,	O
2013	O
;	O
Bordicchia	O
et	O
al	O
.,	O
2014	O
).	O

Behavioral	O
and	O
Psychosocial	O
Factors	O
during	O
Pregnancy	O
Self	O
-	O
reported	O
measures	O
of	O
dietary	O
intake	O
and	O
exercise	O
expenditure	O
were	O
obtained	O
by	O
trained	O
assessors	O
at	O
study	O
entry	O
and	O
30	O
-	O
weeks	O
gestation	O
.	O

In	O
these	O
studies	O
,	O
the	O
normally	O
weaned	O
steers	O
remained	O
on	O
pasture	O
during	O
nursing	O
and	O
weaning	O
at	O
231	O
d	O
(	O
study	O
1	O
)	O
and	O
213	O
d	O
of	O
age	O
(	O
study	O
2	O
),	O
respectively	O
,	O
and	O
they	O
were	O
then	O
placed	O
on	O
a	O
finishing	O
diet	O
.	O

The	O
total	O
mean	O
was	O
19	O
.	O
4	O
±	O
3	O
.	O
9	O
ng	O
/	O
mL	O
[	O
56	O
].	O

The	O
influence	O
of	O
the	O
educational	O
level	O
of	O
respondents	O
is	O
predominant	O
here	O
as	O
it	O
is	O
noticed	O
that	O
those	O
at	O
a	O
high	O
educational	O
level	O
are	O
more	O
likely	O
to	O
be	O
critical	O
about	O
care	O
received	O
and	O
defer	O
a	O
positive	O
satisfaction	O
.	O

And	O
in	O
order	O
to	O
determine	O
changes	O
over	O
time	O
,	O
the	O
repeated	O
measures	O
analysis	O
was	O
used	O
.	O

Lesions	O
of	O
testis	O
and	O
epididymis	O
associated	O
with	O
prenatal	O
diethylstilbestrol	O
exposure	O
.	O

However	O
,	O
this	O
difference	O
was	O
not	O
observed	O
in	O
Alentejana	O
bulls	O
,	O
indicating	O
a	O
breed	O
difference	O
in	O
IMF	O
content	O
in	O
response	O
to	O
the	O
roughage	O
-	O
to	O
-	O
concentrate	O
ratio	O
.	O

©	O
2009	O
Dove	O
Medical	O
Press	O
Limited	O
.	O

In	O
summary	O
,	O
some	O
investigations	B
have	O
shown	O
an	O
association	O
between	O
length	O
of	O
labor	O
and	O
autism	O
,	O
but	O
findings	O
have	O
been	O
inconsistent	O
owing	O
to	O
differences	O
in	O
sampling	O
and	O
methods	O
.	O

We	O
assessed	O
violation	O
of	O
the	O
proportionality	O
assumption	O
with	O
Schoenfeld	O
residuals	O
.	O

In	O
order	O
not	O
to	O
deprive	O
the	O
participants	O
from	O
antenatal	O
supplements	O
all	O
participating	O
mothers	O
were	O
allowed	O
to	O
use	O
prescribed	O
supplementation	O
outside	O
this	O
study	O
’	O
s	O
protocol	O
.	O

During	O
pregnancy	O
.	O

Ratings	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
The	O
follow	O
-	O
up	O
questionnaire	O
contained	O
20	O
questions	O
on	O
psychotic	O
-	O
like	O
symptoms	O
,	O
(	O
Additional	O
file1	O
),	O
constituting	O
the	O
positive	O
symptoms	O
of	O
the	O
CAPE	O
(	O
Community	O
Assessment	O
of	O
Psychic	O
Experiences	O
)	O
questionnaire	O
,	O
a	O
modified	O
version	O
of	O
the	O
Peters	O
et	O
al	O
.	O

However	O
,	O
feed	O
efficiency	O
decreases	O
as	O
animals	O
age	O
due	O
to	O
a	O
decrease	O
in	O
the	O
rate	O
of	O
muscle	O
growth	O
[	O
70	O
].	O

Conversely	O
,	O
the	O
two	O
studies	O
by	O
Oken	O
et	O
al	O
.	O

Hypocalcemia	O
is	O
common	O
in	O
preterm	O
infants	O
,	O
infants	O
born	O
to	O
gestational	O
diabetic	O
mothers	O
and	O
infants	O
on	O
cow	O
'	O
s	O
milk	O
.	O

However	O
,	O
the	O
number	O
of	O
differentially	O
expressed	O
probe	O
-	O
sets	O
increased	O
extensively	O
at	O
adult	O
stage	O
.	O

The	O
intestinal	O
mucosa	O
is	O
renewed	O
every	O
5	O
to	O
6	O
days	O
and	O
will	O
absorb	O
as	O
much	O
iron	O
as	O
necessary	O
to	O
maintain	O
iron	O
balance	O
;	O
however	O
,	O
mature	O
cells	O
will	O
stop	O
absorbing	O
iron	O
entirely	O
if	O
they	O
are	O
flooded	O
with	O
it	O
,	O
even	O
if	O
there	O
is	O
an	O
iron	O
deficit	O
.	O

The	O
activities	O
carried	O
out	O
in	O
the	O
health	O
centres	O
were	O
similar	O
in	O
the	O
institutions	O
involved	O
in	O
the	O
study	O
.	O

In	O
final	O
adjusted	O
model	O
,	O
women	O
with	O
a	O
higher	O
adherence	O
to	O
western	O
dietary	O
pattern	O
had	O
4	O
.	O
88	O
times	O
larger	O
odds	O
for	O
having	O
an	O
infant	O
with	O
low	O
birth	O
head	O
circumference	O
than	O
those	O
with	O
a	O
lower	O
adherence	O
level	O
(	O
OR	O
:	O
4	O
.	O
88	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
79	O
-	O
30	O
.	O
19	O
P	O
=	O
0	O
.	O
35	O
).	O

Although	O
peripheral	O
ossifying	O
fibroma	O
exhibits	O
features	O
of	O
vascular	O
proliferation	O
and	O
ossification	O
,	O
it	O
mostly	O
contains	O
fibroblasts	O
and	O
stroma	O
.	O

Urinalysis	O
was	O
significant	O
for	O
a	O
specific	O
gravity	O
of	O
1	O
.	O
008	O
,	O
red	O
blood	O
cells	O
8	O
–	O
10	O
/	O
high	O
-	O
power	O
field	O
,	O
and	O
30	O
mg	O
/	O
dL	O
of	O
protein	O
.	O

Although	O
the	O
precise	O
mechanism	O
is	O
unclear	O
,	O
it	O
is	O
thought	O
that	O
epigenetic	O
modifications	O
(	O
study	O
of	O
heritable	O
changes	O
in	O
gene	O
activity	O
that	O
are	O
not	O
caused	O
by	O
changes	O
in	O
the	O
DNA	O
sequence	O
)	O
play	O
a	O
role	O
in	O
both	O
neural	O
tube	O
defects	O
and	O
decreased	O
fertility	O
of	O
men	O
with	O
a	O
folate	O
deficiency	O
[	O
8	O
].	O

These	O
studies	O
do	O
not	O
necessarily	O
rule	O
out	O
an	O
epigenetic	O
mechanism	O
of	O
toxicity	O
per	O
se	O
,	O
but	O
they	O
do	O
exclude	O
a	O
link	O
between	O
the	O
specific	O
epigenetic	O
,	O
exposure	O
and	O
/	O
or	O
adverse	O
endpoints	O
/	O
markers	O
investigated	O
.	O

In	O
the	O
core	O
region	O
of	O
the	O
nucleus	O
accumbens	O
,	O
neurons	O
have	O
dense	O
spines	O
,	O
which	O
may	O
reflect	O
the	O
degree	O
of	O
synaptic	O
plasticity	O
required	O
for	O
the	O
integrative	O
function	O
of	O
cells	O
in	O
this	O
region	O
[	O
36	O
].	O

At	O
the	O
beginning	O
of	O
the	O
test	O
,	O
the	O
rats	O
were	O
individually	O
housed	O
and	O
exposed	O
to	O
the	O
two	O
types	O
of	O
food	O
(	O
chocolate	O
and	O
standard	O
chow	O
)	O
for	O
4	O
days	O
.	O

The	O
results	O
were	O
not	O
meaningfully	O
affected	O
by	O
additional	O
adjustment	O
for	O
tobacco	O
use	O
or	O
vitamin	O
D	O
supplementation	O
or	O
by	O
excluding	O
cases	O
of	O
preeclampsia	O
(	O
data	O
not	O
shown	O
).	O

Introduction	O
Risk	O
of	O
obesity	O
is	O
shaped	O
,	O
in	O
large	O
part	O
,	O
by	O
early	O
life	O
events	O
starting	O
during	O
gestation	O
.	O

The	O
final	O
version	O
of	O
the	O
database	O
will	O
be	O
stored	O
under	O
protected	O
zipped	O
files	O
.	O

